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Abstract 
 
Methylation of histone 3 (H3) at lysine 36 (K36) has been implicated in several 
biological processes, such as DNA replication, DNA repair, and transcription. To 
date, at least eight distinct mammalian enzymes have been described to methylate 
H3K36 in vitro and/or in vivo. In this work, Set2, Nsd1, and Nsd3 Venus tagged 
proteins were successfully expressed in mouse embryonic stem cells and, then, 
analyzed by confocal microscopy, mass spectrometry (MS), and chromatin 
immunoprecipitation sequencing (ChIP-seq). MS analysis revealed that Setd2, 
Nsd1, and Nsd3 do not associate in protein complexes with each other. Setd2 was 
associated with RNA polymerase II subunits and two transcription elongation 
factors (Supt5 and Supt6), whereas Nsd1 associated with the transcription factor 
Zfx. In contrast, Nsd3 interacted with multiple protein complexes including Kdm1b 
and Brd4 complexes. Interestingly, Nsd1 and Zfx seem to be bound to chromatin 
during cell division. ChIP-seq analysis of the H3K36 methyltransferases showed 
different binding profiles at transcribed genes: Nsd1 binds near the transcription 
start site (TSS), Setd2 loading starts near the TSS and spreads along the gene 
body, while, Nsd3 is preferentially enriched at the 5’ and 3’ gene regions. 
Sequential deletion of PWWP and zinger-finger like domains was achieved to study 
any possible changes in Nsd1 and Nsd3 function. Deletion of either PHD1-4 or 
PHD5/C5HCH domains decreased Nsd1 recruitment to chromatin. Particularly, the 
PHD5/C5HCH were identified as the protein-protein interface for Zfx interaction. In 
agreement, Zfx knockdown also decreased Nsd1 deposition at the Oct4 and Tcl1 
promoter regions. Furthermore, Nsd1 depletion reduced bulk histone H3K36me2 
and histone H3K36me3 loading at the coding regions of Oct4, Rif1, Brd2, and 
Ccnd1. In addition, Nsd1 knockdown led to an increased Zfx deposition at 
promoters. Our findings suggest Zfx recruits Nsd1 to its target loci, whereas Nsd1 
regulates Zfx chromatin release and further contributes to transcription regulation 
through its H3K36 dimethylase activity. On the other hand, loss of Nsd3’s 
PHD5/C5HCH or PWWP domains decreased Nsd3 binding to DNA. In addition, we 
demonstrate that Nsd3 is recruited to target genes in a Brd4-dependent manner. 
Herein, we provided further insights on how H3K36 methyltransferases are 
regulated, and how they contribute to changes in the epigenetic landscape in 
mouse embryonic stem cells.  
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1. Introduction 
1.1. Epigenetics 
For the past several decades, genetic research has focused on DNA as the 
heritable molecule that carries information about the phenotype from 
progenitors to their offspring. DNA mutations have been linked to several 
phenotypes and diseases in humans, but for most cases the situation is far 
more complex. Moreover, the development of organisms requires a tight 
transcriptional network regulation to correctly express the genetic information 
encoded in their genomes. Epigenetic regulatory elements play a critical role in 
the regulation of all DNA-based processes, such as DNA replication, DNA 
repair, and transcription. 
The term ‘‘epigenetics’’ was originally proposed by Conrad Hal Waddington, 
who described it as “the branch of biology which studies the causal interactions 
between genes and their products, which brings the phenotype into being” 
(Waddington, 2012). Currently, epigenetics is most commonly used to describe 
stable changes in gene expression which are not directly attributed to DNA 
sequence (Goldberg et al., 2007). 
Epigenetic events are crucial for development and cell type differentiation. In 
addition, they can also arise in mature organisms, either by random or 
environmental factors (Feinberg, 2007). More recently, there is increasing 
evidence that epigenetic marks can also be transmitted across mitosis and 
meiosis in both mammals and plants, causing phenotypic consequences from 
parent to offspring via the gametes (Daxinger and Whitelaw, 2012). 
The genetic material of eukaryotic cells is packaged into the nucleus in a 
complex of DNA and proteins, called chromatin. Epigenetic mechanisms can 
modulate the accessibility of chromatin structure to the transcriptional 
machinery. 
 
1.2. Chromatin structure 
The eukaryotic genome possesses several meters of DNA, which has to be 
packaged in a limited space within the nucleus of our cells and yet remain 
functional and accessible to transcriptional machinery. Therefore, DNA is 
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packaged into chromatin with histone and non-histone proteins (Fig. 1). The 
basic unit of chromatin is the nucleosome, which consists of 145-147 base pairs 
(bp) of DNA wrapped around a core complex of four dimeric histone proteins: 
H2A, H2B, H3, and H4. The four core histones share a similar structure, with a 
globular and hydrophobic internal region that forms the histone fold, and a 
flexible N‐terminal region that protrudes from the nucleosome core (Luger et al., 
1997). 
Throughout the genome, nucleosomes assemble on an 11 nm filament array 
known as “beads on a string”. These 11 nm filaments further interact among 
themselves to compact the nucleosomal array into a structure known as 30 nm 
fiber. Moreover, linker histone proteins, like H1, bind to DNA between each 
adjacent nucleosome in order to stabilize and help compact the 30 nm fiber into 
secure chromatin fibers that will form the fully packaged metaphase 
chromosomes. 
 
 
Figure 1. Chromatin structure and organization. Chromatin is composed of DNA engaged with 
histone proteins. The basic unit of chromatin is the nucleosome, which can be organized into 
higher order structures, like the 11 nm and the 30 nm filaments. The level of packaging can have 
profound consequences on all DNA-mediated processes including gene regulation. Modified from 
(Pierce, 2008). 
 
Higher order chromatin structure is generally associated with open chromatin 
formation or a more highly compacted chromatin state (Huisinga et al., 2006). 
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The former conformation is generally gene-rich and permissive to transcription, 
whereas the more compact state, which usually occurs in highly condensed 
pericentromeric and subtelomeric regions of the genome, is gene-poor and 
generally repressive to transcription. 
Apart from the clear differences in levels of compaction in both states, they 
possess distinct molecular signatures, which include covalent modifications to 
DNA and to histone proteins of the nucleosome unit (Kouzarides, 2007). 
 
1.3. Chromatin modifications 
The nucleosomes can undergo structural rearrangements through DNA and 
histones unfolding and refolding. These rearrangements are usually subjected 
to covalent modifications and they can modulate gene expression. Currently, 
several mechanisms have been described to alter chromatin architecture: 
i. DNA can be methylated at carbon 5 of cytosine residues within 
dinucleotide CpGs by DNA methyltransferases (DNMT). This 
modification plays an important role in several biological processes such 
as gene regulation, X chromosome inactivation, genomic imprinting and 
long-term silencing of transposons (Ye and Li, 2014). This can be 
achieved through recognition of the methyl group by specific methyl-DNA 
binding proteins that recruit transcriptional machinery complexes and 
histone modifying activities (Scarano et al., 2005). 
ii. ATP-dependent chromatin remodeling enzymes catalyze a broad range 
of chromatin modifications, such as nucleosome conformation and 
positioning (Narlikar et al., 2013). They are usually involved in replication, 
DNA repair, transcription, and other forms of chromatin alteration such as 
post-translational modification of histones. 
iii. Canonical histones in a nucleosome can be replaced by histone variants 
through a DNA-replication independent deposition mechanism (Ray-
Gallet and Almouzni, 2010). Histone variants play an important role in 
regulating gene expression and DNA damage repair (Volle and Dalal, 
2014). 
iv. Non-coding RNAs can interact with chromatin to regulate gene 
transcription and alternative splicing (Gupta et al., 2010; Tsai et al., 
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2010). For instance, the long intergenic noncoding RNA HOTAIR is 
transcribed from Hoxc locus and targets subunits of the Polycomb 
Repressive Complex 2 (PRC2, responsible for H3K27 methylation) in 
order to silence Hoxd and some other specific genes (Rinn et al., 2007). 
v. Post-translational modifications of histone tails include phosphorylation, 
acetylation, ubiquitylation, methylation and others (Tan et al., 2011). It is 
believed that they contribute to the control of gene expression by 
influencing chromatin compaction or signaling to other protein complexes 
(Musselman et al., 2012b). 
 
1.4. Post-translational modifications (PTMs): histone lysine 
methylation 
Post-translation histone modifications were first described in the 1960’s, when 
Vincent Allfrey and colleagues made the observation that two histone 
modifications, namely acetylation and methylation, may function to regulate 
RNA synthesis (Allfrey et al., 1964). However, it took over 30 years before 
significant evidence of their molecular functions in epigenetic control began to 
be revealed. A breakthrough came from the identification of the first histone 
acetyltransferase (Gcn5) and histone deacetylase (Rpd3) in yeast and their role 
as transcriptional co-activator and co-repressor, respectively (Brownell et al., 
1996; Taunton et al., 1996). 
A great deal of evidence suggests that histone PTMs are important in diverse 
biological processes, such as cell differentiation and organismal development, 
and that aberrant modifications contribute to several diseases in humans 
(Dawson and Kouzarides, 2012). Therefore, research has been focused on 
identifying and mapping new histone PTMs, including lysine acetylation, 
arginine and lysine methylation, phosphorylation, proline isomerization, 
ubiquitylation, ADP ribosylation, arginine citrullination, sumoylation, 
carbonylation, biotinylation and more exotic modifications such as crotonylation 
(Kouzarides, 2007; Tan et al., 2011). 
Histone PTMs may play a direct role in affecting chromatin structure or 
assembly either by altering the net charge of histone molecules or by altering 
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inter-nucleosomal interactions, thereby regulating the access of DNA-binding 
proteins such as transcription factors (Lee et al., 2010a). Furthermore, PTMs 
can recruit specific binding proteins, which recognize histone modifications via 
specialized structures, like bromo-, chromo-, plant homeo- (PHD) and PWWP 
domains (Patel and Wang, 2013). Alternatively, histone PTMs can also inhibit 
the interaction of specific binders with chromatin. Through these mechanisms of 
chromatin modifications, histone PTMs have been implicated in several cellular 
processes, including transcription, DNA damage repair, apoptosis and cell cycle 
regulation (Musselman et al., 2012b). 
The majority of known histone PTMs is found within the N-terminal tail domain 
of core histones, although, they have also been observed in the globular 
domain. While the functional importance of histone tail PTMs depends on the 
protein-binding partner, the function of globular domain PTMs is based on a 
direct structural impact on nucleosome dynamics and chromatin regulation 
(Tropberger and Schneider, 2013). 
Histone methylation has proven to be a complex entity. It can occur on all basic 
amino acid residues: arginine, lysine and histidine. Lysines can be 
monomethylated (me1), dimethylated (me2) or trimethylated (me3) on their ε-
amine group; arginines can be me1, symmetrically or asymmetrically me2 on 
their guanidinyl group; and histidines have been reported to be monomethylated 
(reviewed in Greer and Shi (2012)). Distinct histone lysine residues have 
different functions when methylated, as well as the different degrees of 
methylation (me1-3) on the same residue may also have vastly differing 
functions (Barski et al., 2007; Lee and Mahadevan, 2009). 
In general, it has been observed that methylation of histone H3 lysine 4 (H3K4), 
H3K36, and H3K79 is linked to transcriptional activation, whereas methylation 
of H3K9, H3K27, and H4K20 is linked to repression (Barski et al., 2007). These 
statements could suggest that there is some kind of histone code that could 
dictate biological outcomes. However, there are several examples that prove 
otherwise. For instance, H3K4me3 is usually associated with active genes, but 
in the context of DNA damage response, the inhibitor of growth 2 (ING2) tumor 
suppressor recognizes the H3K4me3 mark through its PHD domain, leading to 
transcriptional silencing of the cell cycle genes (Shi et al., 2006). Furthermore, 
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in response to genotoxic stress, the H3K4me3 mark can be recognized by 
ING4, which, through associated histone acetyltransferase activity, promotes 
the transcription of cellular adhesion genes (Hung et al., 2009). Thus, 
determining how these histone modifications work in concert in the eukaryotic 
nucleus to regulate genes remains a pivotal challenge in molecular biology. 
 
1.5. Histone lysine methyltransferases (HKMTs) 
HKMTs catalyze mono-, di-, or tri-methylation by transferring one to three 
methyl groups, from S-adenosyl-L-methionine (AdoMet) to the ε-amino group of 
a lysine residue (Fig. 2). Except for Dot1 (Min et al., 2003; Sawada et al., 2004), 
all known HKMTs contain an evolutionary conserved SET (Su(var)3-9, 
Enhancer of Zeste, Trithorax) domain comprised of ~ 130 amino acids (aa), 
harboring the enzymatic activity (Qian and Zhou, 2006). The SET domain was 
originally identified in three Drosophila proteins involved in epigenetic 
processes: (i) the suppressor of position-effect variegation 3–9 (Su(var)3–9); (ii) 
an enhancer of the eye color mutant zeste (E(z)); (iii) and the homeotic gene 
regulator trithorax (Trx) (Jenuwein et al., 1998). H3K9 methyltransferases were 
the first identified mammalian homologues of Drosophila Su(var) 3–9 (Rea et 
al., 2000). 
 
 
Figure 2. Methylation on lysine residues of histones. Histone lysine methyltransferases (HKMTs), 
like the Set1 complex, can transfer the methyl group from the S-adenosyl-L-methionine (AdoMet) to 
lysine residues, leaving the S-adenosyl-L-homocysteine (AdoHcy) as a product. Modified from 
Shilatifard (2006). 
 
With a few exceptions (e.g., Setd5 and Setd8 in mouse), most HKMTs also 
contain another protein domain or homologous sequence motif in addition to 
SET, which is used to classify them into distinct subfamilies (Zhang et al., 
2012). 
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1.6. Trithorax (TrxG) and Polycomb (PcG) group proteins 
The highly conserved Trithorax (TrxG) and Polycomb (PcG) group proteins 
were originally identified in Drosophila melanogaster and are present in all 
higher eukaryotes (Shilatifard, 2012; Schwartz and Pirrotta, 2013). They play a 
pivotal role in transcription regulation during development, as in many other 
biological processes, like proliferation, stem cell identity and X inactivation 
(Schuettengruber et al., 2007). 
The first H3K4 methyltransferase, Set1, was identified in yeast, and was 
subsequently purified in a macromolecular complex named Set1 complex 
(Set1C) (Nislow et al., 1997; Roguev et al., 2001). Afterwards, it was observed 
that the SET domain of Set1 presents high similarity to the one in Trithorax 
(Trx), indicating that Trx is also an H3K4 methyltransferase (Roguev et al., 
2001; Roguev et al., 2003). Since then, four SET domain-containing proteins in 
Drosophila have been reported to methylate H3K4: Trx, Trithorax-related (Trr), 
dSet1, and Ash1 (Eissenberg and Shilatifard, 2010). In Drosophila, Trx was first 
discovered by the identification of several mutations in this gene that gave a 
partial transformation of halteres, a pair of lobe-like projections that lie behind 
the wings, into wings (Ingham P.W., 1980). With the exception of Ash1, which 
has also been implicated with H3K36 methylation (Tanaka et al., 2007; Yuan et 
al., 2011), all other enzymes are related to subunits of the Set1/TrxG-related 
complexes in mammals.  
In mammals, there are at least six Set1/TrxG-related proteins: Setd1a, Setd1b, 
and Mll1 to Mll4 (Glaser et al., 2006). The high conservation and multiplicity of 
the H3K4 methyltransferases suggest that they have crucial and distinct 
functions in the cell during development. 
Set1/TrxG-related proteins can catalyze trimethylation of H3K4 at the promoter 
region and facilitate maintenance of active gene states during development, in 
part by antagonizing the functions of PcG proteins. PcG proteins play a crucial 
role in maintaining the repressed transcriptional states of their target genes in 
stem cells and differentiated cells (Sawarkar and Paro, 2010). 
PcG proteins were first identified in Drosophila melanogaster as regulators of 
Hox genes (Lewis, 1978; Jurgens, 1985). In PcG-mutant flies, Hox genes are 
abnormally expressed, causing body-patterning defects, where anterior 
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segments are transformed into more posterior segments (Sato and Denell, 
1985). Because mutations in PcG genes result in ectopic expression of Hox 
genes, these genes were classified as repressors. To date, five PcG complexes 
have been identified in various organisms: Pc-repressive complexes 1 (PRC1) 
and 2 (PRC2), Pho-repressive complex (PhoRC), dRing-associated factors 
(dRAF) complex, and Pc-repressive deubiquitylase (PR-DUB) complex 
(Lanzuolo and Orlando, 2012). 
Biochemical studies revealed that the zinc finger protein Pleiohometic (PHO) of 
PhoRC is required for PRC2 recruitment (Wang et al., 2004b). Once recruited, 
the PRC2 complex, via its catalytic subunit E(z), trimethylates H3K27 (Czermin 
et al., 2002; Kuzmichev et al., 2002), which serves as docking site for PRC1 
(Cao et al., 2002). The PRC1 complex has several catalytic functions, including 
mono-ubiquitylation of histone H2A lysine 119 (H2AK119ub1) (Wang et al., 
2004a) and chromatin packaging (Francis et al., 2004). On other hand, PR-DUB 
complex is able to deubiquylate H2A (Scheuermann et al., 2010). Intriguingly, 
both PRC1 and PR-DUB protein activities are important for proper gene 
silencing in vivo. In Drosophila, it was shown that dKdm2, a subunit of the dRAF 
complex, enhance the H2A ubiquitilase activity of PRC1 proteins and mediate 
the removal of the active H3K36me2 mark (Lagarou et al., 2008). 
 
1.7. Embryonic stem cells (ESCs): regulatory network and 
histone methylation profile 
Embryonic stem cells were first established from the inner cell mass (ICM) of 
mouse blastocysts in 1981 (Evans and Kaufman, 1981). These cells present 
two remarkable features: (i) pluripotency, which is the capacity of a single cell to 
generate any cell types of the three germ layers (ectoderm, mesoderm and 
endoderm); and (ii) self-renewal, which is the ability of a cell to proliferate in the 
same state (Evans and Kaufman, 1981; Thomson et al., 1998). For this reason, 
ESCs are thought to hold great promise for regenerative medicine (Maherali et 
al., 2007; Amabile and Meissner, 2009). Furthermore, they have been 
extensively used in biomedical research and as a model to study early 
mammalian development (Lubitz et al., 2007; Glaser et al., 2009). 
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Murine ESCs can be maintained in a proliferative and undifferentiated state in 
vitro by growing them with the leukemia inhibitory factor (LIF) in the presence of 
serum (Smith et al., 1988; Smith, 2001). LIF binds to the LIF and the gp130 
receptor, triggering the activation of the latent transcription factor Stat3 (Niwa et 
al., 1998), which helps prevent mouse ESCs differentiation (Matsuda et al., 
1999) (Fig. 3). 
However, LIF alone is not sufficient to keep the ESCs state in the absence of 
serum. Bone morphogenetic proteins (BMPs) were identified as the growth 
factors that work together with LIF to promote self-renewal in the absence of 
serum (Ying et al., 2003). More specifically, addition of Bmp4 to the growth 
media leads to the phosphorylation of Smad1 and the activation of members of 
the Id (inhibitor of differentiation) gene family (Fig. 3), which are effectors of the 
BMP pathway (Ying et al., 2003). 
 
Figure 3. Scheme depicting the main factors of the external signaling pathway and the 
transcription network that maintain the pluripotency state in mouse ESCs (from Chen et al. (2008)). 
LIF and BMP molecules phosphorylate and activate nuclear translocation of Stat3 and Smad1, 
respectively. In the nucleus, Stat3 and Smad1 co-bind specific genomic regions with Oct4, Sox2, 
and Nanog to form ESC-specific enhanceosomes. Co-activators such as p300 are selectively 
recruited to these enhanceosomes and facilitate the transcription of pluripotent specific genes. 	  
Currently, it is also possible to grow mouse ESCs without serum factors by 
adding two small molecule kinase inhibitors (2i) in combination with LIF (Ying et 
al., 2008). The 2i molecules, PD0325901 and CHIR99021, target mitogen 
activated protein kinase (MAPK) and glycogen synthase kinase-3 (Gsk3), 
respectively. The inhibitors maintain the pluripotent state by preventing 
fully connected triad motif, and multiple input motif, were
identified in the ES cell regulatory network. These building
blocks of complex architecture may serve to stabilize gene
expression patterns in undifferentiated ES cells.
In an independent study, Kim et al. (2008) reported the
mapping of nine biotin-tagged transcription factors
including Oct4, Sox2, Nanog, Klf4, c-Myc, Dax1, Rex1,
Zfp281, and Nac1 using ChIP-on-Chip methodology
(Kim et al. 2008). Similarly, the authors found cobinding
of at least four transcription factors at 800 gene promot-
ers. The difference in the number of multiple transcrip-
tion-factor-bound loci identified could be attributed to the
different factors studied and the different methodology
used (ChIP-Seq versus ChIP-on-Chip). However, both
groups found similar wiring patterns of the ES cell
genome: the extensive colocalization of multiple tran-
scription factors; distinct binding behavior of c-Myc from
Oct4, Sox2, and Nanog; and an association of multiple
binding loci to gene expression in ES cells (Chen et al.
2008; Kim et al. 2008). With these large-scale transcrip-
tion factor/cofactor location maps, it is imperative to inte-
grate these data with expression data and arrive at a
regulatory code behind ES-cell-specific gene expression.
The knowledge gained in ES cells may be useful for
understanding the mechanisms behind reprogramming
whereby somatic cells can be reverted to pluripotent cells
via coexpression of Oct4, Sox2, c-Myc, and Klf4
(Takahashi and Yamanaka 2006). Klf4 is extensively
connected with Oct4, Sox2, or Nanog. It binds to the key
regulatory regions of Pou5f1 and Nanog. More than 40%
of Klf4 sites within the MTL clusters are also bound by
Oct4, Sox2 or Nanog. During the process of reprogram-
ming, the wiring of the transcriptional regulatory network
of a pluripotent cell needs to be reformed. It is possible
that Oct4, Sox2, and Klf4 are able to jump-start the partial
or entire ES cell expression program in somatic cells
through targeting key nodes of the pluripotency network.
AlthoughMyc is not necessary for reprogramming, it is of
interest to note that Oct4, Sox2, Klf4, and five other tran-
scription factors bind to n-Myc, and n-Myc can replace
c-Myc in reprogramming somatic cells to induced pluri-
potent cells (Blelloch et al. 2007). Therefore, it is con-
ceivable that the reprogramming factors are able to
activate endogenous n-Myc to form part of the transcrip-
tional regulatory network unique to pluripotent cells.
Embedded within this network is an additional level of
complexity due to the presence of transcription factors
exhibiting redundant functions. This is best exemplified
by the finding that Klf4 alone is not important for the
maintenance of ES cells (Nakatake et al. 2006). Instead,
the concurrent depletion of Klf4 and two other Krüppel-
like factors (Klf2 and Klf5) is required for the differenti-
ation phenotype to be manifested (Jiang et al. 2008).
Hence, there is functional redundancy for the Krüppel-
like factors in maintaining ES cell properties.
CONCLUSIONS
Transcription factors are key for specifying gene
expression programs and imparting distinct cellular phe-
notypes. Recent advancements in genomic technologies
provide powerful platforms for a comprehensive mapping
of chromatin modification profiles and binding sites of
transcription factors and coregulators in ES cells
(Mikkelsen et al. 2007; Chen et al. 2008). These efforts,
coupled with previous knowledge of the ES cell transcrip-
tome, will provide a framework for understanding the ES
cell transcriptional regulatory networks in higher eukary-
otes and facilitate a more precise association, hopefully
prediction, of gene expression through the transcription-
factor-binding pattern. In addition, these studies will
greatly assist in the identification of novel self-renewal
pathways, factors, and reprogramming regulators. The
rapid progress made in tackling the transcriptome and
genome use of ES cells will serve as a framework for fur-
ther investigation to understand the biology of stem cells.
With the derivation of different pluripotent cells (Rossant
2008), it will be of interest to delineate the core transcrip-
tional regulatory network common in these cells.
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Figure 2. Integration of external signaling pathways with the
core transcription network in maintaining pluripotency of mouse
ES cells: A model for ES-cell-specific enhanceosome. LIF and
BMP signaling pathways phosphorylate and activate nuclear
translocation of STAT3 and Smad1, respectively. In the nucleus,
STAT3 and Smad1 cobind specific gen mi regions with Oct4,
Sox2, and N og to form ES-cell-specific enhanceosomes.
Other novel transcription factors may also be present at these
sites. Coactivators such as p300 are selectively recruited to the
enhanceosomes and facilitate the transcription of ES-cell-spe-
cific genes. Certain genes under the influence of these enhanceo-
somes may, however, be silenced by other nearby repressive
cis-regulatory elements.
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fibroblast growth factor-4 from stimulating the MAPK/ERK pathway and by 
alleviating the repressor activity of Tcf3 on the pluripotency factors (Kunath et 
al., 2007; Wray et al., 2011). 
Apart from the mentioned signaling pathways, which are related to the presence 
of extrinsic growth factors in the environment, transcription factors such as 
Oct4, Sox2 and Nanog have been identified as being essential for maintaining 
the undifferentiated state of ESCs (Boyer et al., 2005; Loh et al., 2006; Silva 
and Smith, 2008). Basically, they co-occupy and activate expression of the 
genes necessary for maintenance of the undifferentiated state, while 
contributing to the repression of lineage-specific transcription factors that would 
lead to differentiation (Chen et al., 2008) (Fig. 3). These key transcription 
factors positively regulate their own promoters, forming an autoregulatory loop 
that prevents ESCs from exiting the pluripotency state (Chew et al., 2005). In 
addition to the core regulatory network, other transcriptional factors also have 
been identified as important to sustain the ESC state, such as Klf4, Tbx3, Esrrb, 
Zfx, and more recently Patz1 (Ivanova et al., 2006; Galan-Caridad et al., 2007; 
Jiang et al., 2008; Zhang et al., 2008; Niwa et al., 2009; Ow et al., 2013). 
ESCs exhibit higher global transcription levels than somatic cells (Efroni et al., 
2008). This particular feature can be attributed to a less compacted chromatin 
structure and a highly dynamic chromatin organization, presenting abundance 
of acetylated histone modifications and increased access to nucleases 
(Meshorer et al., 2006). 
This high level of gene transcription in ESCs is also associated with the active 
epigenetic mark H3K4me3, which is frequently observed at the promoter 
regions of pluripotency related genes and is mediated by members of the 
Set/Mll complexes (Mikkelsen et al., 2007). Genome-wide and knockdown 
experiments suggest that several subunits of these complexes (such as Wdr5, 
Cfp1 and Ash2l) are key regulators of open chromatin in ESCs (Ang et al., 
2011; Clouaire et al., 2012; Wan et al., 2013). 
Members of the Polycomb repressive complex 2 (PRC2), which mediate H3K27 
methylation, also have a role in pluripotency and differentiation. They can 
directly repress many developmental regulators in murine ESCs (Boyer et al., 
2006; Lee et al., 2006). 
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One very distinct feature of histone modifications in ESCs is the so-called 
“bivalent state”, where genes encoding lineage-specific developmental 
regulators contain nucleosomes with both H3K4me3 and H3K27me3 (Bernstein 
et al., 2006; Pan et al., 2007). It has been hypothesized that these bivalent 
domains act not only to repress such genes in order to keep pluripotency, but 
also allow them to remain poised for transcription, so they can be rapidly 
activated upon differentiation (Azuara et al., 2006; Vastenhouw and Schier, 
2012). However, a recent study demonstrated that the bivalent domain of 
pluripotent stem cells is only transiently formed during differentiation (Marks et 
al., 2012). Naïve ESCs, cultured with LIF and 2i in the absence of serum, 
exhibited a decreased amount of H3K27me3 on bivalent domains when 
compared with that observed in mouse ES cells grown in LIF plus serum 
conditions. Overall, the distribution of the H3K4me3 mark was similar in both 
culture conditions. 
Highly compact chromatin is usually linked to H3K9me2/3. In ESCs, 
H3K9me2/3 demethylases such as Jmjd1a and Jmjd2c are upregulated upon 
Oct4 expression. Depletion of these two demethylases leads to a decreased 
expression of pluripotency genes and differentiation of ESCs (Loh et al., 2007; 
Ma et al., 2008). Nonetheless, some H3K9 methyltransferases are actually 
important to maintain the undifferentiated state in ESCs. For example, 
conditional deletion of the Setdb1 gene leads to upregulation of trophectoderm 
differentiation markers (Lohmann et al., 2010). 
 
1.8. Role of lysine 36 (K36) methylation on histone 3 (H3) in 
gene expression 
H3K36 methylation is mainly described to be associated with active chromatin, 
though it has also been implicated in several biological processes, such as 
transcriptional repression, alternative splicing, dosage compensation, DNA 
replication and repair, DNA methylation, and transmission of gene expression 
memory from parents to offspring during development (Wagner and Carpenter, 
2012). 
In yeast, SET domain-containing 2 (Set2) is the sole H3K36 methyltransferase 
(Lee and Shilatifard, 2007), but in higher eukaryotes there is accumulating 
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evidence that these methylation marks require a division of labor between the 
mono- and dimethylases and the Set2-type trimethylase. To date, at least eight 
distinct mammalian enzymes have been described to methylate H3K36 in vitro 
and/or in vivo: Setd2, Nsd1-3, Ash1l, Smyd2, Setmar, and Setd3 (Wagner and 
Carpenter, 2012). 
Genome-wide chromatin studies have demonstrated that H3K36 methylation is 
generally associated with actively transcribed genes; though, dimethylation 
(H3K36me2) and trimethylation (H3K36me3) show different patterns (Bannister 
et al., 2005; Rao et al., 2005; Mikkelsen et al., 2007). H3K36me2 appears 
uniformly distributed across transcribed genes and is not correlated with 
transcription frequency, whereas H3K36me3 seems to be most prevalent 
towards the 3’ end of coding regions and is positively correlated with the rate of 
transcription. However, zebrafish quiescent genes, which are developmentally 
regulated during spermatogenesis, showed H3K36me3 enrichment at the 5’ 
promoter region (Wu et al., 2011). Little is known about H3K36me1 localization 
in chromatin. In humans, there are two reports showing preference of 
H3K36me1 at active promoters, though in some genes it can also be detected 
at coding regions (Kim et al., 2007a; Lucio-Eterovic et al., 2010). 
Although, H3K36 methylation is usually observed across the gene body of 
active genes, either uniformly distributed or peaking towards the 3’ region, 
some H3K36 methyltransferases do not follow the same DNA-binding patterns. 
In human cells, NSD1 binds near various promoter regions and regulates the 
levels of H3K36me1-3 within the gene bodies of bone morphogenetic protein 4 
(BMP4) and zinc finger protein 36 C3H type-like 1 (ZFP36L1/TPP) (Lucio-
Eterovic et al., 2010). Moreover, NSD1 depletion leads to a decrease in RNA 
polymerase II (RNAPII) recruitment to the BMP4 promoter, suggesting a role for 
NSD1-dependent methylation in transcription initiation. In contrast, NSD3 
appears to reside in multiple protein complexes (including KDM1b and BRD4 
complexes) and, thus, localizes to either promoter or coding regions to promote 
H3K36 methylation and thereby influence initiation and elongation processes 
(Fang et al., 2010; Rahman et al., 2011). 
Several studies have demonstrated in various organisms that H3K36 
methylation is associated with the elongation phase of transcription. Set2-type 
	   21	  
proteins have a C-terminal domain (CTD) that interacts with the large subunit of 
RNAPII (Krogan et al., 2003; Schaft et al., 2003; Kizer et al., 2005; Sun et al., 
2005). Set2 preferentially recognizes phosphorylated residues in the CTD of 
Rbp1, the large subunit of RNAPII. The Ser2-phosphorylated form of the CTD is 
indicative of elongation and the Ser5-phosphorylated form is characteristic of a 
paused polymerase at a promoter (Phatnani and Greenleaf, 2006). 
In yeast, Set2 catalyzes H3K36 methylation co-transcriptionally and recruits the 
reduced potassium dependency 3 small (Rpd3S) deacetylase complex 
(Carrozza et al., 2005; Keogh et al., 2005). Rpd3S removes the histone 
acetylation mark, previously created to facilitate passage of the elongating 
polymerase, in order to restore the original chromatin structure, in this way 
preventing cryptic transcription initiation from within coding regions (Carrozza et 
al., 2005; Keogh et al., 2005; Govind et al., 2010). Subsequently, it was shown 
that H3K36me2 is the preferred substrate for Rpd3S binding (Li et al., 2009a).  
The Set2-Rpd3S pathway does not seem to exist in mammals, since it has 
been demonstrated that depletion of Setd2 in mouse cells did not affect the 
global levels of various H3 and H4 acetyl modifications (Edmunds et al., 2008). 
This study suggests that H3K36me3 may inhibit intragenic transcription in 
mammalian cells by other means that do not involve histone acetylation. In 
murine ESCs, it was observed that H3K36me3 recruits histone H3K4me2/3 
demethylase Kdm5b via an Rpd3S-like complex (Xie et al., 2011). Therefore, 
this study proposed that Kdm5b represses cryptic transcription by removing 
intragenic H3K4me3. 
In addition to Set2, other factors, like histone chaperone FACT (FAcilitate 
Chromatin Transcription) and Spt6 (Orphanides et al., 1999; Formosa, 2012), 
are crucial to repress transcription from cryptic promoters located within active 
genes (Kaplan et al., 2003; Cheung et al., 2008). Recently, it was reported that 
H3K36me3 mark in transcribed genes enhances the recruitment of FACT, 
which promotes the exchange of H2A–H2B dimers (Carvalho et al., 2013). 
Moreover, FACT recruitment by SETD2 methylation is crucial to reassemble 
nucleosomes in the wake of RNAPII elongation, thereby repressing cryptic 
intragenic transcription initiation. 
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Beyond H3K36 methylation-mediated regulation of spurious initiation, this 
epigenetic mark has also been related to transcription repression. For instance, 
in human neuroblastoma cells, NSD1 repress the oncogene MEIS1 (Berdasco 
et al., 2009). Furthermore, Nsd2 together with the cardiac-specific factor Nkx2-5 
can repress the expression of the platelet-derived growth factor-α (Pdgfrα) 
(Nimura et al., 2009), probably by modulating H3K36 methylation levels. 
More recently, several studies showed that two PRC2-associated polycomb-like 
(PCL) proteins PHF1 and PHF19 bind to the H3K36me3 mark through their N-
terminal Tudor domains (Ballare et al., 2012; Brien et al., 2012; Musselman et 
al., 2012a; Cai et al., 2013). PCL recognition of H3K36me3 recruits PRC2 
complexes into active chromatin regions, which is important to promote optimal 
repression of poised developmental genes. In mouse ESCs, another case was 
reported where Phf19 recruits the PRC2 complex and the H3K36me3 
demethylase NO66 to stem cell genes during differentiation, which leads to 
PRC2-mediated H3K27me3, loss of H3K36me3 and transcriptional silencing 
(Brien et al., 2012). 
The H3K36me3 mark is enriched at exons and its intensity is proportional to 
transcriptional activity. Moreover, its level at alternatively spliced exons is 
reported to correlate with their inclusion into the spliced transcript (Hon et al., 
2009). A direct link between H3K36me3 and an effect on mRNA splicing comes 
from the observation that MORF-related gene 15 (MRG15), a protein whose 
chromodomain can recognize H3K36me3, recruits polypyrimidine tract binding 
protein (PTB), a known repressor of exon inclusion, to alternatively spliced 
exons (Luco et al., 2010). 
Genome-wide analysis of H3K36me3 in human cell lines and mouse primary T 
cells revealed that intron-containing genes are preferentially marked relative to 
intron-less genes (de Almeida et al., 2011). Furthermore, splicing inhibition 
impaired recruitment of SETD2 and reduced H3K36me3, whereas splicing 
activation had the opposite effect. Overall, H3K36 methylation appears to play a 
role in mRNA splicing, although it is unclear how the spliceosome regulates this 
histone modification. 
Histone methylation has also been implicated in the maintenance of genomic 
stability, including DNA damage response (Sanders et al., 2004). Interestingly, 
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Setmar was shown to directly mediate H3K36me2 formation near DNA double 
strand breaks (DSBs) (Fnu et al., 2011). This histone signature improved the 
association of early DNA repair components, including Nijmegen breakage 
syndrome 1 (NBS1) and Ku70, to the marked DSBs, and enhanced DSB repair 
through non‐homologous end‐joining (NHEJ). Moreover, Setd2-dependent 
H3K36me3 is required in human cells to recruit the mismatch recognition 
protein hMutSα onto chromatin and, subsequently, mediate DNA mismatch 
repair (Li et al., 2013a). 
 
1.9. Set2 subfamily of H3K36 methyltransferases 
In mammals, all eight H3K36 methyltransferases described thus far have the 
catalytic SET domain in common, yet they have distinct preferences not only for 
methylase activity towards H3K36 (me1-3), but they can methylate different 
histone substrates. An evolutionary analysis comprising at least 40 SET 
domain-containing proteins from various organisms (Sun et al., 2005) revealed 
a group comprised of: Setd2 (yeast Set2 and Caenorhabditis elegans Met-1 
ortholog), the three nuclear SET domain containing protein family Nsd1-3 (C. 
elegans Mes-4 orthologs) and Ash1l, a TrxG protein (Drosophila Ash1 ortholog). 
This group was classified as the Set2 subfamily and it is the group of study of 
this thesis. 
The Set2 subfamily members possess multiple chromatin-interacting domains 
(Fig. 4), including those known to interact with methylated H3K36 itself (e.g., the 
PWWP) (Vezzoli et al., 2010) and with additional methylated histone residues 
(e.g., PHD fingers) (Pasillas et al., 2011). 
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Figure 4. Schematic view of the domain structure of mouse H3K36 methyltransferases. The SET 
domain is shown with its associated with SET (AWS) and post-SET domains (postSET); BAH, 
bromo-associated homology; bromodomains (BROMO) are involved in the recognition of 
acetylated lysine residues in histone tails; AT hook is a DNA-binding domain; plant homeodomain 
(PHD) is usually involved in protein–protein interactions; high-mobility group (HMG) domains are 
involved in binding DNA with low sequence specificity; NIDs, nuclear receptor interaction 
domains; WW domains are known to interact with Pro-rich peptides; Set2 Rbp1–interacting (SRI) 
domain interacts with RNAPII; PWWP domain is Pro-Trp-Trp-Pro motif; C5HCH is a zinc-finger 
domain. Protein size information was retrieved from Ensembl mouse GRCm38 
(http://www.ensembl.org/). 	  
The H3K36 HKMTs possess many discrepancies regarding the level of 
methylation imparted, as well as the substrate that is targeted. These 
inconsistencies may arise from multiple factors, including the nature of the 
substrate tested (e.g., peptides and histones versus nucleosomes), the source 
of enzyme (for example, full length versus SET domain only) and the assay 
conditions (e.g., antibody specificity versus mass spectrometry). Over the years, 
several researchers have tried to determine the H3K6 HKMTs substrate 
specificities using a different range of tools. A summary of these targets is 
depicted in Table 1. 	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Table 1. Reported substrate specificities for the Set2 subfamily of H3K36 methyltransferases. 
Enzyme Experiment conditions Histone substrates identified Refs* 
Setd2 
(Kmt3a, 
Hypb) 
Nucleosomes H3, H3K36me1-3 1 
Cell based and/or in vivo H3K36me3 2 
Nsd1 (Kmt3b) Nucleosomes H3, H3K36, H3K36me1/2, H4K20, 
H4K44, H1.5K168 
3 
Cell based and/or in vivo H3K36me1/2, H4K20me3, H1.5K168 4 
Nsd2 (Whsc1, 
MMSET) 
Nucleosomes H3, H3K36, H3K36me1-3 5 
Cell based and/or in vivo H3K27me2, H3K36me2/3, 
H4K20me2/3 
6 
Nsd3 
(Whsc1l1) 
Nucleosomes H3, H3K36 7 
Cell based and/or in vivo H3K36 8 
Ash1; Ash1l Nucleosomes H3, H3K36, H3K36me2/3 9 
Cell based and/or in vivo H3K4, H3K4me3, H3K9, H4K20, 
H3K36, H3K36me2 
10 
* List of references: 1 - (Sun et al., 2005; Yuan et al., 2009); 2 - (Edmunds et al., 2008; Yoh et al., 2008; 
Yuan et al., 2009; Hu et al., 2010; Carvalho et al., 2013; Fontebasso et al., 2013; Li et al., 2013a); 3 - 
(Rayasam et al., 2003; Li et al., 2009b; Lucio-Eterovic et al., 2010; Qiao et al., 2011; Kudithipudi et al., 
2014); 4 - (Wang et al., 2007; Berdasco et al., 2009; Lucio-Eterovic et al., 2010; Qiao et al., 2011; 
Kudithipudi et al., 2014); 5 - (Berdasco et al., 2009; Li et al., 2009b; Nimura et al., 2009; Lucio-Eterovic et 
al., 2010; Kuo et al., 2011); 6 - (Kim et al., 2008; Nimura et al., 2009; Lucio-Eterovic et al., 2010; Hajdu et 
al., 2011; Kuo et al., 2011; Martinez-Garcia et al., 2011; Pei et al., 2011; Asangani et al., 2013; Huang et 
al., 2013); 7 - (Li et al., 2009b); 8 - (Rahman et al., 2011); 9 - (Gregory et al., 2007; Tanaka et al., 2007; An 
et al., 2011; Yuan et al., 2011; Miyazaki et al., 2013); 10 - (Beisel et al., 2002; Byrd and Shearn, 2003; 
Gregory et al., 2007; Cabianca et al., 2012; Dorighi and Tamkun, 2013; Miyazaki et al., 2013). 
 
1.9.1. SET domain-containing protein 2 (Setd2, Hypb or Kmt3a) 
The SETD2 gene was originally isolated from hematopoietic stem/progenitor 
cells (Mao et al., 1998; Zhang et al., 2000). Other studies characterized the 
encoded protein as a factor that interacts with the Huntington disease protein 
huntingtin (HTT), and thus it was also named as huntingtin interacting protein B 
(HYPB) (Faber et al., 1998; Passani et al., 2000). Afterwards, SETD2 was 
identified as a H3K36 specific methyltransferase that interacts with hyper-
phosphorylated RNAPII (Sun et al., 2005; Yoh et al., 2008). 
Setd2 acts as the mammalian ortholog of the yeast Set2 and it is responsible 
for H3K36 trimethylation (Edmunds et al., 2008; Yuan et al., 2009; Hu et al., 
2010). In contrast, Set2 can perform all three methylation reactions at H3K36 
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and it has been implicated in preventing cryptic transcription initiation within the 
transcribed regions (Carrozza et al., 2005; Kizer et al., 2005). 
Due to the importance of H3K36 methylation in higher eukaryotes, gene 
mutations can cause developmental defects and disease. In mice, homozygous 
disruption of Setd2 resulted in embryonic lethality at E10.5-E11.5 with severe 
defects in blood vessel development (Hu et al., 2010). Moreover, defects in 
SETD2 are implicated in sporadic clear renal cell carcinoma, a disease that is 
marked by the loss of the short arm of chromosome 3 (Duns et al., 2010). 
SETD2 has also been proposed to be a tumor suppressor in breast cancer and 
acute leukemia (Newbold and Mokbel, 2010; Zhu et al., 2014). 
In addition to its association with RNAPII, SETD2 also associates with the 
heterogeneous nuclear ribonucleoprotein L (HNRNPL), and a HNRNPL 
knockdown leads to decreased levels of H3K36me3 but not H3K36me1/2 (Yuan 
et al., 2009). HNRNPL is part of a RNA-binding protein family that has been 
implicated in various RNA-related processes, particularly in mediating selective 
exon inclusion during alternative splicing and facilitating polyadenylation (Hui et 
al., 2003; Guang et al., 2005; Melton et al., 2007; Hung et al., 2008). 
Another study showed that the SUPT6H:IWS1 complex associates with SETD2 
in order to link nucleosome reassembly with elongation-coupled H3K36me3 in 
vivo (Yoh et al., 2008). SUPT6H is a histone H3 chaperone that promotes 
transcription elongation (Endoh et al., 2004). IWS1, a SUPT6H partner protein, 
recruits SETD2 and modulates H3K36me3 accumulation across the coding 
regions of several genes in 293T and HeLa cells (Yoh et al., 2008). More 
recently, an independent study proposed that the H3K27 demethylases JMJD3 
and KIAA1718 associate in a protein complex with transcription regulators, 
including SUPT6H, SUPT16H, CDC73 and SETD2. It suggested a model in 
which these different components cooperate to demethylate H3K27me3 on their 
direct target genes and facilitate the release of poised RNAPII and 
subsequently gene transcription (Chen et al., 2012). 
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1.9.2. Nuclear receptor-binding SET domain protein 1 (Nsd1 or Kmt3b) 
Mouse Nsd1 was first identified in a two-hybrid screen with the retinoic acid 
receptor alpha (RARα) as bait (Huang et al., 1998) and subsequently shown to 
belong to an emerging family of proteins that includes Nsd2 and Nsd3. It was 
shown that Nsd1 interacted with a number of nuclear hormone receptors, 
including the estrogen receptor, retinoic acid and thyroid hormone receptors. 
Moreover, it was proposed that Nsd1 could either act as a co-repressor or a co-
activator of these nuclear receptors depending on the cellular context and the 
presence or absence of the respective hormones (Huang et al., 1998). Since 
then, several in vitro and in vivo experiments showed that Nsd1 has specific 
mono- and dimethylase activity for H3K36 (Li et al., 2009b; Lucio-Eterovic et al., 
2010; Qiao et al., 2011), although there are also mixed reports as to whether it 
methylates H4K20 (Rayasam et al., 2003; Yang et al., 2008; Berdasco et al., 
2009). More recently, Kudithipudi and colleagues (2014) claimed that Nsd1 
does not methylate H4K20 in vitro and proposed two new substrates: H4K44 
and H1.5K168. Apart from histone substrates, NSD1 was also reported to 
mono- and dimethylate p65, an NF-kB family transcription factor, at K218 and 
K221, which stimulates the expression of p65-dependent tumorigenic genes (Lu 
et al., 2010). However, another report did not observe any methylation at p65, 
though it proposed 25 new non-histone substrates of Nsd1 that were 
methylated strongly at peptide level, including Atrx K1033 and U3 K189 
(Kudithipudi et al., 2014). 
Nsd1 is involved in post-implantation development; mice deficient in Nsd1 
exhibit an embryonic lethal phenotype due to apoptosis at E10.5 (Rayasam et 
al., 2003). It binds to several promoter proximal regions and regulates many 
genes that have roles in development (Lucio-Eterovic et al., 2010). Nsd1 can 
also alter transcription by interacting with the protein zinc finger with KRAB and 
SCAN domains 17 (Zkscan17, also abbreviated Nizp1 or Znf496) (Nielsen et 
al., 2004).  
NSD1 also plays a role in several pathologies. Nearly 5% of all human acute 
myeloid leukemia (AML) patients harbor the NUP98-NSD1 fusion oncoprotein 
due to a chromosomal translocation (Cerveira et al., 2003). This fusion protein 
can enhance expression of Hox genes by antagonizing repressive chromatin 
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structure in a manner that depends on NSD1 methyltransferase activity (Wang 
et al., 2007). Furthermore, translocations involving NSD1 were also found in 
breast cancer (Zhao et al., 2009), and epigenetic inactivation of the NSD1 
promoter through CpG hypermethylation has been reported to have a role in 
neuroblastomas and glioblastomas (Berdasco et al., 2009). 
In addition to its role in development and cancer, haploinsufficiency of Nsd1 
causes the Sotos syndrome (Kurotaki et al., 2002), a childhood developmental 
condition characterized by a broad set of phenotypes, such as macrocephaly, 
advanced bone age, facial dimorphism, learning disabilities, and seizures 
(Leventopoulos et al., 2009). 
 
1.9.3. Nuclear receptor-binding SET domain protein 2 (Nsd2, Whsc1, or 
MMSET) 
NSD2 was identified by two different studies when searching for genes related 
to Wolf–Hirschhorn syndrome (WHS) (Stec et al., 1998) and multiple myeloma 
tumors with a t(4;14) translocation (Chesi et al., 1998), for this reason it has 
also been called WHSC1 (Wolf-Hirschhorn syndrome candidate 1 protein 
homolog) and MMSET (multiple myeloma SET domain). WHS is a malformation 
condition characterized by brain developmental defects, immunodeficiency, 
microcephaly, craniofacial phenotypes, and congenital heart defects (Battaglia 
and Carey, 2008). Apart from the NSD2 involvement with the t(4;14) 
translocation in 15-20% of multiple myelomas, overexpression of this protein 
has also been associated with several other types of human cancer, including 
neuroblastoma, carcinomas of the stomach and colon, small-cell lung cancers, 
and bladder cancers (Hudlebusch et al., 2011). 
In humans, the NSD2 gene undergoes complex alternative splicing and 
differential promoter usage. Two major transcripts were identified: isoform 1 
encodes a protein of 647 aa and isoform 2 encodes a protein of 1365 aa (Fig. 
5) (Chesi et al., 1998). Another mRNA transcript comprising the 3’ half of NSD2 
gene was subsequently identified and it encodes a protein named RE-IIBP of 
584 aa (Garlisi et al., 2001). RE-IIBP is found to be upregulated in blood cells of 
various leukemic patients. It also exhibits H3K27 methyltransferase activity and 
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exerts a transcriptional repression effect by recruiting histone deacetylases 
(Hdac1 and 2) (Kim et al., 2008).  
NSD2 binds to chromatin at transcriptionally active regions (Ram et al., 2011) 
and it is believed to specifically dimethylate H3K36 (Li et al., 2009b; Kuo et al., 
2011). However, another line of evidence proposed a role for NSD2 in DNA 
damage response through H4K20 methylation and 53BP1 recruitment to sites 
of DNA damage (Hajdu et al., 2011). Another report reinforced that Nsd2 
deficiency leads to alteration in H4K20 methylation, though it did not show a 
relation with 53BP1 recruitment (Hartlerode et al., 2012). 
The Nsd2 protein plays an important role in chromatin regulation and 
mammalian development. Interestingly, Nsd2 deficient mice showed growth 
retardation and various WHS-like midline defects, including congenital 
cardiovascular anomalies (Nimura et al., 2009). Nsd2 can associate with 
different protein complexes depending on the cell type. In ESCs, it has been 
shown to interact with transcriptional factors, such as Sall1, Sall4 and Nanog, 
while in embryonic hearts Nsd2 associated with Nkx2-5 (Nimura et al., 2009), a 
central transcriptional regulator of cardiac development. In mouse embryonic 
fibroblasts (MEFs) Nsd2 interacted with bromodomain protein 4 (Brd4) and 
positive transcription elongation factor b (P-TEFb), and facilitated transcriptional 
elongation (Sarai et al., 2013). Furthermore, Nsd2 also associated with HIRA, 
the H3.3-specific histone chaperone, in MEFs independently of Brd4 and P-
TEFb. 
 
Figure 5. Schematic representation of mammalian Nsd2 main isoforms and their domain structure. 
The SET domain is shown with its associated with SET (AWS) and post SET domains (postSET); 
plant homeodomain (PHD); high-mobility group (HMG) domain; PWWP domain is Pro-Trp-Trp-Pro 
motif; C5HCH is a zinc-finger domain. 
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1.9.4. Nuclear receptor-binding SET domain protein 3 (Nsd3 or Whsc1l1) 
NSD3 was first identified as a highly similar gene to Nsd2 when searching for 
WHS related genes (Stec et al., 2001). Subsequently, NSD3 was characterized 
as a SET domain protein found amplified in human breast cancer cell lines 
(Angrand et al., 2001). Indeed, NSD3 has been implicated in several 
pathologies, such as hematologic malignancies, breast carcinomas and lung 
carcinomas, suggesting an important role in controlling cell growth and 
differentiation (Morishita and di Luccio, 2011; Wagner and Carpenter, 2012; 
Kang et al., 2013). 
Human NSD3 mRNA is alternatively spliced to generate three isoforms (Fig. 6). 
In silico data suggests that transcripts 1 and 2 are co-expressed in tissues and 
they encode proteins of 1437 aa and 645 aa respectively (Angrand et al., 2001), 
while the third isoform, named WHISTLE (506 aa), is expressed in a lower level 
than the other two (Kim et al., 2006; Kim et al., 2007b). Although NSD3 has 
been reported to act as H3K36 methyltransferase (Li et al., 2009b; Rahman et 
al., 2011), its isoform WHISTLE can dimethylate H3K4 and H3K27 (Kim et al., 
2006). Moreover, WHISTLE interacts with Hdac1 and mediates transcription 
repression (Kim et al., 2007b). 
 
Figure 6. Schematic representation of mammalian Nsd3 main isoforms and their domain structure. 
The SET domain is shown with its associated with SET (AWS) and post SET domains (postSET); 
plant homeodomain (PHD); PWWP domain is Pro-Trp-Trp-Pro motif; C5HCH is a zinc-finger 
domain. 
BRD4 can recruit NSD3 to the promoter regions of active genes and together 
influence the levels of H3K36 methylation (Rahman et al., 2011). Additionally, 
NSD3 can also bind to the coding regions when it is part of a protein complex 
with KDM1B (H3K4 demethylase) and G9a (H3K9 HKMT) (Fang et al., 2010). 
The biological function of Nsd3 remains obscure, and more effort should be 
made towards unraveling Nsd3 substrate specificity and functional relevance. 
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1.9.5. Absent small and homeotic disks protein 1 homolog (Ash1l) 
Human ASH1L was first identified as an EST clone homologous to the 
Drosophila Ash1 SET domain (Nakamura et al., 2000). Mammalian Ash1l differs 
from its fly homolog in the N-terminal region by addition of a bromodomain. 
Experiments using recombinant nucleosomes have demonstrated that ASH1L 
is a specific H3K36 dimethylase (Tanaka et al., 2007; An et al., 2011; Yuan et 
al., 2011). It is still controversial as to which lysine residue is targeted in vivo. 
Thus far, reports have suggested that Lys4 and Lys36 of histone H3 are the 
most plausible candidates (Gregory et al., 2007; Cabianca et al., 2012; 
Miyazaki et al., 2013). 
Both Ash1 and Ash1l bind to chromatin and have been localized specifically in 
promoter proximal regions of active genes (Papp and Muller, 2006; Gregory et 
al., 2007; Miyazaki et al., 2013). Studies have shown that Ash1 and Ash1l play 
a role in antagonizing PcG silencing (Beisel and Paro, 2011; Yuan et al., 2011; 
Dorighi and Tamkun, 2013; Miyazaki et al., 2013). In contrast, another report 
observed that ASH1L H3K36 methyltransferase activity actually causes 
repression rather than activation of Hox genes (Tanaka et al., 2011). Regarding 
Ash1l’s role in mouse development, it has been reported that a knock-in mutant 
that lacked part of the SET domain presented several alterations in the 
vertebrae (Miyazaki et al., 2013). 
Although Ash1 was one of the first identified members of the TrxG proteins 
(Eissenberg and Shilatifard, 2010), both Ash1 and Ash1l protein complexes 
remain poorly characterized. In Drosophila, a physical interaction between Ash1 
and the bromodomain and extraterminal family protein FSH has been reported 
(Kockmann et al., 2013). In addition, both proteins co-localize on chromatin, 
especially at sites bound by PcG complexes and gene promoters. 
The exact function of Ash1l and how it is recruited to its targets are still poorly 
understood. Additionally, there is still insufficient data regarding the role of 
ASH1L in diseases. More recently, mutations in ASH1L were observed in nine 
lung cancer cell lines (Liu et al., 2012). Thus, it remains to be seen what this 
particular protein can regulate and its effect in mammals. 
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1.10. H3K36 demethylases 
At first, histone methylation was thought to be an irreversible mark. This belief 
was challenged in 2004, when the first lysine specific demethylase (LSD1 or 
KDM1A) was discovered (Shi et al., 2004). Since then several other 
demethylases have been described and now they have been classified in two 
major conserved families: the amine oxidase-related enzymes and the Jumonji 
C-terminal domain (JmjC)-containing enzymes, which catalyzes the 
hydroxylation of a lysine methyl group via an α-keto-glutarate and Fe(II)-ion 
dependent reaction (Klose et al., 2006; Kooistra and Helin, 2012). The JmjC 
family consists of 30 members, and so far 8 proteins have been implicated with 
H3K36 demethylase activity (Kooistra and Helin, 2012), including members of 
the Kdm2 and Kdm4 clusters, plus Kdm8 (or Jmjd5) and NO66. 
The mammalian Kdm2 proteins Kdm2a (also abbreviated Jhdm1a or Fbxl11) 
and Kdm2b (also abbreviated Jhdm1b or Fbxl10) are specific to H3K36me1/2. 
Moreover, an H3K4me2 demethylase activity was also reported for Kdm2b 
(Frescas et al., 2007; Kooistra and Helin, 2012). Both proteins play a repressive 
role in RNA polymerase-I and RNAPII dependent transcription genes through a 
mechanism involving their H3K36 demethylase activity (Frescas et al., 2007; He 
et al., 2008; Lu et al., 2009; Tanaka et al., 2010). In addition to KDM2A’s role in 
transcription repression of centromeric satellite repeats (Frescas et al., 2008), it 
has also been shown to demethylate H3K36me2 at non-methylated CpG island-
containing promoters, thus discriminating CpG islands from bulk chromatin 
(Blackledge et al., 2010; Zhou et al., 2012). In addition, KDM2B has a CxxC-
zinc finger domain that can recognize non-methylated DNA in CpG islands and 
recruit PRC1, thus contributing to H2AK119ub1 and gene repression (Farcas et 
al., 2012; He et al., 2013b; Wu et al., 2013c). Both Kdm2a and Kdm2b were 
also reported to facilitate reprogramming of somatic cells to pluripotent stem 
cells (Wang et al., 2011; Liang et al., 2012). 
The mammalian Kdm4/Jmjd2/Jhdm3 cluster contains four proteins, Kdm4a–d. 
They possess specificity towards H3K9 and H3K36 residues, either di- or 
trimethylated, with a preference for the latter (Cloos et al., 2006; Fodor et al., 
2006; Kooistra and Helin, 2012; Berry and Janknecht, 2013). KDM4 proteins 
were also found to demethylate H1.4K26 and to have non-histone substrates 
	   33	  
such as G9a (Ponnaluri et al., 2009; Trojer et al., 2009). Except for Kdm4d, they 
all contain a PHD finger and a Tudor domain at their C-terminal region. Kdm4c 
is the most studied protein of this cluster and it has been characterized as a 
transcriptional co-activator. In addition, Kdm4c is important for self-renewal of 
ESCs through the regulation of Nanog expression during embryonic 
development (Loh et al., 2007). In contrast, KDM4A was mainly described as a 
co-repressor (Gray et al., 2005; Zhang et al., 2005). For instance, KDM4A 
interacts with HDACs and Rb (retinoblastoma protein) (Gray et al., 2005) to 
repress transcription factor E2F-target genes. Conversely, KDM4A has been 
described as a co-activator of androgen receptor (AR) target genes (Shin and 
Janknecht, 2007). Most of the KDM4 enzymes are upregulated in cancers and 
thus have been hypothesized to participate in the control of cellular proliferation 
(Cloos et al., 2006; Kooistra and Helin, 2012; Berry and Janknecht, 2013). 
KDM8 was shown to possess a demethylase activity towards H3K36me2. It 
participates in cell cycle progression by activating the cyclin A1 gene in MCF7 
breast cancer cells (Hsia et al., 2010). KDM8 also participates in both human 
and Arabidopsis circadian systems (Jones et al., 2010). Interestingly, mice 
deficient in Kdm8 exhibited severe growth retardation, resulting in embryonic 
lethality at mid-gestation (Ishimura et al., 2012). 
NO66 was identified as a component of Xenopus laevis nucleoli, where it 
interacts with components of pre-ribosomal complexes (Eilbracht et al., 2004). 
NO66 also localizes in some nuclear highly compacted chromatin foci during 
the late stages of S-phase. In mouse C2C12 cells, NO66 demethylates 
H3K4me2/3 and H3K36me2/3, and its activity is required to inhibit transcription 
of Osterix dependent promoters, an osteoblast-specific transcription factor 
(Sinha et al., 2010). Recently, it was shown in murine ESCs that NO66 
associates with Phf19 and the PRC2 complex to contribute in transcriptional 
silencing of stem cell related genes by removing the H3K36me3 mark (Brien et 
al., 2012). 
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2. Aim of this work 
 
Histone modifications can influence gene expression and genome function by 
tuning chromatin environments and orchestrating DNA-based biological 
processes. H3K36 methylation has been widely associated with active 
chromatin, though it has also been implicated in several other biological 
processes, such as transcriptional repression and alternative splicing. To date, 
at least eight distinct mammalian enzymes have been described to methylate 
H3K36 in vitro and/or in vivo. This work focuses on the Set2 subfamily of H3K36 
methyltranferases: Ash1l, Setd2, and Nsd1-3. Much effort has gone into 
understanding the nature of these enzymes and their substrate specificities, but 
little is known about their regulation and dynamics beyond the well-
characterized model of the yeast Set2 and its relationship with RNA polymerase 
II.  
The major aim of this thesis is to acquire comprehensive proteomic and 
regulomic data about histone methyltransferases in mouse embryonic stem 
cells by Venus tagging and knockdown experiments. The work involved: 
 Generation of BAC transgenic mouse embryonic stem cell lines 
expressing Venus tagged fusion proteins. 
 Investigation of protein-protein and protein-DNA interactions through 
liquid chromatography combined with tandem mass spectrometry (LC-
MS/MS) and chromatin immunoprecipation sequencing (ChIP-seq), 
respectively. 
 Investigation of the functional relevance of PWWP and zinger-finger like 
(PHD and C5HCH) domains of Nsd1 and Nsd3 by sequential deletion of 
these protein domains. 
 Investigation of the protein function-loss phenotype by shRNA 
knockdown and conditional knockout experiments. 
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3. Material and Methods 
3.1. General Materials 
3.1.1. Chemical and reagents 
Reagent Company producer 
  
4',6-diamidino-2-phenylindole (DAPI) Sigma-Aldrich 
Acrylamide/bis-acrylamide 30% Severn Biotech Ltd. 
Agarose Serva 
Ammonium persulfate (APS) Sigma-Aldrich 
Ampicillin Sigma-Aldrich 
Bacto-Agar Difco 
Blasticidin S Life Technologies 
Bovine serum albumin (BSA) Sigma-Aldrich 
Bromophenol blue Merck 
Chloramphenicol Sigma-Aldrich 
Chloroform Merck 
Cold water fish skin gelatin Sigma-Aldrich 
Dimethyl sulfoxide (DMSO) Sigma-Aldrich 
Disuccinimidyl glutarate (DSG) Santa Cruz Biotechnology 
Dithiothreitol (DTT) Sigma-Aldrich 
Electroporation Cuvettes Bio-Rad 
Ethanol Merck 
Ethidium bromide Sigma-Aldrich 
Ethylene diamine tetraacetic acid (EDTA) Sigma-Aldrich 
Ethylene glycol tetraacetic acid (EGTA) Sigma-Aldrich 
Formaldehyde 37% Merck 
Gelatine Merck 
Gentamicin Sigma-Aldrich 
Glycerol Merck 
β-Glycerophosphate disodium salt hydrate Sigma-Aldrich 
Glycine Merck 
Glycogen Santa Cruz Biotechnology 
HEPES Biomol 
Hexadimethrine bromide (polybrene) Sigma-Aldrich 
Hydrochloric acid (HCI) Merck 
Hygromycin B Sigma-Aldrich 
IGEPAL CA-630 Sigma-Aldrich 
Isopropanol Merck 
Kanamycin sulfate Sigma-Aldrich 
L-arabinose Sigma-Aldrich 
Lithium chloride Sigma-Aldrich 
Luminata Classico Western HRP substrate Millipore 
Luminata Forte Western HRP substrate Millipore 
Magnesium chloride (MgCI2) Sigma-Aldrich 
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2-Mercaptoethanol Sigma-Aldrich 
Methanol Merck 
MG-132 Millipore 
Millex-HA Filter, 0.45 µm Millipore 
Mowiol® 4-88 Sigma-Aldrich 
Phenylmethanesulfonyl fluoride (PMSF) Sigma-Aldrich 
Phenol (25):chloroform (24): isoamyl alcohol (1) Sigma-Aldrich 
Phosphate buffered saline	  (PBS) Gibco Life Technologies 
Potassium Chloride (KCI) Merck 
Protease inhibitor cocktail Roche 
Protein G Sepharose 4 Fast Flow GE Healthcare 
QIAzol Lysis Reagent Qiagen 
Sonicated salmon Sperm DNA Stratagene 
Sarcosyl Sigma-Aldrich 
Sepharose CL-4B Sigma-Aldrich 
SDS sample buffer Sigma-Aldrich 
Sodium Bicarbonate (NaHCO3) Merck 
Sodium Chloride (NaCI) Merck 
Sodium dodecyl sulfate (SDS) Serva 
Sodium Hydroxide (NaOH) Merck 
Sodium deoxycholate Sigma-Aldrich 
Tetracycline Sigma-Aldrich 
Tetramethylethylenediamine (TEMED) Sigma-Aldrich 
Triton X- 100 Sigma-Aldrich 
Trizma Merck 
Trizma-Maleate Sigma-Aldrich 
TWEEN-20 Sigma-Aldrich 
Tryptone Sigma-Aldrich 
Whatman® gel blotting paper Sigma-Aldrich 
Yeast extract Sigma-Aldrich 
 
3.1.2. Kits, ladders, nucleotides, and others 
Reagent Company producer 
  
1 kb DNA ladder NEB 
100 bp DNA ladder NEB 
AffinityScript cDNA Synthesis Kit Agilent Technologies 
Benzonase® Nuclease HC, Purity > 90% Millipore 
Colorplus Prestained Protein Marker, broad range (10-
230 kDa) NEB 
dNTP set NEB 
DNase I Life Technologies 
GoTaq® qPCR Master Mix Promega 
HiMark™ Pre-stained Protein Standard Life Technologies 
Immobilon-P Membrane, PVDF Millipore 
Lipofectamine LTX and Plus reagent Life Technologies 
NucleoBond BAC 100 Clontech 
	   37	  
NuPAGE® Novex® 3-8% Tris-Acetate Gel 1.0 mm, 10 
and 12 Well Life Technologies 
Plasmid Purification Kit Qiagen 
Proteinase K Merck 
Taq DNA polymerase kit 5 Prime 
MSB Spin PCRapace Stratec 
Phusion® High-Fidelity DNA Polymerase NEB 
  All restriction enzymes employed in this project are from New England Biolabs Inc. (NEB). 
 
3.1.3. Cell culture media and supplements 
Reagent Company producer 
  
4-hydroxytamoxifen Sigma-Aldrich 
DMEM High Glucose (4500mg/l), GlutaMax Gibco Life Technologies 
DMSO Sigma-Aldrich 
ESGRO (LIF) Millipore 
Fetal Calf Serum (FCS) PAA 
G418 (Geneticin) Gibco Life Technologies 
L-Glutamine Gibco Life Technologies 
MEM non-essential aminoacids Gibco Life Technologies 
Opti-MEM with GlutaMax Gibco Life Technologies 
Penicillin/Streptomycin Gibco Life Technologies 
Puromycin Sigma-Aldrich 
Sodium pyruvate Gibco Life Technologies 
Tissue Culture plates Nunc and Falcon 
Trypsin/EDTA 1x Gibco Life Technologies 
 
Cell lines 
E14TG2a mouse embryonic stem cells (ESCs); genetic background 129; 
feeder independent; wild type, male 
Brd4 conditional knockout 
cells, clones E01 and D3S 
Brd4 targeted C57BL/6N ESCs were obtained from the European 
Conditional Mouse Mutagenesis Program (EUCOMM) 
HEK 293T cells Human Embryonic Kidney 293 cells 
 
Stock solutions cell culture 
2i supplement 
CT (CT-99021, AB253776 from ABCR) 
• dissolve 100 mg in 21.49 ml final volume DMSO for a 10 mM stock (3,333X)  
• Final medium concentration is 3 µM  
PD (PD0325901, AB253775 from ABCR)  
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• dissolve 100 mg in 20.74 ml final volume DMSO for a 10 mM stock (10,000 X)  
• final medium concentration is 1 µM  
 
Antibiotics 
 Stock Final 
Concentration 
Dissolve in: 
G418 50 mg/ml 0.1-0.2 mg/ml 0.1M HEPES 
BSD (Blasticidin) 5 mg/ml 5 µg/ml PBS 
Puromycin 1 mg/ml 1 µg/ml PBS 
 
4-Hydroxytamoxifen (4-OHT) 
• dissolve 5 mg in 1.29 ml ethanol to a stock solution of 10-2 M 
• use 10-6 M for ES cells (1:10,000 in ES medium)  
 
Media composition 
ES medium based on FCS 
Reagent Volume for 500 ml Final concentration 
DMEM Glutamax with 4.5 g/l 
glucose 
Up to 500 ml  
FCS 50 ml 10 % 
L-Glutamine 5 ml 2 mM 
Sodium Pyruvate 5 ml 1 mM 
Non essential amino acids 5 ml 0.1 mM 
Penicillin/Streptomycin 5 ml 100 U/ml / 100 µg/ml 
2-Mercaptoethanol 5 ml 0.1 mM 
LIF 1 ml 1000 U/ml 
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HEK 293T cells medium 
Reagent Volume for 500 ml Final concentration 
DMEM Glutamax with 4.5 g/l 
glucose 
Up to 500 ml  
FCS 100 ml 10 % 
L-Glutamine 5 ml 2 mM 
Penicillin/Streptomycin 5 ml 1 X 
 
2 X Freezing Medium 
Reagent Volume for 10 ml Final concentration 
DMEM Glutamax with 4.5 g/l 
glucose 
5 ml 50 % 
FCS 3 ml 30 % 
DMSO 2 ml 20 % 
 
3.1.4. Antibodies 
Primary antibodies for Western blot 
Target Host Dilution Company 
eGFP goat polyclonal 1: 10,000 MPI-CBG, Dresden 
Ash2l rabbit polyclonal 1: 2,000 A300-112A, Bethyl Lab. 
Nsd1 mouse monoclonal 1: 1,000 04-1565, Millipore 
Nsd3 (Whsc1l1) rabbit polyclonal 1: 1,500 NBP1-04942, Novus Biologicals 
Setd2 (HYPB) goat polyclonal 1: 600 sc-99451, Santa Cruz Biotec. 
Kdm1b rabbit polyclonal 1: 1,000 ABE495, Millipore 
Brd2 rabbit polyclonal 1: 1,000 orb38897, biorbyt 
Brd3 rabbit polyclonal 1: 500 orb39875, biorbyt 
Brd4 rabbit polyclonal 1: 1,200 A301-985A, Bethyl Lab. 
Sfpq rabbit polyclonal 1: 500 orb31988, biorbyt 
Zfx rabbit polyclonal 1: 500 orb31651, biorbyt 
H3 rabbit polyclonal 1: 1,000 06-755, Millipore 
H3K36me1 rabbit polyclonal 1: 500 ab9048, Abcam 
H3K36me2 rabbit polyclonal 1: 500 39255, Active motif 
H3K36me3 rabbit polyclonal 1: 500 ab9050, Abcam 
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Secondary antibodies for Western blot 
Target Host Dilution Company 
IgG (H+L)-HRP Conjugate rabbit anti-goat 1: 10,000 31105, Thermo Scientific 
IgG (H+L)-HRP Conjugate goat anti-rabbit 1: 30,000 31210, Thermo Scientific 
IgG (H+L)-HRP Conjugate goat anti-mouse 1: 5,000 172-1011, Bio-Rad 
 
3.1.5. Plasmids 
pSC101-BAD-RedαβγA-tet 
pSC101-BAD-Dre-tet  
pSC101-BAD-Flpe-tet  
pR6K-zeo-eGFP-IRES-neo-pA-hyg  
pR6K-hyg-PUbC-em7-BSD  
pR6K-amp-2xTy1-rpsl-genta-3xFlag  
pR6K-2xTy1-2xPreS-mVenus-Biotin-PGK-em7-neo  
pR6K-2xTy1-2xPreS-mVenus-Biotin-T2A-gb3-neo  
pR6K-amp-TEV-P2A-mVenus-T2A-neo 
pR6K-mVenus-P2A-neo-2xTy1-2xPreS 
pR6K-rox-hyg-PGK-rox-loxP 
 
3.1.6. Bacterial Artificial Chromosomes (BACs) 
Target gene ID 
Ash1l bMQ-400L8 
Setd2 RP23-262F14 
Nsd1 RP24-345G21 
Nsd2 RP24-493B11 
Nsd3 RP24-391C10 
Kdm1b RP23-81I8 
Brd4 RP23-379O10 
Zfx RP23-269L6 
Zkscan17 RP24-169H19 
Supt6 RP24-187G6 
 
3.1.7. Primer sequences 
Recombineering Sequence (5’ – 3’) 
Nsd1_HA-F CTCTTAACCAGGCTCCTTCTAGTCGCAAATGTGCAGATTCAGAAAAGAAAGAAGTGCAT
ACCAATCAGGAC 
Nsd1_HA-R CCTCCTCAAATGGTACCCTGGGGACAGCTTGTCTAGTTATGTGACATTTACTTGTCGTC
GTCATCCTTGTA 
Nsd2_HA-F AAGGAAAGAGGAAGAAAAGGCGGTGCTGGCGAAGGGTCACAGATGGCAAAGAAGTGC
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ATACCAATCAGGAC 
Nsd2_HA-R TGCCTTCCCACTGTCTGCAGGGCTGGCTGCCCCACACCACCCCAGGATCTACTTGTCG
TCGTCATCCTTGTA 
Nsd2-NHAF ATTTTTTAATGCTGTAGTGTTCTAAGAACCAAAGGATCTAGGCTGGATGGAAAGCAAAG
GAGAGGAGCTGTTCAC 
Nsd2-NHAR CATGCACTTTACAACTTTCTGAACAGAAAGAGGACTTTTTCTGATGCTAAACGACAGGG
GCCCCTGGAACAGAAC 
Nsd3_HA-F AGATCAGATGTAAATGGGAATCCCAAGATAGTGGAGAAGAAGTAAAGGAGGAAGTGCAT
ACCAATCAGGAC 
Nsd3_HA-R CAGGCGTGGCCTCTCTGCGCCTCTTTACTGAGAGCAGTGGGAGGAGGTCACTTGTCGT
CGTCATCCTTGTA 
Nsd3-NYFP-HAF GCTCGATGAGAGAAAGGGAAAGTTAAGGATGCTGGAGCAGAACAATGGATAGCAAAGG
AGAGGAGCTGTTC 
Nsd3-NYFP-HAR GGTTGCTGAATTGTGTTTCCCATGATCCCTTGCATGAAAGAGAAAGAGAAGGAAGTTCC
TATACTTTCTAGAGAATAGGAACTTCTCAG 
Nsd3_IRESHAF TCAGATGTAAATGGGAATCCCAAGATAGTGGAGAAGAAGTAAAGGAGTGAGAATTCCGC
CCCCCCCCCTCT 
Nsd3_IRESHAR GGCCTCTCTGCGCCTCTTTACTGAGAGCAGTGGGAGGAGGTCACCACCGCAGGATTAT
TTTAGGGTCAGAA 
Setd2_HA-F TGCAGAAGTTTGGGGCTGTTTACAAACCTAAAGAGGACACTGAACTAGAGGAAGTGCAT
ACCAATCAGGAC 
Setd2_HA-R GGGCAGAAGCCACAGGATTCATCCTTTCCGCTCATACTCCACTCTGGCCTACTTGTCGT
CGTCATCCTTGTA 
Ash1l_HA-F GGAAACTGCGAAGGCGCACTTTGTTTATACCAGAAAATAGCTTTCGGAAGGAAGTGCAT
ACCAATCAGGAC 
Ash1l_HA-R GCTGGACTTGATGGTGCCGTTGGATCCCAGGTGCTCGCTCGCGGTTCTCACTTGTCGT
CGTCATCCTTGTA 
Ash1-NYFP-HAF TCTGTAAAAGTTTTGTAAGATCCCTTGGCAATAACACACTTGTGATGGACAGCAAAGGA
GAGGAGCTGTTC 
Ash1-NYFP-HAR GAAAATCCTTCGGAATCAGAACCCAATCCTAACATAGCAGTATTCCTAGGGGAAGTTCC
TATACTTTCTAGAGAATAGGAACTTCTCAG 
Kdm1b-HAF TGTCCCCTCTCCTCCCCTCCTTCCCCAGGTTTTCCAAAGCAATGGCCGCAAGCAAAGGA
GAGGAGCTGTTCAC 
Kdm1b-HAR TTATCAGGAGAAAGCTCCAAATTGCTTCTCTTCTTTGACCTCCCTCGAGATGCGGCCGA
CAGGGGCCCCTGGAACAGAAC 
Kdm1b_IRESHAF GGGCATATTTAAGTGGTGTACGAGAAGCAAGCAAGATTGCAGCCTTTTAAGAATTCCGC
CCCCCCCCCTCT 
Kdm1b_IRESHAR CTTCAAACTTCCATTTGGGATACAGAACGTTAGGTCCATACAAGTTCTTTAGGATTATTTT
AGGGTCAGAA 
Zfx-NHAF CCCTTGATTTAGGTGTTCTGGCTGATGAGAATTTAAAGGCCATGGATGAAAGCAAAGGA
GAGGAGCTGTTCAC 
Zfx-NHAR GTTGCATCAAAAAATGAGTTTGGTGCTTGTTGTTGTAATTCAAGTCCATCTTCATCCGAC
AGGGGCCCCTGGAACAGAAC 
Supt6_CHAF CCATGTCCATTGCTGGCGATGCGACCCCACTCCTGGACGAGATGGATCGGGAAGTGCA
TACCAATCAGGAC 
Supt6_CHAR GCCTCTTGGGAGCTTCAGAGGTAACCAGAGTCCGAGGAACAGGCCCCCTACTTGTCGT
CGTCATCCTTGTAG 
Brd4_CHAF CATGAATTTCCAGAGTGATCTTTTGTCAATATTTGAAGAAAATCTTTTTGAAGTGCATACC
AATCAGGAC 
Brd4_CHAR AGAGTCAACATTTTTGCCAGAAAAAGTCAGAAGTCACCTGGGTGCTCTCACTTGTCGTC
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GTCATCCTTGTA 
Zkscan17_NHAF ATAGGGTCGTCTTCTGCCGCTGACCCCCATCAAATCCCATCATGCCCACAAGCAAAGGA
GAGGAGCTGTTCAC 
Zkscan17_NHAR TTCCTGGGCTCCTCACTTTCCTTTGGAGCCAAGACTCGTGGGCACAGGGCTGTGGGCG
ACAGGGGCCCCTGGAACAGAAC 
Nsd3_HAF_dE3-4 TATTATTTTCCCCCATTCTTTTTTGTAAGCTATAGATTAGTCGATACCAGTAACTTTAAATA
ATTGGCATTATTTAAAGTTAGTTTAAACGCGGCCGCATTCT 
Nsd3_HAR_dE3-4 CTTCTCTTCCAGAAGGCCAGAGTTTGAGTCCTAGTACTCAGAACAGGCAGAGACAGAGA
AATTGCACGCCTA 
Nsd3_HAF_dE9-14 ATTGCAATCATTAAAAGCTCTTATTATTTTTTCTAACATTAGTGCCGTTGTAACTTTAAATA
ATTGGCATTATTTAAAGTTAGTTTAAACGCGGCCGCATTCT 
Nsd3_HAR_dE9-14 GGGTTTTGTTTTGTTTCAAGACAGTGTTTCTTTGTGTTCCCCTGGCTATCAGACAGAGAA
ATTGCACGCCTA 
Nsd3_HAF_dE15-16 AAGAGGATCTCTGAGTTGGAGGCTAGCCTGGTCTACAGGGCTAGTTCCAGTAACTTTAA
ATAATTGGCATTATTTAAAGTTAGTTTAAACGCGGCCGCATTCT 
Nsd3_HAR_dE15-16 TGTCTGAAGACAGCTACAGTGTACTCACTTGCAATAAATAAATAAATCTTAGACAGAGAA
ATTGCACGCCTA 
Nsd3_HAF_dE22-23 GCCACTGCGGAGCAGACAACTGTAGTGGATTTCTAGGAGTGCGGCCAAAGTGAGAATT
CCGCCCCCCCCCCTCT 
Nsd3_HAR_dE22-23 GGCCTCTCTGCGCCTCTTTACTGAGAGCAGTGGGAGGAGGTCACCACCGCAGGATTAT
TTTAGGGTCAGAA 
Nsd1_HAF_dE3-4 GAGTTTTCTCCTCCTTTTTTGTGGGTTCCAGGGATTGCACTAAAGTAGTCTAACTTTAAA
TAATTGGCATTATTTAAAGTTAGTTTAAACGCGGCCGCATTCT 
Nsd1_HAR_dE3-4 AAACTGCAGCACAGTTGTAGAAGACCCCAGGATTCTGCCGATGCCAGTACAGACAGAG
AAATTGCACGCCTA 
Nsd1_HAF_dE10-14 ACCACATAAACAAGGTGTATTAGCATATGCCTAGGACTTCAGCATTCTGGTAACTTTAAA
TAATTGGCATTATTTAAAGTTAGTTTAAACGCGGCCGCATTCT 
Nsd1_HAR_dE10-14 GTCTCCATTTGCCATCACAGACTTACTAAAACTGTTTAAATAAAACATGGAGACAGAGAA
ATTGCACGCCTA 
Nsd1_HAF_dE15-16 GTTAAAACGAAGTCCAAAGATCACCTAAAGTGTTCTCAGTGTGCTAAGTCTAACTTTAAA
TAATTGGCATTATTTAAAGTTAGTTTAAACGCGGCCGCATTCT 
Nsd1_HAR_dE15-16 CAAATTCTAAGGCTTCAATATCCATTTAATTACAGAGAAACCCTGTCTCGAGACAGAGAA
ATTGCACGCCTA 
Nsd1_HAF_dE22-23 GTAAATGTGGAGCACCCAACTGCAGTGGCTTCTTGGGTGTGAGGCCAAAGGAAGTGCA
TACCAATCAGGAC 
Nsd1_HAR_dE22-23 CAAATGGTACCCTGGGGACAGCTTGTCTAGTTATGTGACATTTACTGTATTACTTGTCgT
CGTCATCCTTGTA 
Zkscan17IRESneo-
HAF 
AGCGCCTGCACATGAAGCGACGCTCCAAGCAGGCTCTCAACTCATACTGAGAATTCCG
CCCCCCCCCCTCT 
Zkscan17IRESneo-
HAR 
AAGTTAGACACTACCTGAGAGCAAAGGGCAGGTGGTGAGGGTTCTGTGCTTCAGAAGA
ACTCGTCAAGAAG 
 
Genotyping Forward (5’ – 3’) Reverse (5’ – 3’) 
Venus-F GCTCCCTGACAACCACTACC - 
Venus-R - TGACAAATTCCAGGAGGACC 
Biotin - TTCGTGCCACTCGATCTTCT 
Nsd1 CCCTCCCCAATGAAGAAAAG Venus-R 
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Nsd2 N-term. CCATGTTGGTTGGTGGTGAT TTACTTCCTGGGCCTCAAAA 
Nsd2 C-term. ACGGCAGTCAGAGGATGAGT Venus-R 
Nsd3 N-term. TTCTGGATGTGGTGGTGTGT CGGAGGAAGGTCTTCTGTTG 
Nsd3 C-term. GGTGCCCTCTGCACTAGAAG Venus-R 
Setd2 CCTGGAGTGCAATGAGAATG Venus-R 
Ash1l N-term. GATGCTGGTTGCAAGTTTTG CCTCCTTTCCTGCTTCTGTG 
Ash1l C-term. AGCCATTGACGTGACCTACC Venus-R 
Kdm1b N-term. CCAGGGGAGCAAGAATATGA ACAAACAGCAACAGCAGCAC 
Kdm1b C-term. CAGAGACTCAAGGGCGATCT Venus-R 
Zfx AAGACAGGGCCCCACTTATC GAGCCATAACAACCTCCCAAT 
Brd4 AGGGAACAGCACTGGAGCTA Venus-R 
Supt6 GGTGGGTTGCTTCCTGTAAA Venus-R 
Zkscan17 GGAGACCAGAGCATTGAAGC GCAGGATAGCCAAGAACTGC 
 
RT-qPCR bp* Forward (5’ – 3’) Reverse (5’ – 3’) 
Actb 122 CCAACACAGTGCTGTCTGGTGGT GCGCTCAGGAGGAGCAATGATCTTG 
Nsd3 98 GTGAAAGCAAGGAGGCTTTG GACCTGCACCTTCCCTATGA 
Setd2 140 GGCAGCCTCAGTCCTTACAG GATCTTCCCCTCAGGGTCTC 
Nsd1 147 AGTGGCTTCTTGGGTGTGAG ATCCCCACAGCTGAAACATT 
Kdm1b 188 TGAAAGCCATCAACAGCTTG CACCGACATCAGCACACTCT 
Zfx 128 CAAGTGCCCTCTTGCACATA ATGTCCATCTGGGCCAATAA 
Brd4 307 TGGCAGAAGCTCTGGAGAAG GGAGTCTGAAGTGGCTGAGG 
Klf4 241 TGCCAGAGGAGCCCAAGCCA GGCCGGTGCCCTGTGTGTTT 
Rex1 116 AAGAGCTGGGACACGTGGCAA GGCAGCACAGTGAGGCGATCC 
Tbx3 148 TCCCGGAAACAGAATTCATC ATGGACTGCAGTGTGAGCTG 
Tcl1 150 GAAGCTATGTCCCCCAGTCA TTCAAGCAACATGTCCTCCA 
Oct4 131 TGGAAGCCCCCACTTCACCACA AGCATCCCCAGGGAGGGCTG 
* bp: fragment range in base pairs 
 
ChIP qPCR bp* Forward (5’ – 3’) Reverse (5’ – 3’) 
Intergenic region 
(Chromosome 9) 
249 TGGCAGCTTGTGTTGTTAGA CCACTATGGTGTCAGGAAGG 
Bmp4 (Exon 4) 217 CCACTCCCTTGAGGTAACGA TTCCTGGACACCTCATCACA 
Cdk4 promoter 136 ATTATGGAAGGTGGCCCAAT CATCGCACTAGGCACAAAGA 
Klf6 (gene body) 239 CCCTGGAATGAACAGCCTAA ACAACCTTCCCATGAGCATC 
Rif1 promoter 197 GGTTTACTGTCGTTTCTGCCGCACCTG TAAAGGAGACCCATGGCGTGCAT
AACAAAG 
Rif1 (Exon 18) 85 CTGGTCCAACATCACCACTG TGCTCCTTGTTTACCAACTGC 
Esrrb promoter 177 TGAGCTATCAAGTCATTGGCAAAGAGGACA TTGTTCCGGTCACGTTGTGGGTT
CTAT 
Oct4 promoter 169 TCCTCCTAATCCCGTCTCCT TCCCCTCACACAAGACTTCC 
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Oct4 (Exon 4) 176 AGCGGTTTGTTCTTCAGTCC GGTCTCCAGACTCCACCTCA 
Nanog enhancer 204 CCCAGAGGACCCACTTAACA CATTCCTGTCCTGCCTCTTT 
Sox2 promoter 182 CAGAAACAATGGCACACCAC CAAGACGACAGCTCCTTTCC 
Ccnd1 (Exon 3) 110 CCACTTGAGCTTGTTCACCA CGGGTTGACCCAACTCTTTA 
Brd2 (Exon 9) 124 GGCAAGGCAGTAGAGACTGG GGCTGGGCATTAAACACAGT 
Tcl1 promoter 100 CTGCCCGTAGTCATCAAGGT GGTCTCCTGCTACCAGCATC 
Tbx3 promoter 118 GGGCTCGGTCTCAGTATGTC GGGATCCCACCAATCTTTCT 
* bp: fragment range in base pairs 
 
3.2. Methods – DNA 
3.2.1. Obtaining a BAC 
Most sequenced metazoan genomes are available as bacterial artificial 
chromosome (BAC) libraries. BACs are extremely useful because they can 
cover 100–400 kb genomic DNA. Hence, most metazoan genes and their 
regulatory elements can be fully encompassed by a single BAC. 
Available BACs were analyzed using both genome browsers: Ensembl 
(http://www.ensembl.org/index.html) and UCSC (http://genome.ucsc.edu). 
Selected BACs were obtained from the specific genome provider (e.g., 
C57BL/6J BAC from Children’s Hospital Oakland Research Institute (CHORI), 
http://bacpac.chori.org; bMQ BAC from Geneservice, 
http://www.geneservice.co.uk/home/). 
The genomic DNA sequence covered by the selected BACs was exported in 
fasta format into a DNA management program, Gene Construction Kit version 
3.5 (TEXTCO BioSoftware), for in silico design of the final tagged BAC 
transgene. The BAC sequence, covering the genomic DNA and BAC backbone 
(normally pBACe3.6), was essential for the design of the recombineering 
strategy (e.g. generation of constructs, oligonucleotides needed for 
recombineering and sequencing), as well as for the analysis to generate 
restriction maps for analytical BAC digestion.  
 
3.2.2. Design of the tagging cassette 
For N-terminal tagging the cassette pR6K-amp-TEV-P2A-mVenus-T2A-neo (an 
older version) or pR6K-mVenus-P2A-neo-2xTy1-2xPreS was used, while for C-
terminal tagging the cassettes pR6K-2xTy1-2xPreS-mVenus-Biotin-PGK-em7-
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neo and pR6K-2xTy1-2xPreS-mVenus-Biotin-T2A-gb3-neo were used in this 
work (Fig. 7).  
The tagging cassette template plasmids are based on the R6K-origin, which 
requires the Pi protein for their replication (Filutowicz et al., 1986). Most 
standard Escherichia coli hosts lack Pi so R6K plasmids will not replicate. 
Consequently, antibiotic resistant colonies caused by carryover of the PCR 
template (rather than the intended recombineering event) are completely 
eliminated; and this R6K plasmid needs to be grown in a special Pi+ host such 
as GB05-pir. 
Depending on the version, the N or C-terminal tagging cassettes can be 
composed by the elements listed below:  
• 2xTy1, two copies of the Ty1 peptide; 
• PreS, two copies of the recognition sequence for PreScission protease 
enabling the specific elution of the purified protein from affinity-tag columns 
(Walker et al., 1994); 
• mVenus, the coding region for codon optimized, CpG dinucleotide-
reduced, Venus fluorescence protein (Nagai et al., 2002); 
• Biotin, the coding region for the biotin tag (de Boer et al., 2003); 
• P2A, the coding region for the 2A peptide from Porcine teschovirus-1 
(Szymczak and Vignali, 2005); 
• T2A, the coding region for the 2A peptide from Thosea asigna virus 
(Szymczak and Vignali, 2005); 
• FRT, target site for the deletion of the P2A-neo upon Flp (Flpe/FlpO) 
recombination (Raymond and Soriano, 2007) in the N-terminal cassette; 
• 3xFlag, three copies of the Flag tag (Terpe, 2003); 
• rox, a site for the deletion of the PGK-neo or T2A-neo region upon Dre 
recombination in the C-terminal cassette (Anastassiadis et al., 2009); 
• PGK (the human phosphoglycerate kinase) promoter; 
• em7, the E. coli em7 promoter, which is embedded in the 5’ non-coding 
region of the neomycin gene/kanamycin; 
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Figure 7. Plasmids used for BAC tagging. (A) All recombineering steps require the plasmid 
pSC101-BAD-RedαβγA-tet for the L-arabinose inducible expression of the l-Phage proteins αβγ. 
This plasmid conveys tetracycline resistance. (B) The adaptor plasmid pR6K-amp-2xTy1-rpsL-
genta-3xFlag is used for the initial modification of the stop codon of the gene of interest. This 
plasmid serves as a template for PCR amplification using oligonucleotides that also contain the 50 
nt homology arms to the gene of interest. The 2xTy1 and 3xFlag sequences function as internal 
homology/adaptor regions for the subsequent integration of the targeting cassette. The two R6K-
plasmids that contain the C-terminal tagging cassettes are shown in (C) pR6K-2xTy1-2xPreS-
mVenus-Biotin-T2A-gb3-neo and (D) pR6K-2xTy1-2xPreS-mVenus-Biotin-PGK-em7-neo. The new 
version of the N-terminal tagging cassette is shown in (E) pR6K-mVenus-P2A-neo-2xTy1-2xPreS. 
After insertion of the N-terminal tagging cassette into the target BAC, the P2A-neo coding region, 
flanked by FRT sites, is deleted by expressing the plasmid (F) pSC101-BAD-Flpe-tet. 
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• gb3, the E. coli gb3 promoter, which is included within the open reading 
frame of the neomycin/kanamycin antibiotic resistance coding region; 
• neo, the coding region for neomycin/kanamycin resistance gene; 
• poly(A), the SV40 polyadenylation region. 
The antibiotic resistance gene in the tagging cassette was configured to 
express in E. coli as well as in mammalian cells (Angrand et al., 1999). In E. 
coli, the gb3 or em7 promoter drives expression. In mammalian cells, 
expression is driven by an independent eukaryotic promoter (PGK) or 
polycistronically by a T2A or P2A peptide (Szymczak and Vignali, 2005), or an 
IRES sequence (Hellen and Wimmer, 1995). For the polycistronic strategy, 
expression of antibiotic resistance is directly dependent on the expression of 
the tagged gene. Thus, if the tagged gene is low or not expressed in the host 
cells, the PGK version must be used. 
 
3.2.3. Transformation with Red/ET expression plasmid 
Tagging BAC by recombineering requires multiple steps. A resistance to a 
specific antibiotic characterizes each step. The BAC backbone usually carries 
chloramphenicol resistance, while the Red/ET expression plasmid conveys 
tetracycline resistance. On the other hand the tagging cassette presents 
kanamycin resistance, so that the subsequent acquisition of kanamycin 
resistance indicates the insertion of the cassettes into the BAC by homologous 
recombination. 
For recombineering, the first step involved the introduction of an inducible 
Red/ET expression plasmid into the E. coli host harboring the chosen BAC. The 
Red/ET expression plasmid encodes the three genes from the λ phage Red 
operon, Redγ (an inhibitor of RecBCD), Redβ (a DNA annealing protein), and 
Redα.  
Cells were streaked out the glycerol stock of the E. coli BAC host on Luria Broth 
(LB) agar plates with 15 µg/ml chloramphenicol and incubated at 37°C 
overnight with shaking (Eppendorf Thermomixer). 
From 6 to 10 colonies of E. coli carrying the BAC were picked from the plate 
and inoculated into microfuge tubes containing 1.0 ml LB medium plus 15 µg/ml 
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chloramphenicol. The tubes were incubated at 37°C overnight with shaking. 
The next day, two microfuge tubes containing fresh 1.4 ml LB medium with 15 
µg/ml chloramphenicol were set up and inoculated with 30 µl of fresh overnight 
culture. The cells were cultured for 2-3 h at 37°C by shaking at 1000 rpm. The 
cells were centrifuged for 30 s at 7,500 g in a cold bench centrifuge, the 
supernatant was discarded and the cell pellet was placed on ice. The cell pellet 
was resuspended in 1 ml ice cold ddH2O (double-distilled water), pipetted up 
and down three times to mix the suspension. This wash step was repeated 
once more and the cells were resuspended in 20-30 µl of ice cold ddH2O. 100 
ng of pSC101-BAD-RedαβγA-tet or water as a negative control was added to 
the resuspended cells. The cell suspensions were transferred from the tubes to 
the chilled electroporation cuvettes. The cells were electroporated in the 1 mm 
gap electroporation cuvette at 1350 V, 10 µF, 600 Ohms = ~ 5ms pulse time 
(Electroporator 2510, Eppendorf). The cells were diluted by adding 1 ml LB 
medium without antibiotics to the cuvettes and transferred to new microfuge 
tubes. The cells were incubated at 30°C for 1 h, shaking at 1000 rpm for 
recovery. The Red/ET expression plasmid pSC101-BAD-RedαβγA-tet is 
replicated at 30°C, because replication of the pSC101 plasmid is temperature 
sensitive. 100 µl of cells were plated on LB agar plates containing the antibiotics 
to select for the BAC and the Red expression plasmid (e.g., 15 µg/ml 
chloramphenicol plus 3 µg/ml tetracycline). The plates were incubated at 30°C 
overnight. 
 
3.2.4. Polymerase chain reaction (PCR) 
PCR MIX for generating cassettes used for recombineering 
Ingredients Volume for 25 µl reaction Final concentration 
ddH2O Up to 25 µl - 
5 X Phusion HF Buffer 5 µl 1 X 
10 mM dNTPs 0.5 µl 200 µM each 
10 µM forward primer 1.25 ul 0.5 µM 
10 µM reverse primer 1.25 µl 0.5 µM 
Template DNA 30 ng - 
DMSO 100% 1.25 µl 5 % 
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Phusion DNA polymerase 0.25 µl 0.02 U/µl 
 
PCR program for generating cassettes used for recombineering 
30 s at 98oC    
10 s at 98oC 
25 s at 64oC 
30 s to 1 min at 72oC 
 
25 cycles 
 
Elongation of 1 kb fragment / 30 
s 
5 min at 72 oC   
* PCR products were separated on standard agarose gels with ethidium bromide (0.8-2 % agarose 
according to PCR product size) and purified using a standard PCR purification kit (MSB Spin PCRapace). 
 
PCR MIX for genotyping 
Ingredients Volume for 15 µl reaction Final concentration 
ddH2O Up to 15 µl - 
10 X Buffer with MgCl2 1.5 µl 1 X 
10 mM dNTPs 0.3 µl 200 µM each 
10 µM forward primer 0.3 ul 0.2 µM 
10 µM reverse primer 0.3 µl 0.2 µM 
Template DNA 10 ng - 
Taq 5’ DNA polymerase 0.15 µl 0.05 U/µl 
 
PCR program for genotyping 
4 min at 94oC    
30 s at 94oC 
30 s at 55-68oC 
1-2 min at 68oC 
 
30 cycles 
 
Elongation of 1 kb fragment / 1 
min 
5 min at 68oC   
* PCR products were separated on standard agarose gels with ethidium bromide (0.8-2 % agarose 
according to PCR product size). 
 
3.2.5. Inserting a cassette into a BAC by recombineering 
5-10 colonies from the tetracycline and chloramphenicol plate were inoculated 
in one microfuge tube containing 1.0 ml LB medium plus antibiotics and 
incubated while shaking at 30°C overnight. The next day, two microfuge tubes 
(one for sample and another as negative control) containing fresh 1.4 ml LB 
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medium with 15 µg/ml chloramphenicol plus 3 µg/ml tetracycline were 
inoculated with 40 µl of the overnight culture. The cells were cultured for ~ 2 h 
at 30°C, shaking at 1000 rpm until absorbance (OD) 600 nm = 0.3. Expression 
of the Red-proteins from pSC101-BAD-RedαβγA-tet transformed in E. coli host 
containing the BAC was induced by the addition of 20 µl of 10 % L-arabinose to 
the sample but not to the negative control. The cells were incubated at 37°C 
shaking for 45 min to 1 h. The cells were centrifuged for 30 sec at 7,500 g in the 
cold benchtop centrifuge, the supernatant was discarded and the cell pellet was 
placed on ice. The cell pellet was resuspended in 1 ml ice cold ddH2O, pipetted 
up and down three times to mix the suspension. This wash step was repeated 
once more and the cells were resuspended in 20-30 µl of ice-cold ddH2O.  
The purified cassette (200-400 ng of DNA) was electroporated in both induced 
and uninduced (negative control) cells. Cells were electroporated in the 1 mm 
gap electroporation cuvette at 1350 V, 10 µF, 600 Ohms = ~ 5ms pulse time 
(Electroporator 2510, Eppendorf). Cells were diluted by adding 1 ml LB medium 
without antibiotics to the cuvettes and transferred to the microfuge tubes, to be 
then incubated at 37°C with shaking for 1 h for recovery. After recovery, the 
cells were spun down and resuspended in 100 µl of LB medium and then 
streaked onto LB agar plates (pH 8.0) containing 15 µg/ml chloramphenicol (to 
select for the BAC) and 15 µg/ml kanaymcin (to select for the integration of the 
cassette). The plates were incubated at 37°C overnight.  
 
3.2.6. Quality control of recombineering 
To check for successful recombineering of the inserted BAC transgene, two 
tests were performed. First, the BAC transgene was examined using restriction 
enzymes. To isolate the BAC DNA, 5 or more colonies were picked for BAC 
mini-preps and compared to the original unmodified BAC.  
Second, in case of C-terminal tagging, only the 5’ recombineering junction was 
PCR amplified and sequenced. For N-terminal tagging, both 5’ and 3’ junction, 
also including the tagging cassette, was PCR amplified and sequenced. 
Sequencing ensures that the reading frame is intact and excludes the possibility 
that the synthetic oligonucleotide has introduced an unwanted mutation. All 
sequencing reactions were performed by Eurofins Scientific 
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(http://www.eurofins.com) or by the DNA sequencing Facility from MPI-CBG, 
Dresden, Germany. 
 
3.2.7. BAC/plasmid Mini-prep protocol and restriction analysis of DNA 
Single colonies were picked and cultured in 1.8 ml LB plus 15 µg/ml 
chloramphenicol and 15 µg/ml kanamycin. The cells were incubated in a 
ThermoMixer compact (Eppendorf) at 37°C, 1000 rpm for 14-16 hours. From 
each culture 100 µl were transferred into fresh microfuge tubes. These aliquots 
served as backup cultures of the individual clones. The remaining over night 
cultures were spun down at 13,000 g for 1 min and the supernatant was 
discarded. The cells were resuspended in 200 µl of buffer P1 (50 mM Tris-HCl, 
pH 8.0, 10 mM EDTA, pH 8.0, 100 µg/ml Rnase A) and mixed thoroughly. Then, 
the cells were lysed by adding 200 µl of buffer P2 (200 mM NaOH, 1 % SDS) 
and mixed by inverting the sealed tube 4 to 6 times. Lysis was completed by 
incubation at room temperature (RT) for no more than 5 min. The cells were 
finally neutralized with 200 µl of buffer P3 (3.0 M potassium acetate, pH 5.5) by 
immediately inverting the sealed tube 4 to 6 times. The white lysate was spun 
down in a centrifuge at 16,000 g for 20 min at RT. The clear supernatant was 
transferred into the new tubes containing 500 µl of 100 % isopropanol. The 
samples were centrifuged at 16,000 g for 15 min at RT to precipitate DNA. The 
supernatant was discarded and the DNA pellet was gently washed with 1 ml of 
70 % ethanol. The supernatant was carefully aspirated and the DNA pellet was 
dried at 45°C in a ThermoMixer for 10-20 min. The DNA pellet was dissolved in 
20 µl of ddH2O or directly in digestion buffer for the chosen restriction enzyme. 
After restriction digestion, the samples were resolved on a 0.7 % agarose gel at 
70 Volts or less. 
 
3.2.8. BAC Maxi-prep Protocol 
BAC DNA maxi preparations were made with the NucleoBond BAC 100, 
following the manufacturer’s instructions. 
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3.2.9. Tagging strategy 
For each target gene, the protein domain structure was evaluated in order to 
choose the most suitable tagging strategy, C or N-terminal insertion. The C-
terminal tagging strategy consists of two sequential recombineering steps (Fig. 
8) previously published by our group (Hofemeister et al., 2011).  
 
Figure 8. Scheme for sequential C-terminal BAC tagging modified from Hofemeister et al. (2011). 
(A) Short adaptor cassette generated by PCR: (1) terminal homology arms flanking the cassette, (2) 
a streptomycin counter selectable gene (rpsL), (3) gentamicin selectable gene (genta) framed by (4) 
2xTy1 and (5) 3xFlag sequences. (B) After introduction of the recombineering expression plasmid, 
pSC101-BAD-Redαβγ, the adaptor PCR product is electroporated and inserted into the BAC by 
recombineering. (C) The tagging cassette is generated by plasmid linearisation of pR6K- 2Ty1-
2PreS-mVenus-Biotin-PGK-em7-neo or pR6K-2Ty1-2PreS-mVenus-Biotin-T2A-gb3-neo. The 
integrated adaptor cassette contains the homology regions, termed 2xTy1 and 3xFlag, for the 
tagging cassette thus avoiding error prone PCR amplification of the tagging cassette. The tagging 
cassette consists of (1) homology region 2xTy1 at the 5’ end and 3xFlag at the 3’ end (2) the 
protein tag (mVenus) and (3) the neomycin/kanamycin antibiotic resistance gene. (D) The tagging 
cassette replaces the adaptor cassette by recombineering. 
 
First, a short adaptor cassette generated by PCR is inserted (Fig. 8B). Two 
oligonucleotides are synthesized to include the homology arms to the BAC and 
are attached by PCR to the adaptor cassette, using the plasmid pR6K-amp-
2xTy1-rpsL-genta-3xFlag as template DNA (Fig. 8A). The 5’ oligonucleotide 
consists of 50 nucleotides (nt) upstream of the stop codon followed by 21 nt of 
the 5’ PCR primer. Thereby, the sequence of the protein tag is fused in-frame 
	   53	  
onto the coding region of the chosen gene. The 3’ oligonucleotide consists of 
the reverse complement sequence of the first 50 nt downstream of the stop 
codon (also included), followed by 21 nt of the 3’ PCR primer. High fidelity proof 
reading polymerase (Phusion, NEB) was used for the PCR, as described in the 
PCR methods section above.  
In the second recombineering step, the protein tag cassette replaces the 
adaptor one (Fig. 8D). Thereby the tagging cassette is not PCR amplified but 
generated by restriction digestion of a plasmid.  
The N-terminal tagging strategy also comprehended two steps (Fig. 9). First, 
the tagging cassette is generated by PCR using the plasmid pR6K-amp-TEV-
P2A-mVenus-T2A-neo or pR6K-mVenus-P2A-neo-2xTy1-2xPreS as template 
DNA (Fig. 9A). The former plasmid was only used as DNA template in the first 
experiments (Ash1l and Nsd3 N-tagging). Afterwards, the latter plasmid was 
always used. 
Both cassettes consisted of (1) 50 nt of BAC specific homology arms, (2) 
mVenus protein tag and (3) the neomycin/kanamycin antibiotic resistance gene 
flanked by FRT sites (Fig. 9). The homology arms were designed, so the 
tagging cassette was placed after the third codon of the first exon and the 
second and third exon were also added artificially in the 3’ homology arm in the 
primer sequence, just after the tagging cassette (Fig. 9A). This decision was 
made due to the fact that, normally, the enzyme methionine aminopeptidase 
removes the initiating methionine from the growing polypeptide chain on the 
ribosome in prokaryotes and eukaryotes (Giglione et al., 2004) and therefore 
could affect the tag by doing so. Moreover, in order to avoid any problems 
regarding signal peptides in the N-terminal of the target protein by the inserted 
tag, the second and third exon were duplicated after the tag. 
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Figure 9. Schematic representation of the N-terminal tagging strategy. (A) (1) Short N-terminal 
cassette generated by PCR with terminal homology arms flanking the 3rd codon of Exon 1. The 
second and third codon sequence was added in the 3’ homology arm sequence. (2) The cassette 
was targeted in-frame on the BAC. (3) P2A-neo coding region, flanked by FRT sites, was removed 
by transformation and expression of the plasmid pSC101-BAD-Flpe-tet. Insertion of an antibiotic 
resistance gene in the tagged BAC to be expressed in mammalian cells: (B) (1) IRES-neo cassette 
generated by PCR using the plasmid pR6K-zeo-eGFP-IRES-neo-pA-hyg as template DNA. It 
contains homology arms to (2) target the cassette in-frame in the STOP codon of the gene on the 
BAC. (C) Linearization of the plasmid pR6K-hyg-PUbC-em7-BSD by PacI and AscI restriction 
enzymes, (D) followed by electroporation and recombineering in the tagged BAC E. coli host cells. 
The pR6K-hyg-PUbC-em7-BSD digested fragment contains: BSD selection driven by em7 (bacteria) 
and ubiquitin C (mammalian) promoters, 5’ and 3’ homology sequence to the loxP flanking regions 
of the BAC backbone (pBACe3.6). 
 
After introduction of the recombineering expression plasmid, pSC101-BAD-
RedαβγA-tet, the PCR product containing the tag is electroporated and inserted 
into the BAC by recombineering. In the second step, the T2A-neo or P2A-neo 
coding region, flanked by FRT sites, is deleted by transformation and 
expression of the plasmid pSC101-BAD-Flpe-tet (Fig. 9A). Afterwards, the 
tagging cassette incorporated in the target BAC was sequenced to check for 
any mutations occurred during PCR reactions. 
In order to have an antibiotic resistance gene to be expressed in mammalian 
cells, another recombineering step was needed. One alternative employed here 
was to introduce blasticidin resistance in the BAC backbone and another was to 
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introduce an IRES-neo cassette after the stop codon of the target gene. The 
first option consisted of linearizing the pR6K-hyg-PUbC-em7-BSD by PacI and 
AscI restriction enzymes, followed by electroporation and recombineering in the 
tagged BAC E. coli cells (Fig. 9C,D). The pR6K-hyg-Pubc-em7-BSD digested 
fragment contains: (1) BSD selection driven by em7 (bacteria) and ubiquitin C 
(mammalian) promoters, (2) 5’ and 3’ homology sequence targeting the loxP 
flanking regions of the BAC backbone (pBACe3.6) (Fig. 9).  
The second option consisted of generating an IRES-neo cassette by PCR using 
the plasmid pR6K-zeo-eGFP-IRES-neo-pA-hyg as template DNA (Fig. 9B1), 
which was inserted by recombineering. The amplicon consisted of (1) 50 nt of 
BAC specific homology arms targeting up (5’ homology) and downstream (3’ 
homology) of the stop codon of the tagged gene on the BAC, (2) the IRES-
neomycin/kanamycin antibiotic resistance in the center. The blasticidin 
approach applies to similar conditions as discussed above for PGK-neo 
selection in C-terminal tagging strategies, and the IRES-neo approach for the 
T2A-neo. 
 
3.2.10.  Nsd1 and Nsd3 domain deletions strategy 
In order to better characterize protein-protein and protein-DNA interactions of 
Nsd1 and Nsd3; PWWP and zinc-finger like domains were selected and deleted 
from the tagged BAC constructs. Four different regions were deleted: PWWP1 
(exons 3-4 in Nsd1 and Nsd3), PHD1-4 (exons 9-14 in Nsd3; exons 10-14 in 
Nsd1), PWWP2 (exons 15-16 in Nsd1 and Nsd3) and PHD5/C5HCH (exons 22-
23 in Nsd1 and Nsd3).  
The strategy consisted of generating a rox-PGK-hyg-rox cassette by PCR using 
the plasmid pR6K-rox-hygro-PGK-rox-loxP as template DNA. The primer pairs 
included homology arms targeting up and downstream the middle region of the 
5’ and 3’ flanking intron sequences, respectively (Fig. 10). The design was 
made not to provoke a codon frameshift after exon removal and always keeping 
the cassette insertion site at least 50 bp from the 5’ splice site. After 
transformation of the recombineering expression plasmid, pSC101-BAD-
RedαβγA-tet, in the BAC E. coli host cells, the PCR product containing the rox-
PGK-hyg-rox cassette was electroporated and through recombineering it 
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replaced the target exons. Once the presence of a strong promoter/antibiotic 
resistance gene might interfere with the expression of the tagged gene, the 
PGK-hyg coding region, flanked by rox sites, was removed by transformation 
and expression of the plasmid pSC101-BAD-Dre-tet (Fig. 10). 
 
Figure 10. Nsd1’s and Nsd3’s domain deletions strategy. A rox-PGK-hyg-rox cassette was 
generated by PCR using the plasmid pR6K-rox-hygro-PGK-rox-loxP as template DNA. The primer 
pairs included terminal homology arms (HA) targeting up and downstream the middle region of the 
5’ and 3’ flanking intron sequences, respectively. The generated PCR cassette removes the target 
exons (black boxes) through recombineering on the tagged BACs. Afterwards, the PGK-hyg coding 
region is removed by Dre recombinase, leaving one rox site. Straight lines represent introns, while 
grey boxes are exons. 
 
Another strategy was used for the PHD5/C5HCH deletion, since it 
comprehended the removal of the last two exons. For Nsd1, the wild type BAC 
was C-terminally tagged again as described, but using homology sequence 
targeting the 5’ flanking region of the 3’ end of the exon 21 and the 3’ flanking 
region after the stop codon. The exons 22 and 23 were replaced by the adaptor 
cassette (2xTy1-rpsL-genta-3xFlag) and, then, the tag was inserted by a 
second recombineering step. 
For Nsd3, similar targeting homology sequences were used. The difference is 
that the stop codon remains. In addition, a PCR generated cassette with IRES-
neo was used to replace the last two exons in the N-terminal Venus tagged 
BAC E. coli host cells by recombineering. 
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3.3. Methods – Cell culture work 
3.3.1. Culture conditions for mouse embryonic stem cells 
Feeder-independent E14TG2a mouse embryonic stem cells were cultured 
according to standard protocols, using appropriate mouse ES medium as 
described above. For Western blots, ChIP and mass spectrometry assays, the 
cells were grown in ES medium based on FCS, LIF and the 2 inhibitors (CT and 
PD). In the knockdown experiments, the ES medium was not supplemented 
with 2i. Cells were passaged every second day. 
 
3.3.2. Transfection of mouse ESCs to establish stable BAC transgenic cell 
lines 
ESCs were seeded 1 day before transfection with a density of 1.5 x 105 
cells/well in 6-well plates. The next day the medium was changed before 
transfection to keep cells proliferating. Transfection was carried out using 
Lipofectamine LTX PLUS system (Life Technologies) and performed using the 
supplier’s protocol. In brief, 1-2 µg of BAC DNA was diluted in 500 µl Opti-
MEM+GlutaMax and well mixed. The diluted DNA was mixed with 2.5 µl of 
PLUS reagent and incubated for 5 min at RT. Then, 6.25 µl of the 
Lipofectamine LTX solution were gently mixed with the DNA and the mixture 
was incubated for 30 min at RT. The cells were transfected by distributing the 
entire DNA-lipid mixture to one well containing 2 ml of ES medium. For stable 
transfection, the cells were subjected to 100-200 µg/ml G418 or 5 µg/ml BSD 
selection in mouse ES medium 24 h after lipofection. The medium was changed 
every day. After 6-12 days resistant ES cell colonies were picked. To test for 
expression of the tagged protein, several ES cell clones were evaluated by 
genotyping, followed by Western blot and fluorescence imaging.  
 
3.3.3. Picking Colonies for clonal analysis 
G418 or BSD resistant colonies were picked 6-12 days after transfection of the 
ES cells. The mouse ES cell medium was replaced with 2ml PBS. An inverted 
phase contrast/fluorescence Olympus microscope was used at 2.5 to 5 X 
magnification for better visualization of the colonies to pick. Single colonies 
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were scraped from the plastic with a sterile 20 µl pipette tip. The loose colony 
was aspirated into the tip. Each colony was placed into a separate well of a 96 
well dish. The cells were separated by adding 20 µl of 0.25 % trypsin-EDTA to 
each well. The 96 well dish was then incubated for 5 min at 37°C. 180 µl of 
mouse ES medium were added to each well and the mixture was pipetted up 
and down to resuspend the cells as a single cell suspension. The medium was 
daily replaced. After 2-3 days, the cell clusters were dissociated with trypsin, 
and the cell suspension was divided into halves. One half was frozen in the 
plates and stored at -80°C, and the other was plated on 96-well replica plates. 
The latter cells were allowed to grow to confluence (3-5 days) and were used as 
the initial material for the DNA extraction procedure. 
 
3.3.4. Genomic DNA extraction from 96 well and genotyping 
When the ESC lipofected clones reached confluence on the 96-well replica 
plates, genomic DNA was extracted. First, the cells were washed twice with 
PBS, and 50 µl of DNA lysis buffer (10 mM Tris pH 7.5, 10 mM EDTA pH 8.0, 
10 mM NaCl, 0.5 % sarkosyl, and 1 mg/ml proteinase K) was added in each 
well. The plates were incubated overnight at 55°C in a humid atmosphere to 
avoid evaporation. The next day, a mix of NaCl and cold ethanol (200 mM NaCl 
in 100 µl of absolute ethanol) was added (150 µl/well). The plates were allowed 
to stand on the bench for 15-30 min, until the precipitated nucleic acids could be 
seen clearly under a low power microscope. The supernatant was discarded by 
inversion of the plates, and these were washed with 70% ethanol three times, 
each time discarding the alcohol by inversion. After the final wash, the plates 
were left to air dry for 20-30 min. DNA was finally resuspended in 60 µl of 
ddH2O. 
The DNA was screened by PCR to check for the presence of the Venus tag. 
The genotyping strategy for C-terminal tagging consisted of using a forward 
primer annealing in the last exon, upstream of the 5’ homology arm, and a 
reverse primer in Venus. In case of N-terminal tagging, the forward primer was 
in Venus and the reverse in the first exon, downstream of the 3’ homology arm. 
Clones were screened based on the presence of an amplified band in the 
specific range. 
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3.3.5. Immunofluorescence analysis of the Venus tagged proteins 
For fluorescence analysis, mouse ESCs were plated on gelatin-coated glass 
coverslips. The cells were fixed with 4 % formaldehyde in PBS for 10 min at RT. 
Cells were washed twice with PBS and the nuclei counterstained with 0.1 µg/ml 
DAPI. Coverslips were finally mounted with Mowiol-DABCO and imaged with a 
Leica SP5 upright laser scanning confocal microscope. 
In order to enhance the fluorescence signal of some of the Venus fusion 
proteins, immunostaining was performed using anti-eGFP rabbit polyclonal 
antibody (CAB4211, Thermo Scientific). ES cells were fixed and washed as 
described above, then, they were permeabilized with 0.5 % TritonX-100 in PBS 
for 15 min at RT. After washed once with PBS, cells were incubated in blocking 
solution (3 % BSA and 0.1 % Tween-20 in PBS) for 30 min at RT or at 4oC for 
up to 5 days until further processing. 
Fixed cells on coverslips were incubated with 30 µl drops of primary antibody 
diluted 1:100 in incubation solution (10 % FCS in PBS). After overnight 
incubation at 4oC in a humidified atmosphere, coverslips were carefully washed 
twice in PBS. Next, cells were incubated with bovine anti-rabbit IgG-R (sc-2367, 
Santa Cruz Biotechnology) diluted 1:200 in incubation solution for 2 h at RT in a 
humidified atmosphere in the dark. After washed twice in PBS, nuclei were 
stained for 5 min with 0.1 µg/ml DAPI in PBS. Following two washing steps with 
PBS and ddH2O, coverslips were mounted and imaged as mentioned above. 
 
3.3.6. Induction of Brd4 conditional knockout ESCs with 4-OH-tamoxifen 
Brd4 conditional knockout cells were cultured in ES medium supplemented with 
2i. For knockout induction, cells were passaged as usual and the next day 
medium was exchanged to medium containing 10-6 M 4-OH-tamoxifen. Non-
induced cells (control) were treated simultaneously with 0.1 % ethanol. Media 
change containing 4-OH-tamoxifen was performed after 24 h. Following 48 h of 
induction, 4-OH-tamoxifen was removed. Cells were grown for 2 more days in 
standard ES medium plus 2i and, then, harvested for protein and RNA 
extraction. 
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3.3.7. Short hairpin RNA (shRNA) knockdown experiments 
Nsd1, Zfx and Kdm1b shRNA clones were gifts from Dr. Marc Bickle (Head HT-
Technology Development Studio, MPI-CBG, Dresden, Germany). They were 
cloned in the pLKO.1 vector. Nsd3 shRNAs were cloned in the pRS vector 
(Origene). 
For producing recombinant lentiviral particles, the shRNA constructs were co-
transfected with pCMV-dR8.91 packaging plasmid and pCMV-VSV-G envelope 
plasmid into HEK 293T cells using Lipofectamine LTX PLUS system (Life 
Technologies) (Table 2). 
 
Table 2. List of reagents used for production of recombinant lentiviral particles in HEK 293T cells 
(9 x 105 cells/plate were seeded 24 h before the lipofection). 
Reagent per 6 cm plate 
shRNA cloned in pLKO.1 or pRS 2.5 µg 
pCMV-dR8.91 packaging plasmid 2.25 µg 
pCMV-VSV-G envelope plasmid 0.25 µg 
Lipofectamine LTX 12 µl 
Plus reagent 5 µl 
OPTI-MEM up to 500 µl 
 
24 hours after lipofection, media was changed with 6 ml high serum growth 
media for viral harvests (DMEM GlutaMax, 30 % FCS, 100 U/ml penicillin, 100 
µ/ml streptomycin). The supernatant containing the viral particles was collected 
in the following 24 and 48 h. Viral supernatant was filtered through a 0.45 µm 
membrane to remove debris and dead cells.  
Lentiviral infection was performed overnight by adding 2 ml of the filtered viral 
particles in the presence of 8 µg/mL polybrene in 1 x 105 E14TG2a cells per 
well (6-well dishes). The following day, the supernatant was removed and fresh 
ES medium was added. Puromycin selection (1 µg/mL) was added 48 h 
following transduction and stable lines were isolated and expanded. Cells were 
harvested for RNA and protein extraction after 5-7 days of transduction. ChIP 
experiments were performed 2-3 passages after transduction, always keeping 
the puromycin selection. 
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3.4. Methods – RNA 
3.4.1. RNA isolation and cDNA synthesis 
Total RNA from 1-5 x 105 ESCs was isolated with the QIAzol Lysis Reagent 
(Qiagen), following the manufacturer’s instructions. The RNA was measured 
with NanoDrop ND-1000 Spectrophotometer (PEQLAB Biotechnologie). One 
microgram of total RNA was treated with the DNase I kit (Life Technologies) to 
remove possible contaminating genomic DNA. The complementary DNA was 
then synthesized at 55oC using the AffinityScript cDNA Synthesis Kit (Agilent 
Technologies) and a mixture of oligo(dT) and random primers (ratio 1:2). 
 
3.4.2. Quantitative real-time reverse transcription-PCR analysis 
Quantitative real-time reverse transcription PCR (RT-qPCR) reactions were 
performed in triplicate using GoTaq® qPCR Master Mix (Promega) in a 
Stratagene Mx3005P qPCR system (Agilent Technologies). The synthesized 
cDNA was diluted 10 times, and 2 µl were added into each 20 µl qPCR 
reaction. Reactions were run using the following thermal profile: initial 
denaturation at 95oC for 10 min followed by 40 cycles with denaturation at 95oC 
for 30 s, annealing at 60oC for 30 s and extension at 72oC for 30 s. The PCR 
was immediately followed by melting curve analysis, using temperature 
increments of 0.5oC every 10 s to ascertain that the expected products were 
amplified. Primer sequences are given above. The following controls were 
included in each run for each gene: negative control of cDNA synthesis 
(omission of reverse transcriptase) and non-template control. 
Analysis of RT-qPCR data was carried out using the comparative 2-ΔΔCt method 
(Livak and Schmittgen, 2001). For each sample, the cycle threshold (CT) values 
were normalized against that of the internal control (β-actin) and then the data 
was depicted as several fold changes with respect to the transcription level 
observed in the control experiment. 
 
3.5. Methods – Chromatin 
3.5.1. Chromatin Immunoprecipitation (ChIP) protocol 
The basis of ChIP is the immunoprecipitation step, in which an antibody is used 
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to recognize specific chromatin-related proteins with the purpose of discovering 
their direct DNA binding sites. Coupling next-generation sequencing technology 
with ChIP enables to directly sequence the pulled down DNA fragments and 
thereby produces digital maps of ChIP enrichment. 
In the present work, ChIPs were performed for both histone modifications and 
Venus fusion proteins. For cells expressing the tagged proteins approximately 
7-10 x 107 cells were cultured, while for histone ChIPs only one third of this 
number was used. Moreover, 37.5 µg goat anti-GFP antibody were used for 
each Venus tagged cells immunoprecipitation, while for the histone ChIPs 6 µg 
of the specific antibodies (H3K36me1-3) were used. Cells without Venus fusion 
proteins were also grown and submitted to the same ChIP protocol with anti-
GFP antibody (mock-IP).  
First, the adhered cells were fixed for 30 min in 2 mM DSG and 1 mM MgCl2 in 
PBS, followed by 15 min in 1 % formaldehyde in DMEM + GlutaMax, while, for 
histone modification ChIPs, cells were fixed for 15 min in 1 % formaldehyde 
alone. In both cases, formaldehyde was quenched by the addition of glycine to 
a final concentration of 125 µM. 
The supernatant was aspirated and the cells were washed with ice-cold PBS. 
The cells were harvested using a rubber scraper and collected by centrifugation 
for 5 min at 1,500 rpm and 4˚C. The supernatant was removed and the cell 
pellet was resuspended in 5 ml of cell lysis buffer (10 mM Tris-HCl pH 7.5, 10 
mM NaCl, 3 mM MgCl2, 0.5% IGEPAL CA630 plus freshly added 1 mM DTT, 1 
mM PMSF, 10 µM MG-132 and 1 X protease inhibitor cocktail (Roche)) and 
mixed gently. This treatment solubilizes the cell membranes while keeping the 
nuclei mostly intact. The crude nuclear prep was collected by centrifugation at 
1,000 rpm and 4oC for 3 min and, then, resuspended in 3 ml sonication buffer 
(10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0, 0.5 mM EGTA pH 8.0, plus 
freshly added 1 mM DTT, 1 mM PMSF, 10 µM MG-132 and 1 X protease 
inhibitor cocktail (Roche)). 
Sonication was performed using a Covaris S2 sonicator (Covaris) to produce 
fragments of approximately 0.1-1 kb. The following parameters were used: 10 
min, 20 % duty cycles, 8 intensity, 200 cycles per burst, frequency sweeping 
power mode. The samples were centrifuged at 12,000 g for 5 min to precipitate 
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remaining cell debris and the cleared supernatant was transferred into fresh 
tubes. To check the DNA size of the sheared chromatin, 50 µl aliquots were 
collected and treated with 8 µl of 5 M NaCl (200 mM final) to reverse the 
crosslink by incubation at 98˚C for 15 min. After cooling down, 2 µl of 
Proteinase K solution (10 mg/ml) were added and the chromatin solution was 
incubated at 55˚C for 30-60 min. The DNA fragments range was verified by gel 
electrophoresis using a 1.5 - 2% agarose gel.  
For a pre-clearing step, Sepharose CL-4B (Sigma-Aldrich) beads were 
prepared. Shortly, 200 µl of real bead volume per sample were collected by 
centrifugation at 800 g for 2 min. Beads were washed twice with PBS and then 
resuspended in ChIP buffer (0.01 % SDS, 1.1 % Triton X-100, 1.2 mM EDTA 
pH 8.0, 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl plus freshly added 1 mM DTT, 
1 mM PMSF, 10 µM MG-132 and 1 X protease inhibitor cocktail (Roche)). 
The supernatants of the sheared samples were transferred into fresh 15 ml low 
DNA binding polystyrene tubes (BD Falcon). The chromatin was pre-cleared by 
200 µl Sepharose CL-4B (Sigma-Aldrich) beads. Samples were adjusted to 9 ml 
with ChIP buffer and incubated for 1 h while gently rotating/mixing at 4˚C to 
reduce nonspecific protein or DNA binding to the beads. The beads were 
collected by centrifugation at 500 g for 2 min and the whole supernatant was 
transferred into fresh 15 ml low DNA binding polystyrene tubes (BD Falcon). 
Samples were incubated overnight with the proper antibody while gently 
rotating/mixing at 4˚C. On the next day, 100 µl protein G Sepharose 4 Fast Flow 
beads (GE Healthcare) were washed and prepared as previously described. 
After the last washing step, beads were resuspended in 5 ml PBS containing 
200 µg/ml sonicated Salmon Sperm DNA and 1.5 % cold water fish skin gelatin. 
The mixture was incubated while rotating for at least 2 h at 4°C. The beads 
were finally washed once with ChIP buffer and stored in 1 ml ChIP buffer at 
4°C. The pre-blocked beads were added to the ChIP samples, which were then 
incubated while gently rotating/mixing for 2-3 h at 4˚C. 
The beads were collected by centrifugation at 500 g for 2 min. The remaining 
supernatant was discarded. The beads were carefully transferred with 1 ml 
ChIP buffer into 1.5 ml LoBind tubes (Eppendorf) and washed by rotating for 1 
min at 4˚C. The beads were again pelleted by gentle centrifugation at 500 g. 
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After discarding the supernatant, the beads were washed for 1 min at 4˚C in 1 
ml of each buffer listed below:  
a. Once with ice-cold Low Salt Immune Complex Wash Buffer (0.1 % SDS, 
1 % Triton X-100, 2 mM EDTA pH 8.0, 20 mM Tris-HCl pH 8.0, 150 mM 
NaCl); 
b. Twice with ice-cold High Salt Immune Complex Wash Buffer (0.1 % SDS, 
1 % Triton X-100, 2 mM EDTA pH 8.0, 20 mM Tris-HCl pH 8.0, 500 mM 
NaCl); 
c. Once with ice-cold LiCl Immune Complex Wash Buffer (0.25 M LiCl, 1 % 
IGEPAL CA-630, 1 % deoxycholic acid (sodium salt), 1 mM EDTA pH 
8.0, 10 mM Tris pH 8.0); 
d. Once with ice-cold TE buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 
8.0). 
The precipitated protein complexes were eluted by adding 250 µl freshly 
prepared elution buffer (1 % SDS, 0.1 M NaHCO3) to the pelleted beads. 
Samples were briefly mixed and incubated at RT for 15 min while rotating. The 
beads were collected by centrifugation at 12,000 g for 2 min and the 
supernatants were transferred into fresh 1.5 ml LoBind tubes (Eppendorf). 
Elution was repeated once again. Both eluates were combined resulting in 500 
µl total volume. To reverse cross-link the eluates, samples were treated with 20 
µl 5 M NaCl (200 mM final). The protein-DNA complexes were released by 
incubation at 65˚C for at least 4 h or overnight. To digest proteins, the eluates 
were treated with 2 µl proteinase K (10 mg/ml solution), 10 µl of 0.5 M EDTA pH 
8.0 (10 mM final), and 20 µl of 1 M Tris-HCl pH 6.5 (40 mM final). Samples 
were incubated for 1 h at 55˚C shaking at 800 rpm.  
After cooling down, the DNA was purified with 500 µl phenol/chloroform/isoamyl 
alcohol (25: 24: 1) by mixing and spinning down at 12,000 g for 5 min at RT. 
The top aqueous phase was transferred into a new 1.5 ml tube and the DNA 
was precipitated with absolute ethanol at -20oC plus glycogen (20 µg/ml) for at 
least 2 h or overnight. Samples were centrifuged at 16,000 g and 4˚C for 20 
min. The DNA pellet was washed with 1 ml 70 % ethanol and, then, dried at RT 
for 15-30 min. DNA was resuspended in 24 µl ddH2O. Samples were frozen 
down at -20˚C until further use. 
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3.5.2. ChIP-qPCR analysis 
qPCR analysis was used to evaluate and measure the ChIP enrichment. 
Primers were designed to amplify known target sites for each sample. ChIP 
samples were diluted 10 times, and 1 µl were added into each 20 µl qPCR 
reaction as described in the Quantitative real-time reverse transcription-PCR 
analysis section above. 
For each sample, the cycle threshold (CT) values were normalized against that 
of the internal control (intergenic region in chromosome 9 – gene desert). The 
data was depicted as fold enrichment over the mock-IP control experiment. 
In case of ChIP and shRNA knockdown experiments, qPCR was performed in 
triplicates from two biological replicates and the data was treated as means. 
Statistical analysis was carried out with Student's paired t-Test, with a two-tailed 
distribution, comparing control sample versus treatment. Differences were 
considered statistically significant at P-values < 0.05. 
 
3.5.3. Deep sequencing of the immunoprecipitated DNA 
ChIP samples were sequenced by the Deep Sequencing Group (SFB 
655/BIOTEC) facility (Dresden, Germany) using a HiSeq 2000 Next Generation 
Sequencer (Illumina). 
 
3.5.4. ChIP-seq analysis 
The ChIP-seq data was analyzed in collaboration with MSc. Sukhdeep Singh 
(Prof. A. Francis Stewart research group). 
Sequencing data were acquired through the default Illumina pipeline using 
Casava version 1.8. Reads were aligned to the mouse genome (UCSC mm10) 
using a parallel version of BWA (Burrows-Wheeler Aligner) version 0.5.9. Only 
unique mapped reads and up to three mismatches were allowed. Reads were 
extended to 250 bases toward the interior of the 3’ sequenced fragment and 
normalized to total reads aligned (counts per million). 
Samples were then subjected to peak calling using MACS version 1.4 (Model-
based Analysis of ChIP-Seq) at the P-value of 1e-5 and the maximum false 
discovery rate (FDR) of 0.05. Untagged E14tg2A ESCs were also submitted to 
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ChIP-seq with anti-eGFP antibody and it was used as control (mock-IP). 
Gene annotations, and transcript information were generated from refSeq 
tables. The list of bivalent genes was fetched from the BGDB database of 
bivalent genes (Li et al., 2013c). 
ChIP-seq coverage profiles were sorted according to transcription start site 
(TSS) or gene body region and, then, plotted as average reads per base per 
million. For the TSS, a region spanning 3 kb on either side was covered. The 
gene body profile covered 3 kb upstream each TSS plus the whole gene body 
and 1 kb downstream to the transcription termination site (TTS; defined as the 
last base of the annotated transcript). Each coverage profile was divided in 101 
equally sized bins, in which the 51th bin was set as the TSS or the center of the 
gene, respectively. ChIP-seq reads in each bin were averaged over the length 
of the bin. To compensate for differences in sequencing depth and mapping 
efficiency, the total number of unique reads for each sample was uniformly 
equalized, allowing quantitative comparisons.  
The coverage profiles mentioned above were also plotted as heatmap to depict 
the read enrichment over active genes. A custom list of active genes was 
obtained based on the presence of active H3K4me3 and the absence of 
repressive H3K27me3 marks at promoter regions. All coverage profiles were 
sorted according to H3K36me3 levels from high to low average intensity. 
Additionally, we employed a mock-IP subtraction step for each ChIP-seq data. 
Principal component analysis (PCA) was computed using R statistical language. 
The average read density across whole gene bodies was taken to compute the 
principal components depicting the variance in data. Samples having similar 
binding intensity over a certain locus should have a minimum distance between 
the arrows as opposed to different binding. 
Gene Ontology (GO) term and pathway (KEGG; Kyoto encyclopedia of genes 
and genomes) analyses were performed using DAVID version 6.7 (Huang da et 
al., 2009b; Huang da et al., 2009a). 
H3K4me3, H3K27me3, H3K36me3, and RNAPII ChIP-seq data are from GEO 
accession number GSE23943 (Marks et al., 2012). Mll2 (Wbp7) ChIP-seq data 
are from GEO accession number GSE52071 (Denissov et al., 2014). 
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3.6. Methods – Protein 
3.6.1. Preparation of cells for Western blot analysis 
For Western blot analysis 1 x 105 - 107 cells were scraped off the culture dish in 
ice-cold PBS and collected by centrifugation at 800 g for 5 min at 4°C. The cell 
pellet was frozen in liquid nitrogen and kept at -80oC until used. 
Cells were thawed on ice and resuspended in 80-120 µl of ice-cold High Salt 
Buffer (20 mM Tris-HCl pH 8.0, 2 mM EDTA pH 8.0, 0.05 % Tween-20, 2 % 
Glycerol, 500 mM NaCl) with 1 mM DTT, 1 mM PMSF, 10 µM MG-132 and 1 X 
protease inhibitor cocktail (Roche) added immediately prior to use. The solution 
was left on ice for 15 min and, then, insoluble material was precipitated by 
centrifugation at 16,000 g for 20 min at 4°C. 
The cleared supernatants were transferred into new microfuge tubes and 
measured at 280 nm using a NanoDrop ND-1000 Spectrophotometer (PEQLAB 
Biotechnologie). 
Before loading in the SDS-PAGE, 20-100 µg of protein extracts of each sample 
were mixed with 2 X SDS loading buffer (125 mM Tris-HCl pH 6.8, 4 % SDS, 20 
% glycerol, 10 % 2-mercaptoethanol, 0.004 % bromophenol blue) and 
denaturated at 99°C for 5 min  
Finally, the samples were directly loaded and resolved on 6-8 % polyacrylamide 
gel and transferred to Immobilon-P PVDF membranes (Millipore) using the 
XCell II™ Blot Module (Life Technologies). The wet blotting was performed for 
2-4 h at 25 V and the transfer buffer consisted of 20 mM Tris-HCl pH 8.3, 192 
mM Glycine and 10 % methanol. For proteins bigger than 280 KDa, the 
NuPAGE® Novex® 3-8 % Tris-Acetate Gel (Life Technologies) was used. 
After the transfer, the membranes were incubated in blocking solution (3 % 
BSA, 0.1 % Tween-20 in PBS) with the primary antibody overnight at 4°C. After 
extensive washing (three times wash with 0.1 % Tween-20 in PBS for 10 min), 
membranes were incubated with the proper secondary antibody for 1 h at RT. 
Prior to detection, membranes were washed as described above and the bound 
antibody was visualized with Luminata Western HRP substrate (Millipore) in the 
Luminescent Image Analyzer LAS-3000 (Fujifilm Life Science).  
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3.6.2. Histone extraction for Western blot analysis 
Since histones are quite abundant, a smaller amount of cells (~ 1 x 105) was 
needed. Cells were harvested as mentioned above and, then, resuspended in 
40-80 µl of ice-cold Homogenization buffer (20 mM HEPES pH 8.0; 150 mM 
NaCl; 1.5 mM MgCl2; 10 % glycerol; 2 mM EDTA pH 8.0; 0.5 % Tween-20) with 
1 mM DTT and 1 X protease inhibitor cocktail added immediately prior to use. 
Cell extracts were briefly sonicated in the BioRuptor waterbath sonicator 
(Diagenode) to shear the chromatin, using the following settings: high power for 
7 min, 30 s on, and 30s off. 
After cell homogenization by sonication, insoluble material was precipitated by 
centrifugation at 16,000 g for 20 min at 4°C. The cleared supernatants were 
transferred into fresh microfuge tubes and measured at 280 nm using a 
NanoDrop ND-1000 Spectrophotometer (PEQLAB Biotechnologie). Whole cell 
protein lysates were denatured as previously described. 
The samples were loaded and resolved on 15 % polyacrylamide gel and 
transferred to Immobilon-P PVDF membranes (Millipore) by semidry blotting, 
using the Trans-Blot® SD Semi-Dry Transfer Cell system (Bio-Rad). Blotting 
was performed for 40 min at 15 V. Membranes were treated as previously 
described. 
 
3.6.3. Small-scale immunoprecipitation (IP) of Venus-tagged proteins 
For immunoprecipitation of Venus tagged proteins, it was used a polyclonal 
goat anti-GFP antibody (anti-GFP, 15 mg/ml, generated at the MPI-CBG 
Dresden, Germany) together with protein G Sepharose 4 Fast Flow beads (GE 
Healthcare). 
First, the protein G Sepharose beads needed to be prepared for the 
immunoprecipitation. Briefly, 15 µL of pure beads per IP sample were 
centrifuged at 1000 g for 2 min and washed twice with PBS. Then, the beads 
were resuspended in ice-cold Homogenization buffer and stored on ice. 
Cells expressing Venus fusion proteins and control cells (untagged) were 
cultured to yield 1 x 107. Proteins were extracted following the High Salt Buffer 
protocol described above. 
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For the immunoprecipitation, 0.5-2 mg of protein extracts were diluted in 
Homogenization buffer to a volume of 500 µl and incubated with 15 µl of bead 
slurry plus 5 µg of goat anti-GFP antibody. The IP was performed overnight at 
4°C by gently mixing. After incubation, the beads were centrifuged at 500 g and 
subsequently washed 2 times with 1 ml of High Salt buffer. After the last 
washing step, bound proteins were eluted by resuspending the beads in 1 X 
SDS sample buffer followed by denaturation at 99°C for 5 min. Eluates were 
loaded on a polyacrylamide gel for Western Blot analysis. 
 
3.6.4. Co-Immunoprecipitation assay 
Similarly to the small scale IP, the same antibody and beads were used plus the 
Sepharose CL-4B (Sigma-Aldrich) beads, which were used during the pre-
clearing step. The beads were also initially prepared as described above and 2 
mg of protein lysates were used per IP. 
For co-IP experiments, 3-5 x 107 of Venus tagged and control cells (untagged) 
were grown and harvested as previously described. Proteins were extracted 
following a nuclease treatment. Briefly, the cell pellets were resuspended and 
lysed in 0.5 ml ice-cold co-IP buffer (20 mM HEPES pH 8.0, 100 mM KCl, 50 
mM β-Glycerol-Phosphate, 1.5 mM MgCl2, 1 mM DTT, 2 % glycerol, 1 mM 
EDTA, 0.1 % IGEPAL CA-630, 10 µM MG132, 1 mM PMSF, 1 X protease 
inhibitor cocktail) and transferred to a 1.5 ml microfuge tube. Samples were 
always kept at 4°C. To precipitate the nuclei, cells are centrifuged at 800 g for 5 
minutes at 4°C. After removing the supernatant, nuclei were gently 
resuspended in 0.3 ml co-IP buffer supplemented with freshly added benzonase 
nuclease (125 U/ml; Millipore) and 5 mM MgCl2 and, then, incubated at 4°C for 
2h, rotating. After digestion, samples were centrifuged at 12,000 g for 10 min at 
4°C and the clear supernatants were transferred to new microfuge tubes.  
The protein lysates were pre-cleared with Sepharose CL-4B (Sigma-Aldrich). 
For each lysate, it was added 30 µl of pure beads resuspended in co-IP buffer. 
The samples were incubated for 15 min at 4°C and, then, the beads were 
removed by centrifugation at 12,000 g for 5 min. The supernatant was 
transferred into fresh tubes. The lysates were incubated with 6 µg of goat anti-
GFP antibody for 2 h. Thereafter, 25 µl of protein G Sepharose beads slurry 
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was added to each sample and the IP was performed overnight at 4°C by gently 
mixing. The beads were washed and eluted according to the small scale IP 
protocol. 
 
3.6.5. Immunoprecipitation of Venus-tagged proteins for mass 
spectrometry 
Tagged and control cells (untagged) were grown in ES medium supplemented 
with 2i. The experiment was performed in triplicates with 5 x 107 cells each. Big 
scale protein immunoprecipitations for mass spectrometry (MS) were performed 
by Dr. Wai Kit Chu (Prof. Chuna Ram Choudhary’s research group, The Novo 
Nordisk Foundation Center for Protein Research, Copenhagen, Denmark) using 
a label-free approach (Hubner et al., 2010). 
In label-free experiments, tagged and control cells were cultured in normal 
media, and separate pull downs were performed. Eluates were not mixed but 
analyzed separately by liquid chromatography combined with tandem mass 
spectrometry (LC-MS/MS) (Fig. 11). Proteins were quantified with the label-free 
algorithm in Max-Quant software and true interaction partners could be 
distinguished from background binders present in the immunoprecipitations by 
their quantitative ratios.  
Briefly, the statistical significance was assigned using a t test comparing the 
three IPs with the three controls (P-value < 0.05). LC-MS/MS results were 
validated according to the negative logarithmic P-values of the t test and the 
observed fold change of protein intensities between the pull-downs of the 
transgenic and the wild-type cell lines.  
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Figure 11. In label-free experiments, tagged and untagged cells are separately immunoprecipitated 
with an anti-GFP antibody and subjected to LC-MS/MS. Enrichment of tagged samples over 
untagged are measured by the MaxQuant software. Source Hubner et al. (2010).  
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4. Results 
4.1. Expression of the Venus tagged H3K36 HKMTs and their 
respective protein partners 
4.1.1. mRNA expression of the H3K36 HKMTs in different mouse stem cell 
lineages 
In order to understand the relative functional impact of the H3K36 HKMTs in 
different cell lineages mRNA levels were measured. cDNAs from mouse 
epiblast and neural stem cells were kindly provided by MSc. Katrin Neumann 
(Prof. A. Francis Stewart research group). 
In ESCs, Nsd1 and Setd2 exhibited the highest mRNA expression levels (Fig. 
12), while Ash1l, Nsd2, and Nsd3 showed really low values. In more 
differentiated stem cell lineages, Nsd1 and Setd2 expression was decreased. In 
contrast, Ash1l, Nsd2, and Nsd3 showed higher mRNA expression levels in 
neural stem cells. 
 
 
Figure 12. mRNA expression levels of the H3K36 HKMTs in embryonic (ESC), epiblast (EpiSC) and 
neural (NSC) stem cells. Graph shows the average of the normalized expression levels. Error bars 
correspond to the standard deviation of the means. 
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4.1.2. Generation of the Venus tagged BAC constructs 
Histone methyltransferases are essential enzymes that regulate gene 
expression through epigenetic mechanisms. Notably, the H3K36 
methyltransferase activity has been shown to affect several biological 
processes, though little is known about their protein complexes and gene 
targets. 
In order to better understand the H3K36 HKMT function and dynamics, all five 
members of the Set2 subfamily (Ash1l, Setd2, and Nsd1-3) were tagged with 
Venus, allowing single-step affinity purification and, subsequently, identification 
of protein complexes and DNA binding sites through LC-MS/MS and ChIP-seq, 
respectively. 
BACs carrying the genes of interest were obtained from commercial sources 
and modified by recombineering in E. coli. Initially, each protein was C- or N-
terminal fused with a Venus-based tag. The different and multipurpose protein 
tags used are depicted in Fig. 13. 
A promoter-less strategy expressing the neomycin gene was used for the C-
terminal tagging of Setd2, Nsd1, and Nsd3. Ash1l and Nsd3 were instead 
engineered to have a promoter-driven strategy for the expression of the 
selectable marker. For N-terminal tagging, the BAC backbone of Ash1l and 
Nsd2 were modified to express the blasticidin gene driven by ubiquitin C 
promoter, while for Nsd3 an IRES-Neo cassette was inserted after the stop 
codon. 
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Figure 13. Schematic representation of the different tagged genes under study. The distinct tag 
structures and coding regions are represented in rectangles, while the recombinase sites in 
triangles. The black line represents the poly(A) tail (pA). 	  
The adaptor cassette for C-terminal tagging and the N-terminal cassette 
harboring Venus were successfully amplified (Fig. 14A and 15A). Afterwards, 
they were recombined with the BACs carrying the target genes. BAC DNA was 
digested with restriction enzymes to evaluate the success of the recombination 
step. Herein, it is shown the restriction step in which Venus was inserted in both 
tagging strategies (Fig. 14 and 15). At least two clones from each recombined 
BAC showed the correct restriction pattern as predicted in silico with the Gene 
Construction Kit, version 3.5 (TEXTCO BioSoftware). Thereafter, N-terminal 
tagged recombined BACs were transformed with pSC101-BAD-Flpe-tet to 
promote site-specific recombination of the FRT sites flanking the neomycin 
resistant gene. After the last recombineering step, positive Venus tag 
recombined BACs were subjected to DNA sequencing and only the clones that 
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did not present any point mutations or frameshifts within the coding sequence 
were considered as correct. 
 
Figure 14. Restriction digestion of the recombined BAC constructs for the C-terminal tagging 
strategy. (A) Agarose gel electrophoresis of the PCR amplified adaptor cassette (1352 bp) 
containing the homology arm sequences plus 2xTy1-rpsL-genta-3xFlag. (B) In silico prediction of 
the restriction patterns. (C) BAC DNA digestion with the specific restriction enzymes after Venus 
tag insertion. Except for Nsd1, which was digested with EcoRV, all the other BACs were digested 
with SpeI enzyme. Recombined clones are represented by “recomb.”, while “C” corresponds to the 
control BAC from the previous recombineering step, in this case the BACs carrying the adaptor 
cassette. Red arrows represent some of the observed digestion differences between the control 
and recombinant BACs. 
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Figure 15. Restriction digestion of the recombined BAC constructs for the N-terminal tagging 
strategy. (A) Agarose gel electrophoresis of the PCR amplified N-terminal Venus cassette (1842 bp) 
containing the homology arm sequences plus the neomycin resistant gene. (B) In silico prediction 
of the restriction patterns. (C) BAC DNA digestion with the specific restriction enzymes after Venus 
tag insertion. Except for Nsd2, which was digested with BamHI, all the other BACs were digested 
with NcoI enzyme. Recombined clones are represented by “recombinants”, while “C” corresponds 
to the wild-type BAC. Black arrows represent some of the observed digestion differences between 
the control and recombinant BACs. 
 
4.1.3. Generation of BAC transgenic cell lines 
Maxi preparations of sequenced BAC constructs were produced with the 
NucleoBond BAC 100 kit. Undifferentiated mouse ESCs were transfected by 
lipofection with 1-2 µg of BAC DNA in a six well dish format. In order to 
establish stable clones, cells were selected 24 h after transfection with G418 or 
BSD, depending on the selection marker of each tagged BAC. As a control, 
cells were transfected without DNA and cultured under the same selection 
conditions. 
At least 12-36 resistant colonies were picked and, then, genotyped for presence 
of the Venus fused integrated DNA. Venus positive clones, as illustrated in Fig. 
16, were expanded until the 10 cm dish format. No colonies were detected in 
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the mock control. The expression of the tagged proteins in the resistant clones 
was verified by Western blot analysis. 
 
Figure 16. Genotyping of the Venus tag in mouse ESCs genomic DNA. Mouse ESCs genomic DNA 
was used as template for the PCR reactions. The presence of the C-Venus fusion proteins was 
visualized by agarose gel electrophoresis. Herein, Nsd1 and Nsd2 C-Venus genotyping are 
illustrated. Positive clones are marked with green “+” signals. Water was used as negative control, 
while the respective BAC DNA was used as positive control. 
 
4.1.4. Expression of the tagged proteins in mouse ESCs 
Protein extracts were prepared from 4-8 clones of each BAC transgenic cell 
line. Whole cell lysates were resolved by SDS-PAGE and transferred to PVDF 
membranes. Venus fusion proteins were probed with anti-eGFP antibody and 
wild-type E14TG2a protein extracts were used as negative control. 
Unfortunately, none of the tagged proteins could be clearly detected (data not 
shown). Therefore, a small scale IP was performed with anti-eGFP antibody in 
order to enrich the Venus tagged proteins and, thus, increase their signal in the 
Western blot. 
After immunoprecipitation followed by Western blot analysis with anti-eGFP, 
Setd2, Nsd1, and Nsd2 C-Venus tagged were detected at the predicted 
molecular weight (Fig. 17; Setd2 C-Venus ~ 325 KDa, Nsd1 C-Venus ~ 335 
KDa, Nsd2 C-Venus isoform 2 ~ 191 KDa). The Nsd2 isoform RE-IIBP was not 
observed. Moreover, Ash1l C-Venus was not detectable (data not shown), 
whereas Nsd3 C-terminally tagged clones showed a very low signal. N-
terminally tagged Ash1l and Nsd3 instead demonstrated a better protein 
expression in mouse ESCs. After IP, it was possible to observe Ash1l N-Venus 
signal for clone #10 at the predicted molecular weight (~ 360 KDa), though it 
was weak (Fig. 17F). Nsd3 N-Venus presented 3 distinct bands (Fig. 17E); the 
highest one corresponds to Nsd3 isoform 1, which is expected at ~ 190 KDa; 
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the second band probably corresponds to Nsd3 isoform 2 (~ 110 KDa); and the 
lowest one (~ 100K Da) is still unclear. This unidentified band could be either an 
unknown isoform or a proteolysis product. Nsd3 N- and C-Venus 
immunoprecipitations were repeated several other times and analyzed by 
Western blot. Nsd3 N-Venus presented better signal and IP reproducibility than 
the C-Venus tagged protein. From this moment on, only Nsd3 N-Venus cell line 
was further analyzed. 
Western blot analysis of the Nsd2 N-Venus IP showed two bands probably 
corresponding to isoforms 1 and 2 at the expected molecular weight (110 and 
190 KDa, respectively) (Fig. 17D). 
 
Figure 17. Immunoprecipitation of the Venus tagged proteins. (A) Nsd1 and Setd2 C-Venus, (B) 
Nsd2 C-Venus, (C) Nsd3 C-Venus, (D) Nsd2 N-Venus, (E) Nsd3 N-Venus, and (F) Ash1l N-Venus 
were stably expressed in murine ESCs and subjected to small-scale anti-eGFP IPs. Thereafter, the 
samples were separated by SDS-PAGE and immunoblotted with anti-eGFP antibody. Arrows 
indicate the expressed tagged proteins. The screened clones are numbered. 
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4.1.5. Localization of the Venus tagged proteins 
Immunofluorescence analysis by confocal microscopy showed that Setd2 and 
Nsd1-3 Venus fusion proteins have nuclear localization (Fig. 18). Ash1l N-
Venus did not show detectable fluorescence signal, likely due to low expression 
levels in mouse ESCs as confirmed by mRNA quantification. Despite nuclear 
localization of Ash1l could not be confirmed by confocal microscopy, 
immunoprecipitation of tagged Ash1l from nuclear extracts was always 
consistent and reproducible (data not shown). Interestingly, Nsd1 C-Venus 
seemed to be bound to chromatin during cell cycle progression (Fig. 18). 
 
4.1.6. Mass spectrometry (MS) analysis of the H3K36 HKMTs 
MS is a powerful analytical technique used to quantify known materials as well 
as to identify unknown compounds within a sample. Liquid chromatography 
coupled with mass spectrometry (LC-MS/MS) has been widely used to identify 
protein-protein interactions and it helps elucidate multiple protein complexes.  
To gain insights into how the Set2 subfamily associates in protein complexes, 
big scale IPs followed by MS analysis were performed in collaboration with Prof. 
Chuna Ram Choudhary’s research group (The Novo Nordisk Foundation Center 
for Protein Research, Copenhagen, Denmark), using a label free approach 
(Hubner et al., 2010). 
The results revealed that Setd2, Nsd1, and Nsd3 do not associate in protein 
complexes with each other in mouse ESCs (Table 3). Despite all the effort to 
obtain the Ash1l Venus tagged cell line, LC-MS/MS analysis failed to retrieve 
the bait, likely due to its low expression level in mouse ESCs. Nsd2 C-Venus 
MS analysis did not show any significant protein partners, meaning that either 
Nsd2 does not form protein complexes or the tag is somehow affecting the 
protein structure/folding. Thus, Nsd2 was also tagged at the N-terminal region. 
However, Nsd2 N-Venus MS analysis also revealed similar results, whereas 
only the bait was retrieved. 
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Figure 18. Immunofluorescence images of the H3K36 HKMTs. Nuclei were stained with DAPI. 
Fluorescence was detected with confocal microscope at 40 or 63 X magnification. Red arrows 
indicate condensed chromatin over cell cycle progression. * Immunostaining was performed with 
anti-eGFP primary antibody (CAB4211, Thermo Scientific) and anti-rabbit IgG-R (sc-2367, Santa 
Cruz Biotechnology) secondary antibody. 
	   81	  
Table 3. List of Setd2, Nsd1, and Nsd3 associated proteins. Label-free experiments were performed 
in triplicate for both transgenic and untagged cell lines. Results were validated according to the P-
value resulting from a standard ‘equal group variance’ t test of the observed fold change of protein 
intensities between the pull-downs of the transgenic and the wild-type cell lines. P-values < 0.05 
corresponds to -Log10(P-values) > 1.3. 
Protein Description Average peptides number -Log10(P-
value t-test) 
Log2(transgene/ 
control) Setd2 IP Mock IP 
Setd2 
Histone-lysine N-
methyltransferase H3 
lysine-36me3 
114 32 6.37 5.12 
Supt6 Suppressor of Ty 6 24 4 4.38 4.03 
Polr2b RNAPII subunit RPB2 40 21 3.85 2.12 
Polr2a RNAPII subunit RPB1 52 18 3.42 2.36 
Polr2c RNAPII subunit RPB3 9 3 3.39 2.64 
Polr2j RNAPII subunit RPB11 5 1 3.01 5.80 
Supt5 Suppressor of Ty 5 11 2 2.38 2.5 
 
Protein Description Average peptides number -Log10(P-
value t-test) 
Log2(transgene/ 
control) Nsd1 IP Mock IP 
Zfx Zinc finger X-
chromosomal protein 
5 1 5.71 7.74 
Nsd1 Nuclear SET domain-
containing protein 1 
118 17 4.50 6.33 
 
Protein Description Average peptides number -Log10(P-
value t-test) 
Log2(transgene/ 
control) Nsd3 IP Mock IP 
Nsd3 Nuclear SET domain-
containing protein 3 
25 1 2.69 10.43 
Brd3 
Bromodomain-containing 
protein 3 9 1 3.00 6.79 
Brd4 
Bromodomain-containing 
protein 4 20 1 1.51 6.76 
Phf16 Protein Jade-3 9 0 2.20 6.71 
Cbx1 
Chromobox protein 
homolog 1 9 2 1.91 6.60 
Kdm1b 
Lysine-specific histone 
demethylase 1B 29 1 2.00 6.46 
Znf280c Zinc finger protein 280C 12 1 2.54 6.29 
Brd2 
Bromodomain-containing 
protein 2 15 3 3.58 5.84 
Yes1 
Tyrosine-protein kinase 
Yes 9 1 2.20 5.81 
Atad5 
ATPase AAA domain-
containing protein 5 24 4 1.55 5.66 
Zfp451 Zinc finger protein 451 9 1 2.15 5.58 
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Setd2 MS analysis showed the presence of several RNAPII subunits as well as 
two transcription elongation factors (Supt5 and Supt6), thus providing a physical 
link for Setd2 with the elongating RNAPII. Nsd1 was only found associated with 
Zfx, a transcription factor important for self-renewal in embryonic and 
hematopoietic stem cells (Galan-Caridad et al., 2007). 
Nsd3 was associated with several proteins that fall into distinct functional 
groups (Fig. 19), suggesting that Nsd3 may be involved in multiple chromatin 
template-based processes. Particularly, it pulled down several bromodomain-
containing proteins (Brd2-4), which recognize acetylated histones and regulate 
gene transcription. Moreover, the associated protein with highest number of 
peptides was Kdm1b, a H3K4 demethylase. 
To confirm the MS results, co-IP experiments were performed and will be 
described in the following pages. In addition, several putative protein partners 
were chosen for further investigation, such as Supt6, Zfx, Brd4, and Kdm1b. 
 
Figure 19. Graphical overview of Nsd3-associated polypeptides identified by LC-MS/MS analysis. 
Nsd3-associated proteins can be categorized into the following major groups: chromatin 
modifications; chromatin readers; transcription factors; tyrosine kinase; DNA damage response. 	  
4.1.7. Venus tagging of the H3K36 HKMTs protein partners 
Supt6 and Brd4 were C-terminally tagged with Venus by recombineering, while 
Zfx and Kdm1b were N-terminally tagged (Fig. 20). In addition, Zkscan17, 
previously described as Nsd1 protein partner (Nielsen et al., 2004), was also N-
terminally tagged. For selection in mouse ESCs, the blasticidin resistant gene 
was inserted in the BAC backbone of Zfx and Kdm1b, while for Zkscan17 an 
IRES-Neo cassette was inserted after the stop codon. 
	   83	  
 
Figure 20. Schematic representation of the Supt6, Brd4, Kdm1b, Zfx, and Zkscan17 tagged genes. 
The distinct tag structures and coding regions are represented in rectangles, while the 
recombinase sites in triangles. The black line represents the poly(A) tail (pA). 
 
Recombinant clones were verified by restriction enzyme digestion as illustrated 
in Fig. 21. Brd4 C-Venus BAC was kindly provided by Dr. Giovanni Ciotta (Prof. 
A. Francis Stewart research group). The correct tagged clones were sequenced 
to confirm the coding region. 
 
4.1.8. Expression of the tagged protein partners in mouse ESCs 
Supt6, Zfx, Zkscan17, Kdm1b, and Brd4 tagged BAC constructs were 
transfected in E14Tg2a cells. Whole cell protein extracts of resistant colonies 
were prepared and analyzed by Western Blot using an anti-eGFP antibody (Fig. 
22). 
Tagged Kdm1b, Supt6, and Zkscan17 were detected at the predicted molecular 
weight (Kdm1b N-Venus ~ 120 KDa, Supt6 C-Venus ~ 240 KDa, Zkscan17 N-
Venus ~ 100KDa). Zfx and Brd4 tagged proteins exhibited higher molecular 
weight than predicted (~ 120 and 194 KDa, respectively). Overall protein charge 
or presence of post-translational modifications might affect the migration in the 
SDS-PAGE. Brd4 has been reported to be phosphorylated (Wu et al., 2013b). 
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Figure 21. Restriction digestion of the recombined BAC constructs for the protein partners. (A) In 
silico prediction of the restriction patterns. (B) BAC DNA digestion with the specific restriction 
enzymes after Venus tag insertion. Kdm1b and Supt6 BACs were digested with AvaI, while Zfx and 
Zkscan17 with SpeI and NcoI, respectively. Recombined clones are represented by “recomb.”, 
while “C” corresponds to the control BAC from the previous recombineering step, in case of C-
terminal tagging would be the BACs carrying the adaptor cassette or the wild-type BAC in case of 
N-terminal tagging. Black arrows represent some of the observed digestion differences between 
the control and recombinant BACs. 
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Figure 22. Immunoblot of whole cell protein extracts from mouse ESCs. (A) Zfx N-Venus, (B) 
Kdm1b N-Venus, (C) Supt6 C-Venus, (D) Brd4 C-Venus, and (E) Zkscan17 N-Venus samples were 
separated by SDS-PAGE and immunoblotted with anti-eGFP antibody. Arrows indicate the 
expressed tagged proteins. The screened clones are numbered. 
 
4.1.9. Cellular localization of the tagged protein partners 
Supt6, Zfx, Zkscan17, Kdm1b, and Brd4 were imaged by confocal microscopy 
to determine their cellular localization. All proteins were localized in the nuclei 
(Fig. 23). Interestingly, Zfx appeared to be bound to chromatin during mitosis as 
Nsd1, while Zkscan17 did not. 
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Figure 23. Immunofluorescence images of the tagged protein partners. Nuclei were stained with 
DAPI. Fluorescence was detected with confocal microscope at 40 or 63 X magnification. Red 
arrows indicate condensed chromatin over cell cycle progression. * Immunostaining was 
performed with anti-eGFP primary antibody (CAB4211, Thermo Scientific) and anti-rabbit IgG-R (sc-
2367, Santa Cruz Biotechnology) secondary antibody. 
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4.1.10.  Co-Immunoprecipitation of the Venus tagged proteins 
In order to confirm the MS results, nuclear extracts were prepared from 107 
cells and used for protein immunoprecipitation with the anti-eGFP antibody. 
Immunocomplexes were analyzed by Western blot. 
Nsd1 pulled down Zfx and this result was confirmed by the reciprocal co-IP (Fig. 
24A). However, Zkscan17 did not immunoprecipitate Nsd1 (Fig. 24A), 
suggesting that Nsd1 interacts with Zfx alone in mouse ESCs. Zfx’s and 
Zkscan17’s domain structure present several distinct modules (Fig. 25), thus 
Nsd1 might have different roles depending on the protein partner and cell type. 
Supt6 pulled down Setd2, confirming the LC-MS/MS result (Fig. 24B). The 
Western blot also showed that Nsd3 immunoprecipitated with Brd4 and Kdm1b, 
but not Brd2 and Brd3 (Fig. 24C). MS analysis is quite sensitive, thus indirect 
interactions might also be detected. Thereafter, it was investigated whether 
Brd4 could be the bridge between the other bromodomain containing proteins 
and Nsd3. Indeed, Brd4 pulled down Brd3, but not Brd2 (Fig. 24D).  
The immunoblots of Kdm1b and Brd4 IPs probed with anti-Nsd3 antibody were 
not conclusive (data not shown), because the mock control also showed a 
background band with similar molecular weight. In order to further investigate if 
Kdm1b and Brd4 could also pull down Nsd3, MS analysis was performed for 
those two proteins. 
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Figure 24. Co-Immunoprecipitation of the Venus tagged proteins. Mouse ESCs nuclear extracts 
were immunoprecipated with anti-eGFP antibody and immunoblotted with the indicated antibodies. 
(A) Nsd1, Zfx, and Zkscan17 pull downs. (B) Supt6 immunoprecipitation. (C) Nsd3 and (D) Brd4 pull 
downs. 
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Figure 25. Schematic representation of mouse Zfx’s and Zkscan17’s domain structure. AD 
corresponds to the transcription activator domain; C2H2 is a zinc-finger domain; C2HR domain is 
derived from a consensus zinc finger by the substitution of the last core histidine residue to an 
arginine (R) residue; SCAN box is a leucine rich region domain; KRAB is the Krueppel-associated 
box. Protein size information was retrieved from Ensembl mouse GRCm38 
(http://www.ensembl.org/). 
 
4.1.11. Mass spectrometry analysis of Kdm1b and Brd4 protein complexes 
Mass spectrometry analysis revealed that only Kdm1b immunoprecipitated with 
Nsd3, while Brd4 did not (Table 4). Kdm1b was associated with several 
members of the Polycomb-repressive deubiquitylase (PR-DUB) complex 
(Hcfc1, Foxk1, Foxk2, Asxl2 and Bap1), which is responsible to deubiquitylate 
histone H2A and regulate gene expression. In addition, Kdm1b also pulled 
down two poorly characterized proteins associated with highly compacted 
chromatin (Mbd5 and Mbd6). Controversially, members of the Mll3/Mll4 
complex (Mll3 and Paxip1), which methylate H3K4, were found to be associated 
with Kdm1b, a H3K4 demethylase.  
The composition of the Brd4 complex is notably diverse. Brd4-associated 
proteins presented distinct functional groups (Fig. 26), such as DNA damage 
response, transcription, chromatin modification and remodeling, etc. Despite the 
fact that Brd4 did not pull down Nsd3, Atad5 was observed in both complexes 
(Tables 3 and 4), thus suggesting a link between the two proteins. 
Unexpectedly, neither Brd2 nor Brd3 were found associated with Brd4, although 
previously co-IP experiments showed that Brd4 associates with Brd3. MS is 
often unable to discriminate between closely related sequences, which could be 
the case for the bromodomain-containing proteins. Moreover, a particular 
antibody usually selects a subpopulation of its target protein based on the 
epitope exposure, thus failing to recognize any protein in complexes competing 
with the same epitope. 
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Table 4. List of Kdm1b’s and Brd4’s associated proteins. Label-free experiments were performed in 
triplicate for both transgenic and untagged cell lines. Results were validated according to the P-
value resulting from a standard ‘equal group variance’ t test of the observed fold change of protein 
intensities between the pull-downs of the transgenic and the wild-type cell lines. P-values < 0.05 
corresponds to -Log10(P-values) > 1.3. 
Protein Description Average peptides number -Log10(P-
value t-test) 
Log2(transgene/ 
control) Kdm1b IP Mock IP 
Hcfc1 Host cell factor 1 19 6 4.95 3.18 
Foxk2 Forkhead box protein K2 7 0 4.77 7.15 
Mll3 Mixed-lineage leukemia 
protein 3 homolog 
7 0 3.91 5.33 
Foxk1 Forkhead box protein K1 4 0 3.91 5.28 
Kdm1b Lysine-specific histone 
demethylase 1B 
62 0 3.74 12.22 
Paxip1 PAX-interacting protein 1 3 0 3.13 5.04 
Asxl2 Additional sex combs-like 
protein 2 
56 0 2.96 9.06 
Mbd6 Methyl-CpG-binding 
domain protein 6 
4 0 2.86 5.59 
Mbd5 Methyl-CpG-binding 
domain protein 5 
2 0 2.38 3.54 
Bap1 Ubiquitin carboxyl-
terminal hydrolase BAP1 
29 0 1.94 8.89 
Nsd3 Nuclear SET domain-
containing protein 3 
8 0 1.54 5.17 
 
Protein Description Average peptides number -Log10(P-
value t-test) 
Log2(transgene/ 
control) Brd4 IP Mock IP 
Brd4 Bromodomain-containing 
protein 4 
38 1 5.79 10.79 
Ino80 DNA helicase INO80 16 2 5.75 4.85 
Znf592 Zinc finger protein 592 6 0 5.55 5.58 
Ccnt1 Cyclin-T1 22 4 4.97 5.93 
Hax1 HCLS1-associated protein 
X-1 
6 0 4.14 5.54 
Zmynd8 Zinc finger MYND domain-
containing protein 8 
6 0 4.03 5.03 
Znf532 Zinc finger protein 532 5 0 3.33 5.57 
Nup205 205 kDa nucleoporin 4 1 3.33 5.82 
Mga MAX gene-associated 
protein 
76 3 3.32 7.30 
Setd5 SET domain-containing 
protein 5 
8 0 2.94 4.97 
Ino80b INO80 complex subunit B 4 0 2.84 5.14 
Atad5 ATPase AAA domain-
containing protein 5 
23 1 2.81 6.21 
Psmc2 26S protease regulatory 
subunit 7 
5 0 2.73 5.72 
Pcgf6 Polycomb group RING 
finger protein 6 
10 1 2.68 7.70 
Cdk9 Cyclin-dependent kinase 9 12 2 2.50 6.52 
L3mbtl2 Lethal(3)malignant brain 
tumor-like protein 2 
7 0 2.20 6.70 
Zfp609 Zinc finger protein 609 7 1 1.89 5.32 
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Figure 26. Graphical overview of Brd4-associated polypeptides identified by LC-MS/MS analysis. 
Brd4-associated proteins can be categorized into the following major groups: chromatin 
modification; chromatin remodeling; transcription; DNA damage response; signaling and others. 	  
4.2. Genome localization of the Venus tagged proteins in 
mouse ESCs 
4.2.1. Genome-wide peak distribution of the Venus tagged proteins 
Ash1l, Setd2, Nsd1-3, Supt6, Zfx, Kdm1b, and Brd4 Venus tagged and the 
control untagged mouse ES cell lines were subjected to double crosslinking 
with DSG and formaldehyde. ChIP was performed with protein G sepharose 
beads coupled with anti-eGFP antibody. Immunoprecipitated DNA was 
submitted to deep sequencing using Illumina HiSeq 2000 Sequencer. The DNA 
sequences were mapped against the mouse mm10 reference genome with the 
BWA mapping software package. ChIP-seq enriched regions were identified 
using the peak caller MACS version 1.4. The ChIP-seq data was analyzed in 
collaboration with MSc. Sukhdeep Singh (Prof. A. Francis Stewart research 
group). 
Peak calling analysis revealed that Ash1l and Nsd2 failed to identify significant 
(FDR < 0.05) binding sites (data not shown). Due to the fact that both LC-
MS/MS and ChIP-seq analyses of Ash1l and Nsd2 failed to reproduce reliable 
results, only Setd2, Nsd1, and Nsd3 were carried forward for characterization 
along with their protein partners. 
Peak calling analysis reported on average ~ 19,000 significant enriched regions 
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for each ChIP (Table 5). Supt6 and Zfx presented the highest peak calling 
efficiency (> 80 % of significant peaks), while the remaining proteins only had ~ 
45 % for an FDR of 0.05. 
Table 5. ChIP-seq peak calling analysis was performed with MACS v1.4. Statistical enrichment of 
samples over mock-IP was computed at a P-value of < 1e-5 and a FDR (false discovery rate) of < 
0.05. 
Protein Total Peaks Peaks with FDR < 0.05 % of Significant peaks 
Setd2 55,183 21,742 39.4 
Nsd1 35,959 19,148 53.2 
Nsd3 28,645 13,172 46.0 
Supt6 25,157 21,264 84.5 
Zfx 24,423 19,066 78.1 
Kdm1b 34,131 14,387 42.2 
Brd4 53,777 24,073 44.8 
 
The majority of significant binding sites were found at the promoter and coding 
regions (Fig. 27). Nsd1-Zfx complex showed the highest percentage of peaks in 
the vicinity of the TSS (transcription start site, defined as the first base of the 
annotated transcript). 
 
Figure 27. Distribution of the significant peaks in the mouse genome. Venus tagged proteins are 
indicated on the top of each plot. 
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4.2.2. H3K36 HKMTs exhibit distinct distribution profiles over their target 
genes 
ChIP-seq results showed that the tagged proteins mostly bind to the promoter 
and coding regions. Therefore, we sought to find out how the H3K36 
methyltransferases are distributed across all gene sequences. 
The results showed that the three H3K36 methyltransferases are more enriched 
in the vicinity of the TSS (Fig. 28A), although each one exhibited distinct profiles 
across the gene body. Nsd1 profile showed a sharp peak near TSS, while 
Setd2 levels still remained high across the gene body, thus reinforcing the idea 
that Setd2 associates with the elongating RNAPII. Nsd3 levels were lower than 
the other two enzymes, suggesting that it probably has less binding sites. In 
addition, Nsd3 levels were preferentially enriched at the TSS and TTS. As 
expected, the level of H3K36me3 increased towards the TTS. 
The majority of the Setd2 occupied genes (~ 80 %) were co-bound by Nsd1 
(Fig. 28B). Although Nsd3 had a more restricted number of target genes, it still 
showed high overlap with Setd2 and Nsd1 (~ 78 and 77 %, respectively). These 
results demonstrated that Setd2, Nsd1, and Nsd3 co-localize in several target 
genes, though, it remains unclear whether they have redundant roles in 
transcription regulation. 
 
Figure 28. Read density distribution of the H3K36 HKMTs. (A) Composite profiling of Setd2, Nsd1, 
and Nsd3 ChIP-seq signals over the coding and promoter regions. The x axis extends from 3 kb 
upstream of TSS to 1 kb downstream of TTS divided in 101 equally sized bins. Values were 
normalized to total number of reads in each sequencing reaction. (B) Venn diagram showing 
overlap of Setd2, Nsd1, and Nsd3 bound genes over the promoter regions (± 3 kb of TSS). * Public 
available ChIP-seq data were used for comparison (Marks et al., 2012).	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4.2.3. Genome-wide mapping characterization of each protein complex 
Based on LC-MS/MS and co-IP experiments, it was shown that Nsd1 interacts 
with Zfx. ChIP-seq analyses showed that both proteins exhibit similar binding 
profiles, being mostly enriched around the TSS (Fig. 29A). Additionally, the vast 
majority of Nsd1 target genes (92 %) overlap with Zfx’s (Fig. 29B). 
Setd2 and Supt6 showed similar enrichment over the TSS. However, Supt6 
profile over the gene bodies demonstrated a more pronounced dip, followed by 
an increased enrichment near the 3’ end (Fig. 29A). This is in agreement with 
the paused RNAPII distribution at the promoter proximal regions and the 
accumulation of the elongating polymerase towards the TTS. Nevertheless, 
Setd2 bound genes are highly co-occupied by Supt6 (~ 84 %, Fig. 29B). 
Interestingly, Nsd3 profile over gene bodies was almost identical as Kdm1b’s, 
while Brd4 had a more prominent peak around the TSS like the Nsd1-Zfx profile 
(Fig. 29A). This suggested that Brd4 might play distinct roles that do not only 
relate with Nsd3. Conversely; Nsd3 bound genes co-localized more with Brd4 
(~ 88 %) than Kdm1b (~ 69 %). The high number of peaks for Brd4 might have 
consequently produced a higher overlap between Nsd3 and Brd4 (Fig. 29B). 
Further analysis showed that all proteins under study are enriched near the 
TSS of active genes (Fig. 30A) and that Setd2, Nsd3, and Kdm1b levels are 
also spread along the gene bodies (Fig. 30B). A statistical analysis that 
correlated the read density variance over gene bodies was able to identify three 
major groups (Fig 31). These groups seemed concordant with the observations 
made with the read density distribution plot (Fig. 29A): (1) Nsd1, Zfx, and Brd4 
possess high ChIP-seq signal near the TSS; (2) Setd2 and Supt6 exhibited high 
ChIP-seq signal near the TSS and they also bound at lower extent to the gene 
body and TTS; (3) Nsd3 and Kdm1b showed similar loading over the TSS and 
TTS with a small dip across the conding region. 
In addition to the fact that all ChIP-seq datasets showed enrichment at the 
promoter proximal regions, it was observed that they bound to both CpG and 
non-CpG island promoters (Fig. 32), whereas Nsd1 showed a preference for the 
CpG and Nsd3 to the non-CpG promoters. 
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Figure 29. Read density distribution of the tagged proteins within each protein complex. (A) 
Composite profiling of Setd2, Nsd1, and Nsd3 protein complexes ChIP-seq signals over the coding 
and promoter regions. The x axis extends from 3 kb upstream of TSS to 1 kb downstream of TTS 
divided in 101 equally sized bins. Values were normalized to total number of reads in each 
sequencing reaction. (B) Venn diagrams showing overlap of Setd2, Nsd1, and Nsd3 protein 
complexes target genes over the promoter regions (± 3 kb of TSS). 
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Figure 30. Heatmap representation of the binding profiles. ChIP-seq signals are depicted for all 
active genes surrounding the (A) TSS or (B) across the coding region. The gene list was sorted 
according to H3K36me3 levels (Marks et al., 2012) from high (top) to low (bottom) average 
intensity. In (A) H3K36me3 ChIP-seq signals are shown over the gene body, because it does not 
bind to the TSS. Color scales are indicated on the bottom right side. 
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Figure 31. Principal component analysis (PCA) of the read density variance observed along gene 
bodies. The x and y axis show the two components that represent most of the observed variance. 
Three major groups were observed: (1) Nsd1, Zfx, and Brd4; (2) Setd2 and Supt6; (3) Nsd3 and 
Kdm1b.  * Public available ChIP-seq data were used for comparison (Marks et al., 2012). 
 
 
 
Figure 32. Percentage of significant peaks at CpG and non-CpG island promoters. In total there are 
12,441 CpG and 3,582 non-CpG island promoters in the mouse genome. 	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4.2.4. Functional assessment of the H3K36 HKMTs target genes 
GO analysis of the closest genes to the significant peaks of Setd2, Nsd1, and 
Nsd3 revealed that many of these genes are linked to cell division, transcription 
regulation, macromolecule biosynthetic processes, cellular response to stress, 
among others (Fig. 33). Nsd3 also showed enrichment to chromatin related 
biological processes. 
KEGG pathway analysis showed that the most significant enriched term for all 
three enzymes was pathways in cancer (Fig. 33). In addition, Nsd3 revealed 
enrichment in several other specific types of cancer, including acute and 
chronic myeloid leukemia, prostate, endometrial, and pancreatic cancer. Nsd1 
is particularly involved in several signaling pathways, such as mitogen activated 
protein kinase (MAPK), Wnt, and Hedgehog.  
A deeper look at their binding sites in the UCSC genome browser revealed that 
the three H3K36 HKMTs are localized in pluripotency (Oct4 and Klf4) and cell 
division related genes (Cdk4) (Fig. 34). 
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Figure 33. GO and KEGG pathway enrichment analyses of the nearest genes to the significant 
peaks of Setd2, Nsd1, and Nsd3. Benjamini-corrected P-values as reported by DAVID (Huang da et 
al., 2009b; Huang da et al., 2009a) are shown. 
 
	   100	  
 
Figure 34. UCSC genome browser track images of the tagged proteins at pluripotency and cell 
division related genes. Read counts are shown on the left side. CpG islands are represented by 
green rectangles. * Public available ChIP-seq data were used for comparison (Marks et al., 2012). 
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4.2.5. Nsd1 and Zfx co-occupy bivalent promoters 
In mouse ESCs, genes encoding lineage-specific developmental regulators 
contain nucleosomes with both H3K4me3 and H3K27me3 modifications, and 
have thus been called “bivalent” (Bernstein et al., 2006; Vastenhouw and 
Schier, 2012). These genes apparently experience some level of transcription 
initiation, and therefore TrxG-mediated histone H3K4 methylation, but are 
silenced by PcG complexes. Our group and others have identified Mll2 (Wbp7) 
as responsible for H3K4me3 deposition at bivalent promoters (Hu et al., 2013; 
Denissov et al., 2014). It is still unknown whether H3K36 methyltransferases 
also bind to these promoters and contribute to the poised transcription state in 
mouse ESCs. 
Nsd1 occupied bivalent promoters with similar intensity as Mll2 (Fig. 35A), while 
Setd2 was bound at lower levels. In addition, Zfx was also highly enriched on 
bivalent promoters (Fig. 35B), thus suggesting that the Nsd1-Zfx complex might 
have a role in regulating lineage specific genes during differentiation. The 
binding profile at known bivalent genes reinforced the point that Nsd1 and Zfx 
co-occupy these promoters together with Mll2 (Fig. 36). 
 
Figure 35. Read density distribution over bivalent promoters (A) Composite profiling of Setd2, 
Nsd1, and Nsd3 ChIP-seq signals with respect to the TSS of bivalent genes. A list of public 
available bivalent genes was used to subset the ChIP-seq data (Li et al., 2013c). Setd1a ChIP-seq 
data was provided by Dr. Giovanni Ciotta and it was used as negative control for bivalency, while 
Mll2 was used as positive control (Denissov et al., 2014). Values were normalized to total number 
of reads in each sequencing reaction. (B) Composite profiling of Nsd1-Zfx ChIP-seq signals with 
respect to TSS of bivalent genes. 	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Figure 36. UCSC genome browser track images at known bivalent genes. Read counts are shown 
on the left side. CpG islands are represented by green rectangles. * Public available ChIP-seq data 
were used for comparison (Marks et al., 2012; Denissov et al., 2014). 
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4.3. Functional analysis of Nsd1 and Nsd3 in mouse ESCs 
4.3.1. Generation of Nsd1 and Nsd3 domain deletion constructs 
After characterizing the genome-wide localization and protein complexes of 
Set2 subfamily members, the next logic step would involve studying their 
functional properties. Nsd1 and Nsd3 contain several protein domains 
associated with chromatin and protein-protein interactions, such as PWWP and 
zinc-finger like domains (Fig. 4). Sequential deletion of these protein domains 
was achieved to study any possible changes in Nsd1 and Nsd3 function. Three 
outcomes were observed: (1) loss of protein-protein interactions through co-IP 
experiments, (2) chromatin binding by ChIP-qPCR, and (3) protein localization 
through confocal microscopy. 
BACs carrying the Nsd1 and Nsd3 genes were modified through 
recombineering in order to replace the targeted exons with a specific cassette 
containing either neomycin or hygromycin resistant genes. BAC digestion 
showed that at least one clone of each construct was properly recombined (Fig. 
37 and 38). 
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Figure 37. Restriction digestion of the recombined BAC constructs for Nsd1 domain deletions. (A) 
In silico prediction of the restriction patterns. (B) BAC DNA digestion with the specific restriction 
enzymes after deletion of the targeted domains. The following restriction enzymes were used: 
SpeI-ΔPWWP1, BamHI-ΔPHD1-4, EcoRV-ΔPWWP2, and AvaI-ΔPHD5/C5HCH. Recombined clones 
are represented by “recomb.” or “rec.”, while “C” corresponds to the control (Nsd1 BAC with the 
C-terminal adaptor cassette). Black arrows represent some of the observed digestion differences 
between the control and recombinant BACs. 
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Figure 38. Restriction digestion of the recombined BAC constructs for Nsd3 domain deletions. (A) 
In silico prediction of the restriction patterns. (B) BAC DNA digestion with the specific restriction 
enzymes after deletion of the targeted domains. The following restriction enzymes were used: 
BamHI-ΔPWWP1, EcoRI-ΔPHD1-4, EcoRI-ΔPWWP2 and NcoI-ΔPHD5/C5HCH. Recombined clones 
are represented by “recomb.” or “rec.”, while “C” corresponds to the control (Nsd3 N-Venus BAC). 
Black arrows represent some of the observed digestion differences between the control and 
recombinant BACs. 
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4.3.2. Characterization of Nsd1’s PWWP and zinc-finger like domains 
All four constructs encoding truncated variants of the Nsd1 protein (Fig. 39) 
were successfully transfected and expressed in E14Tg2a cells (data not 
shown). Co-IP experiments showed that deletion of the PHD5/C5HCH domains 
abrogated the protein-protein interaction with Zfx (Fig. 40A). Moreover, the 
ΔPHD5/C5HCH cell line also showed reduced levels of Nsd1 at the promoter 
regions of several pluripotency and cell division related genes (Fig. 40B), 
suggesting that Nsd1 might bind to DNA in a Zfx-dependent manner. However, 
Zfx is probably not the only factor that contributes to Nsd1 recruitment to 
chromatin, since deletion of the PHD1-4 domains also showed significant 
reduced levels of Nsd1 at the Oct4 and Tcl1 promoter regions (Fig. 40B). 
 
 
Figure 39. Schematic representation of the Nsd1 protein truncated forms. The SET domain is 
shown with its associated with SET (AWS) and post-SET domains (postSET); NIDs, nuclear 
receptor interaction domains; plant homeodomain (PHD); PWWP domain is Pro-Trp-Trp-Pro motif; 
C5HCH is a zinc-finger domain; Venus tag. 
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Figure 40. Characterization of Nsd1’s protein domains. (A) Co-Immunoprecipitation of the Nsd1 C-
Venus truncated forms. Mouse ESC nuclear extracts were immunoprecipated with anti-eGFP 
antibody and immunoblotted with the indicated antibodies. (B) ChIP-qPCR analysis of the Nsd1 C-
Venus truncated forms at specific promoter regions. Target genes were selected according to 
ChIP-seq data. ChIP signals were normalized against a gene desert region (Chr9 intergenic region) 
and plotted as fold enrichment over mock-IP. Error bars represent the standard deviation of the 
means. * Significantly different (P-value < 0.05) from the full length Nsd1 C-Venus ChIP. 
 
None of the deleted domains affected the nuclear protein localization of Nsd1. 
Although, Nsd1 could not be observed bound to chromatin during cell cycle 
progression when the PHD1-4 and PWWP2 domains were deleted (Fig. 41). 
This reinforced the hypothesis that Nsd1 PHD fingers are important for 
chromatin binding as first pointed out by the ChIP-qPCR analysis. Due to the 
close localization between PHD1-4 and PWWP2 domains (Fig. 39), it is still 
unclear whether PWWP2 really has a direct or indirect role in chromatin binding. 
One alternative hypothesis would be that loss of the PWWP2 domain 
destabilizes the PHD1-4 domains structure. 
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Figure 41. Immunofluorescence images of the Nsd1 C-Venus truncated versions. Nuclei were 
stained with DAPI. Fluorescence was detected with confocal microscope at 40 or 63 X 
magnification. Red arrows indicate condensed chromatin over cell cycle progression. 
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4.3.3. Preliminary characterization of Nsd3’s PWWP and PHD5/C5HCH 
domains 
Except for the Nsd3 ΔPHD1-4 truncated form, all the other constructs were 
successfully transfected and expressed in E14Tg2a cells (Fig. 42). This result 
might suggest that the PHD fingers are crucial for the protein structure and 
stability in mouse ESCs. 
 
Figure 42. Expression of the Nsd3 truncated versions. (A) Schematic representation of the Nsd3 
protein truncated forms. The SET domain is shown with its associated with SET (AWS) and post-
SET domains (postSET); plant homeodomain (PHD); PWWP domain is Pro-Trp-Trp-Pro motif; 
C5HCH is a zinc-finger domain; Venus tag. (B) Immunoblot of whole cell protein extracts from 
mouse ESCs. Samples were separated by SDS-PAGE and immunoblotted with anti-eGFP antibody. 
Arrows indicate the expressed tagged proteins. The screened clones are numbered. 	  
Currently, co-IP experiments with the Nsd3 N-Venus truncated versions are still 
in progress. The goal is to check possible loss of protein interaction with Brd4 
and Kdm1b. Confocal microscopy showed that PWWP and PHD5/C5HCH 
domains do not affect the Nsd3 nuclear localization (Fig. 43A). All truncated 
forms showed a decrease in Nsd3 deposition at the promoter regions of some 
specific genes (Fig. 43B). The PWWP1 domain seemed to be the most 
important for DNA binding, since it showed the lowest Nsd3 levels in most 
target genes. These results were not in agreement with those observed with 
Nsd1. Therefore, Nsd1 and Nsd3 might bind to chromatin through different 
mechanisms. 
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Figure 43. Preliminary characterization of Nsd3’s protein domains. (A) Immunofluorescence 
images of the Nsd3 N-Venus truncated forms. Nuclei were stained with DAPI. Fluorescence was 
detected with confocal microscope at 40 X magnification. (B) ChIP-qPCR analysis of the Nsd3 N-
Venus truncated forms at specific promoter regions. Target genes were selected according to 
ChIP-seq data. ChIP signals were normalized against a gene desert region (Chr9 intergenic region) 
and plotted as fold enrichment over mock-IP. Error bars represent the standard deviation of the 
means. * Significantly different (P-value < 0.05) from the full length Nsd3 N-Venus ChIP. 
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4.3.4. Nsd1 knockdown showed a decrease in H3K36me2 bulk levels 
In order to evaluate the effect of Nsd1 and Zfx removal in mouse ESCs, 
knockdown experiments were performed with shRNAs against the H3K36 
methyltransferase and its protein partner. Unfortunately, from 5 five Nsd1 
shRNA plasmids tested only one gave a good knockdown (~ 75 %). Next, it was 
investigated whether knockdown of Nsd1 and Zfx would affect the ESC 
properties. It has been reported that Zfx deletion impaired self-renewal in ESCs 
(Galan-Caridad et al., 2007). However, no significant changes were observed at 
mRNA levels for several self-renewal related markers (Fig. 44A), suggesting 
that even low expression levels of Nsd1 or Zfx were sufficient to keep the ESC 
state.  
 
Figure 44. Nsd1 and Zfx knockdowns in mouse ESCs. (A) Relative mRNA expression of ESC-
specific genes after Nsd1 and Zfx knockdowns. Values were normalized with β-actin. Error bars 
represent the standard deviation of the means. *Significantly different (P-value < 0.05) from the 
scramble control. (B) Immunoblots on whole cell protein extracts from Nsd1, Zfx, and scramble 
shRNAs stable ES cell lines. Samples were separated by SDS-PAGE and immunoblotted with the 
indicated antibodies. Ash2l and total H3 were used as loading controls. 
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Nsd1 depletion caused downregulation of Zfx and vice versa. This observation 
was also observed at protein level (Fig. 44B). Nsd1 knockdown also led to 
reduced histone bulk levels of H3K36me2 (Fig. 44B), corroborating with 
previous studies that characterized Nsd1 as a H3K36 dimethylase. 
Nsd1 knockdown also decreased the levels of the H3K36me3 mark in the 
coding regions of Oct4, Rif1, Brd2, and Ccnd1 (Fig. 45A). This observation is 
probably a consequence of the H3K36me2 depletion. Antibodies used for the 
H3K36 mono- and dimethylation marks were not sufficiently effective for 
chromatin immunoprecipitation. 
Intriguingly, Zfx levels were higher at the promoter regions of Nsd1 depleted 
cells (Fig. 45A). On the other hand, Zfx knockdown decreased Nsd1 levels at 
the Oct4 and Tcl1 promoter regions (Fig. 45B). This result was in agreement 
with the phenotype observed after deletion of the Nsd1’s PHD5/C5HCH 
domain, in which the Nsd1-Zfx interaction was abrogated (Fig. 40). However, 
Nsd1 enrichment in the scramble control was low at the Tbx3, Sox2, and Cdk4 
promoter regions (Fig. 45B), thus implying that the ChIP did not perform as well 
as expected. This experiment will be repeated in order to confirm these 
preliminary results. Nevertheless, the current results suggest that Nsd1 could 
regulate Zfx chromatin release, whereas Zfx would play a role in Nsd1 
recruitment to chromatin. 
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Figure 45. ChIP experiments in (A) Nsd1 and (B) Zfx depleted mouse ESCs. ChIP assays were 
carried out for the indicated genes at the promoter (Nsd1 C-Venus and Zfx N-Venus ChIP) and gene 
body (H3K36me3 ChIP) regions. Target genes were selected according to the ChIP-seq data. ChIP 
signals were normalized against a gene desert region (Chr9 intergenic region) and plotted as fold 
enrichment over mock-IP. Error bars represent the standard deviation of the means. *Significantly 
different (P-value < 0.05) from scramble control. 
 
4.3.5. Kdm1b depletion did not affect bulk levels of H3K36 methylation 
Mass spectrometry and co-IP experiments showed that Nsd3 associates with 
Kdm1b and Brd4. In order to further study their functional roles associated with 
H3K36 methylation, mouse ESCs were infected with lentiviral particles 
containing Nsd3 and Kdm1b shRNAs. None of the Nsd3 shRNAs was able to 
cause an efficient knockdown (< 40 % decrease, data not shown). On the other 
hand, Kdm1b shRNA stable cell lines exhibited good knockdowns (Fig. 46A). 
Western blot analysis confirmed that Kdm1b protein was downregulated, 
though no changes were observed for Nsd3 and H3K36 bulk methylation levels 
(Fig. 46B). Future experiments will be performed to explore whether Kdm1b 
depletion would affect Nsd3 recruitment to chromatin by ChIP-qPCR analysis. 
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Figure 46. Kdm1b knockdown in mouse ESCs. (A) Relative mRNA expression of Kdm1b after 
lentiviral infection. Values were normalized with β-actin. Error bars represent the standard 
deviation of the means. (B) Immunoblots on whole cell protein extracts from Kdm1b and scramble 
shRNAs stable cell lines. Samples were separated by SDS-PAGE and immunoblotted with the 
indicated antibodies. The splicing factor Sfpq and total H3 were used as loading controls. 
 
4.3.6. Nsd3 is recruited to target genes in a Brd4-dependent manner 
Conditional targeted Brd4 ESCs were kindly provided by Dr. William C. Skarnes 
(Wellcome Trust Sanger Institute, Cambridge, UK; Fig. 47). Cre-mediated 
deletion creates a frameshift and subsequent termination mutation of the 
conditional allele. These ESCs containing Rosa26:CreERT2 could efficiently 
delete Brd4 by administration of 4-hydroxy-tamoxifen (4-OHT) (Fig. 48). At 
global levels, Brd4 was undetectable 48h after addition of 4-OHT (data not 
shown).  
Interestingly, Brd4 knockout cells showed high cell death by day 6 after the first 
administration of 4-OHT (Fig. 48A). In addition, these cells gradually lost their 
round shaped ESC phenotype and became flat and spiky, similar to fibroblast 
cells. Therefore, it indicated that Brd4 is essential for ESC self-renewal state. 
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Figure 47. Knockout strategy for Brd4 deletion. First, one allele is deleted by targeting the critical 
exon. The next targeting events insert loxP sites flanking the critical exon of the other allele. 
Thereafter, cre-mediated deletion creates a frameshift and subsequently deletes Brd4 second 
allele. SA: splicing acceptor; bsd: blasticidin resistant gene; pA: poly(A) tail. 
 
Brd4 knockout cells were harvested 4 days after 4-OHT administration and 
analyzed through Western blot and ChIP-seq. Immunoblot showed a third band 
below the one corresponding to isoform 2 after Brd4 knockout (Fig. 48C). One 
plausible explanation would be that in the absence of Brd4, Nsd3 looses 
stability and becomes more susceptible to proteolysis. 
H3K36 bulk methylation levels in Brd4 knockout cells were unchanged (Fig. 
48C). ChIP-seq experiments were performed to evaluate Nsd3 and H3K36me3 
genome-wide profiles in presence and absence of Brd4. Nsd3 N-Venus BAC 
was successfully transfected in Brd4 conditional ESCs and chromatin 
immunoprecipitation was performed with anti-eGFP antibody. Global and gene-
specific analyses showed that H3K36me3 levels were not affected in the 
absence of Brd4 (Fig. 49). Interestingly, Nsd3 levels were definitely reduced, 
thus suggesting that Brd4 is important for Nsd3 recruitment to its target genes. 
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Figure 48. Brd4 knockout in mouse ESCs. (A) Pictures of non-induced cells (+/-) and at day 6 after 
the first induction with 4-OHT (-/-). Phase contrast microscope in 10 X magnification. Brd4 deficient 
(-/-) ESCs exhibited an apoptotic phenotype compared to Brd4 (+/-). (B) Relative mRNA expression 
of Brd4 at day 4 after first induction with 4-OHT. Values were normalized with β-actin. Error bars 
represent the standard deviation of the means. (C) Immunoblots on whole protein extracts from 
heterozygous and knockout Brd4 cells. Samples were separated by SDS-PAGE and immunoblotted 
with the indicated antibodies. The splicing factor Sfpq and total H3 were used as loading controls. 
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Figure 49. ChIP-seq analysis of H3K36me3 and Nsd3 in the presence and absence of Brd4. (A) 
Composite profiling of ChIP-seq signals over the coding and promoter regions. The x axis extends 
from 3 kb upstream of TSS to 1 kb downstream of TTS divided in 101 equally sized bins. Values 
were normalized to total number of reads in each sequencing reaction. (B) Heatmap representation 
of the ChIP-seq signals across the gene bodies of active genes (13105) in mouse ESCs. The gene 
list was sorted according to H3K36me3 levels from high (top) to low (bottom) average intensity. 
Color scale is indicated on the bottom right side. (C) UCSC genome browser track images of 
H3K36me3 and Nsd3 target genes in Brd4 heterozygous and knockout ESCs. Read counts are 
shown on the left side. CpG islands are represented by green rectangles.  
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5. Discussion 
5.1. Venus tagged H3K36 HKMTs expression and their protein-protein 
interactions 
Embryonic stem cells (ESCs) are pluripotent and self-renewing cells that are 
derived from the inner cell mass of the developing blastocyst. Under 
appropriate culture conditions, mouse embryonic stem cells can proliferate in 
vitro and retain the ability to differentiate into all cell types of the adult organism 
(Evans and Kaufman, 1981; Smith, 2001). For these reasons, ESCs represent 
an ideal system for the study of early development pathways and are thought to 
hold great promise for regenerative medicine. 
The balance between pluripotency and differentiation is regulated by the 
interplay between pluripotency and lineage specific transcription factors, in 
which epigenetic modifiers play a crucial role (Keenen and de la Serna, 2009). 
Histone modifications can affect gene expression and genome function by 
tuning chromatin environments and orchestrating DNA-based biological 
processes. Methylation of histone 3 (H3) at lysine 36 (K36) has been widely 
associated with active chromatin, though it has also been implicated in several 
other biological processes, such as transcriptional repression and alternative 
splicing (Wagner and Carpenter, 2012). 
In yeast, SET domain-containing 2 (Set2) performs all three methylation events 
at H3K36 (Lee and Shilatifard, 2007), while in mammals there are at least eight 
distinct enzymes capable to methylate H3K36 in vitro and/or in vivo: Setd2, 
Nsd1-3, Ash1l, Smyd2, Setmar, and Setd3. This raises the question of why so 
many different enzymes are available for the methylation of the same target 
residue. One explanation could be that the product specificities of these 
enzymes differ. For instance, Nsd1 and Nsd2 are thought to monomethylate 
and dimethylate their substrate (Li et al., 2009b; Lucio-Eterovic et al., 2010), 
while Setd2 can only trimethylate H3K36 (Edmunds et al., 2008). Another 
possibility could be that H3K36 is not the only physiological substrate for some 
of these enzymes. 
Much effort has gone into understanding the nature of these enzymes and their 
substrate specificities, but little is known about their regulation and dynamics 
beyond the well-characterized model of the yeast Set2 and its relationship with 
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RNA polymerase II. In the present study, we aimed to gain further insights in 
how five of these H3K36 methyltransferases (Ash1l, Setd2, and Nsd1-3) are 
regulated and how they contribute to changes in the epigenetic landscape in 
mouse embryonic stem cells. 
It is still quite difficult to describe the molecular properties of individual proteins 
in vivo, such as their gene targets, physical interactions, and localization. The 
protein variations in size, charge, and folding present a challenge to the 
systematic generation of reagents that specifically recognize individual proteins 
like antibodies. These problems can be circumvented by using fluorescent and 
affinity protein tags. When fused to the protein of interest, these tags allow in 
vivo visualization and use of standard affinity purification methods to identify 
protein-protein interactions (Ciotta et al., 2011; Hofemeister et al., 2011). 
To better understand the regulatory dynamics behind the H3K36 HKMTs, we 
generated BAC transgenic Venus expressing ES cell lines in order to perform a 
comprehensive set of analyses, including: (1) protein localization through high-
resolution confocal microscopy, (2) proteomic analyses, (3) chromatin 
immunoprecipitation (ChIP) followed by deep sequencing methodologies, and 
(4) functional dissection of specific protein domains through sequential 
deletions. 
It was quite challenging to work with these H3K36 HKMTs in mouse ESCs, 
because of their high molecular weight and low expression levels. mRNA 
expression analysis showed that Ash1l, Nsd2, and Nsd3 were much less 
expressed than Nsd1 and Setd2, and these values varied according to the cell 
lineage. Except for Nsd3 N-Venus, the tagged proteins could only be detected 
by Western blot after immunoprecipitation. 
Though we succeeded in generating all tagged cell lines, Ash1l and Nsd2 failed 
to produce reliable LC-MS/MS and ChIP-seq results. Therefore, they were 
excluded from the group of study. Ash1l showed the lowest expression levels 
and also could not be observed by immunofluorescence analysis. Ash1l 
probably does not have a substantial role in embryonic stem cells and could 
become more important upon differentiation. Ash1l-mediated H3K36 
methylation was reported to counteract Polycomb silencing and promote Hox 
genes activation in retinoic acid differentiated ESCs (Miyazaki et al., 2013). 
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Nsd2-Venus fusion protein exhibited nuclear localization and could be easily 
immunoprecipitated, though; MS analysis did not detect any protein partners. 
This is improbable, since Nsd2 has been reported to form different protein 
complexes, including transcription factors (Sall1, Sall4, and Nanog) in ESCs 
(Nimura et al., 2009) and Brd4 together with the P-TEFb complex in MEFs 
(Sarai et al., 2013). Genetically encoded tags such as Venus are widely used 
for proteomic and regulomic research. However, tags can cause significant 
perturbations to a protein's structure and consequently to its function. Thus, we 
decided to focus on Setd2, Nsd1, and Nsd3 proteins. 
Mass spectrometry analysis revealed that Setd2, Nsd1, and Nsd3 do not 
physically interact with each other. This reinforces the hypothesis that there is a 
division of labor between the H3K36 HKMTs, which might play non-redundant 
roles in the regulatory network. 
Setd2 was found associated with several RNAPII subunits as well as two 
transcription elongation factors (Supt5 and Supt6). The SETD2 enzyme 
specifically binds to hyper-phosphorylated (Ser2-P and Ser5-P) CTD repeats of 
RNAPII large subunit (POLR2a) (Sun et al., 2005; Yoh et al., 2008). In 293T 
and HeLa cells, IWS1 was shown to be the physical link between SETD2 and 
SUPT6H (Yoh et al., 2008), although our LC-MS/MS results did not detect Iws1 
as a significant protein partner. Although human IWS1 depletion does not alter 
SUPT6H binding to target genes, IWS1 is required for optimal loading of SETD2 
and for stable accumulation of H3K36me3 across coding regions (Yoh et al., 
2008). IWS1 also interacts with the mRNA export adaptor protein, REF1/Aly, 
and knockdown of either SETD2 or IWS1 induced bulk HeLa poly(A)+ mRNAs 
to accumulate in the nucleus (Yoh et al., 2007; Yoh et al., 2008). MS is a highly 
sensitive technique, but it is not immune to errors. Co-immunoprecipitation 
experiments with Setd2 and Iws1 in mouse ESCs might clarify this issue. 
SUPT4H and SUPT5H associate in the DRB (5,6-dichloro-1-β-D-ribofuranosyl-
benzimidazole) sensitivity-inducing factor (DSIF) complex, which regulates 
mRNA processing and transcription elongation by RNA polymerase II (Wada et 
al., 1998). In yeast, biochemical data suggested that Spt4 and Spt5, homologs 
of Supt4 and Supt5, form a tight complex that associates only weakly with Spt6, 
homolog of Supt6 (Hartzog et al., 1998). Herein, we report a physical link 
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between Setd2 and Supt5. Nevertheless, it is still unclear whether Setd2 
interacts directly with Supt5 or if this association is mediated by Supt6. 
MS and co-IP experiments strongly indicated that Nsd1 interacts with Zfx and 
not with Zkscan17 in mouse ESCs. Zkscan17 was originally observed as an 
Nsd1 interacting protein in mouse N2A neuroblastoma cells (Nielsen et al., 
2004). Zkscan17 possesses transcriptional repression and activation ability 
mediated by Jarid2 interaction (Mysliwiec et al., 2007), a protein associated with 
the PRC2 complex. On the other hand, Zfx is a transcription factor encoded on 
the X chromosome, which plays an important role in controlling the self-renewal 
of embryonic and adult stem cells (Galan-Caridad et al., 2007; Harel et al., 
2012). In mouse ESCs, Zfx together with c-Myc and the cofactors Cnot3 and 
Trim28 form a network that regulates the transcription of genes involved in cell 
cycle, cell death, and cancer (Hu et al., 2009). In addition, Zfx has suppressive 
potential towards H1 linker histone genes (Gokhman et al., 2013). Histone H1 
to core histone stoichiometry has been observed to correlate with the extent of 
cell differentiation, with the lowest ratio in ESCs and the highest ratio in 
quiescent cells (Fan et al., 2005). 
Nsd1 was first characterized as a nuclear protein (Huang et al., 1998). 
Interestingly, our immunofluorescence analysis showed that Nsd1 binds to 
chromatin during mitosis, a feature shared with Zfx. An image-based RNA 
interference (RNAi) screen performed in HeLa cells identified 226 genes, 
including NSD1, that, when suppressed, resulted in structural defects in the 
mitotic spindle (Rines et al., 2008). Moreover, ZFX silencing results in cell cycle 
arrest at G0/G1 phase in several cancer types (Jiang et al., 2012; Li et al., 
2013b; Yang et al., 2014). Overall, it seems Nsd1 and Zfx have a role in cell 
cycle, which needs further study. 
Nsd3 interacts with multiple and distinct protein complexes. We focused on 
describing its interactions with the chromatin modifier Kdm1b and the 
bromodomain-containing proteins Brd2-4.  
Kdm1a was the first identified histone demethylase (Shi et al., 2004). Since 
then, it has been extensively studied while the enzymatic activity and biological 
function of its homolog Kdm1b have just begun to emerge. Kdm1b is a 
H3K4me1/2 demethylase like Kdm1a. However, Kdm1b is a component of a 
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different cellular complex and has distinct functions from those of Kdm1a. 
Biochemical studies indicate that KDM1B associates with transcriptional 
elongation factors and phosphorylated RNAPII (Fang et al., 2010). Notably, a 
genetic study has linked H3K4 demethylation by Kdm1b to the establishment of 
maternal imprinting in mouse oocytes (Ciccone et al., 2009). Herein, we showed 
that Nsd3 co-immunoprecipitated with Kdm1b, and the reciprocal is also true. In 
HeLa cells, KDM1B forms active complexes with the chromatin histone 
methyltransferases G9a and NSD3 (Fang et al., 2010). Additional investigation 
is required to fully understand the nature of Kdm1b and Nsd3 interaction.  
Our MS analysis also revealed that Kdm1b mostly associates with members of 
the PR-DUB complex (Hcfc1, Foxk1, Foxk2, Asxl2 and Bap1), which specifically 
mediates deubiquitylation of histone H2AK119ub (Scheuermann et al., 2010). 
Bap1 is the catalytic component of the complex and it has several described 
functions: (1) epigenetic regulation of PcG target genes by opposing the PRC1 
complex (Scheuermann et al., 2010), (2) regulation of gene transcription (Yu et 
al., 2010) via association with other protein partners (e.g., Hcf1, Ogt, and YY1), 
and (3) regulation of gluconeogenesis and possibly mitochondrial biogenesis 
(Ruan et al., 2012) by increasing the stability of peroxisome proliferator-
activated receptor-γ co-activator 1α (PGC1α). Bap1 core complex, which also 
includes Kdm1b, is quite diverse and flexible, thus it could influence different 
pathways in a cell type‐specific manner (Yu et al., 2010). 
Brd4, along with Brd2, Brd3, and testes/oocyte-specific BrdT, comprises the 
bromodomain and extra-terminal domain (BET) family of proteins in mammals, 
which is characterized by the presence of tandem, amino-terminal 
bromodomains, and an extraterminal (ET) domain. LC-MS/MS analysis 
revealed that Nsd3 associates with Brd2-4, although co-IP experiments 
validated only the interaction with Brd4. Indirect interactions could be detected 
by MS and BRD4 was reported to interact with BRD2 and BRD3 in HeLa cells 
(Rahman et al., 2011). Our co-IP experiments showed that Brd4 pulls down 
only Brd3. In contrast, Brd4 MS analysis did not detect Brd2, Brd3, and Nsd3 as 
protein partners. One of the major challenges of protein complex analysis by 
MS is distinguishing between true specific interactors and background binders. 
Since LC-MS/MS is sensitive it produces a large number of protein 
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identifications in each pull down, most of them being unspecific co-isolated 
proteins. MS also presents some disadvantages by not being able to distinguish 
closely related sequences. In addition, the immunoprecipitation itself can be the 
cause of failure of protein complexes identification, since it is based on the 
epitope exposure to its target protein. 
Brd4 MS results showed its interaction with the P-TEFb complex (Ccnt1 and 
Cdk9). Brd4 is capable of releasing the P-TEFb complex from the inhibitory 
factors, HEXIM1/2 and 7SK snRNA, through its direct interaction with Cyclin T1 
(Ccnt1), resulting in phosphorylation of RNAPII, which leads to efficient 
transcriptional elongation (Jang et al., 2005; Yang et al., 2005). Rahman and 
colleagues (2011) showed that BRD4 ET domain interacts with NSD3, but pull 
down of the full length BRD4 did not retrieve NSD3. This corroborates with our 
results and, though, it seems Brd4 is one of the main Nsd3 protein partners, this 
is not reciprocal. Brd4 is a nuclear protein, which binds to acetylated H3 and H4 
tails, and plays an essential role in maintaining chromatin architecture (Wang et 
al., 2012). Brd4 has been reported in several protein complexes, including P-
TEFb, general transcription cofactor Mediator, gene-specific pro-inflammatory 
factor NF-kB, and virus-encoded transcriptional regulators (Chiang, 2009). 
BRD4 impairment is clinically linked to NUT midline carcinoma and several 
other cancers (French et al., 2003; Lockwood et al., 2012; Segura et al., 2013). 
In addition, Brd4 is functionally associated with primary stress responses 
(Hargreaves et al., 2009). 
More recently, BRD4 was further characterized as an inhibitor of DNA damage 
response signaling by recruiting the condensin II chromatin remodeling complex 
to acetylated histones through bromodomain interactions (Floyd et al., 2013). 
Interestingly, both Nsd3 and Brd4 interacted with Atad5 (also abbreviated 
Frag1), which was originally implicated with DNA damage response (Ishii et al., 
2005). ATAD5 also interacts with several proteins associated with the DNA 
damage repair pathway, including the ubiquitin-specific protease 1 (USP1) and 
the bromodomain adjacent to zinc finger domain protein 1B (BAZ1B) (Rahman 
et al., 2011). It has been proposed to regulate proliferating cell nuclear antigen 
(PCNA) deubiquitylation by recruiting the USP1-associated factor (UAF1) 
complex to ubiquitylated PCNA (Lee et al., 2010b). PCNA performs critical 
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functions during DNA replication as a processivity factor for DNA polymerases 
as well as a docking site for many post-DNA synthesis proteins (Moldovan et 
al., 2007). ATAD5 knockdown led to overall DNA replication decrease through 
accumulation of DNA replication factories in a PCNA-dependent manner (Lee et 
al., 2013).  
Our results indicate that Nsd3 may be involved in multiple biological processes, 
such as transcription regulation, DNA damage response, and deubiquitylation 
signaling. Additional studies should focus on how Nsd3 contributes in these 
different biological events. 
 
5.2. Genome-wide localization of the H3K36 HKMTs and their protein 
partners 
DNA-binding proteins are essential for many cellular processes, such as 
transcription, splicing, replication, and DNA repair. These proteins include 
transcription factors and chromatin modifiers that bind preferentially to specific 
DNA sequences and histone proteins, respectively. Chromatin states can 
influence transcription directly by altering DNA packaging to allow access to 
DNA-binding proteins, or they can modify nucleosomes to enhance or prevent 
recruitment of effector protein complexes. Moreover, particular sequence 
features such as promoters, CpG islands, and repetitive elements can influence 
characteristic modification patterns and chromatin states. 
These distinctive chromatin features can regulate targeting of transcription 
factors and regulatory machinery to active genomic loci in mammalian 
genomes. Recent advances indicate that this interplay between chromatin and 
transcription is quite dynamic and complex (Spitz and Furlong, 2012). In order 
to better understand the chromatin status of developmental processes and 
disease states, one should perform epigenome profiling in multiple cell types 
(Zhou et al., 2011). 
Chromatin immunoprecipitation (ChIP) is the standard method for mapping the 
localization of post-translationally modified histones and histone variants in the 
genome, and for identifying DNA target sites for transcription factors and other 
chromosome-associated proteins. In ChIP, antibodies are used to select 
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specific proteins or nucleosomes, which enriches for DNA fragments that are 
bound to these proteins or nucleosomes.  
The introduction of next generation sequencing allowed the fragments obtained 
from ChIP to be directly sequenced (ChIP-seq), therefore enabling a genome-
wide view of DNA–protein interactions in a cost-effective approach. Tens of 
millions of DNA fragments can be sequenced in a single experiment producing 
high-quality, high-specificity, and high-sensitivity data (Furey, 2012). 
We performed ChIP-seq of the Setd2, Nsd1, Nsd3, Supt6, Zfx, Kdm1b, and 
Brd4 Venus tagged proteins. The H3K36 HKMTs showed different binding 
profiles around gene bodies: Nsd1 mainly binds in the vicinity of the TSS, Setd2 
loading starts near TSS and also spreads along the gene body, and Nsd3 binds 
preferentially to the TSS and TTS. Nevertheless, they showed high overlap of 
target genes (> 75 %), suggesting that either they have redundant roles or they 
might regulate gene transcription at different layers. 
In HeLa cells, ChIP-qPCR in a specific set of genes demonstrated that SETD2 
binds to coding regions of active and intron-containing genes (Yoh et al., 2008; 
de Almeida et al., 2011). Our genome-wide analysis showed that Setd2 binds to 
most active genes in mouse ESCs and it accumulates near the TSS and along 
the coding region up to the TTS. MS analysis showed a physical link between 
Setd2 and Supt6. Supt6 is a histone chaperone that travels with the elongating 
RNAPII and mediates reassembly of nucleosomes displaced by promoter-
bound activators (Belotserkovskaya and Reinberg, 2004). Nucleosome 
reassembly during elongation is coordinated with the de novo deposition of 
several post-translational histone modifications, including H3K36me3 (Li et al., 
2007), which is mediated by Setd2.  
Supt6 exhibited higher binding at TSS and, then, it decreased along the coding 
region and rose again near the TTS. Supt6 showed similar profile in mouse 
myogenic cells, which positively correlated with RNAPII occupancy at 
transcribed genes (Mousavi et al., 2012; Wang et al., 2013). Our statistical 
analysis suggested a correlation between Setd2 and Supt6 ChIP-seq signals. 
Moreover, Setd2 and Supt6 exhibited high overlap occupancy at the promoter 
regions (~ 84 %). Hence, Setd2 and Supt6 genome-wide distribution resemble 
	   126	  
RNAPII’s, supporting the link between nucleosome reassembly by Supt6 and 
the de novo H3K36me3 deposition by Setd2 with the elongating RNAPII. 
In mouse ESCs, Nsd1 and Zfx are highly enriched near the TSS and the 
majority of Nsd1 target genes (92 %) are co-bound by Zfx. In human HCT116 
colorectal cancer cells, ChIP-chip experiments also reported that NSD1 binds to 
the promoter proximal regions and controls the levels of methylated H3K36 
(Lucio-Eterovic et al., 2010). Moreover, NSD1 knockdown reduced the levels of 
RNAPII occupancy at the bone morphogenic protein 4 (BMP4) promoter, thus 
implicating a role of NSD1 in transcription initiation. Zfx integrates the core 
transcriptional network in ESCs and it is found significantly enriched near 
promoter regions (Chen et al., 2008; Gokhman et al., 2013). 
We showed that Nsd3 is part of multiple complexes, including Kdm1b and Brd4 
complexes. Nsd3 global distribution over gene bodies highly resembled 
Kdm1b’s, though Kdm1b did not occupy ~ 31 % of Nsd3 target genes. In HeLa 
cells, KDM1B showed intragenic binding preferentially at the 3’ end by ChIP-
chip, and NSD3 occupied a small subset of KDM1B targets (Fang et al., 2010). 
In mouse ESCs, we detected intragenic binding preferentially at both 5’ and 3’ 
gene regions. ChIP-seq offers many advantages over ChIP–chip, including 
higher resolution and coverage. 
In contrast, Brd4 loading was highly enriched only near TSS, though, Nsd3 
target genes highly overlapped with Brd4’s (~ 88 %). This matches recent 
BRD4 ChIP-seq data, which showed strong enrichment at promoter regions of 
actively transcribed genes (Chapuy et al., 2013; Anders et al., 2014; Knoechel 
et al., 2014). Moreover, BRD4 and NSD3 localization was biased towards the 
promoter of cyclin D1 (CCND1) and decapping enzyme scavenger (DCPS) in 
HeLa cells, while in the pim-2 oncogene (PIM2) was more enriched in the 
coding region (Rahman et al., 2011). 
Previous publications and ours suggest that Nsd3 can localize to either 
promoter or intragenic regions and thereby could influence initiation and 
elongation processes, possibly through H3K36 methylation. This flexibility is 
probably due to the fact that Nsd3 interacts with multiple and distinct protein 
complexes. 
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5.3. Setd2, Nsd1, and Nsd3 target genes 
H3K36 methylation plays an important role in several biological processes, 
including transcription and DNA repair. ChIP-seq of Setd2, Nsd1, and Nsd3 
revealed that their target genes are mostly involved with cell cycle and 
transcription regulation. In addition to the fact that Nsd3 was the only H3K36 
methyltransferase physically associated with multiple chromatin modifiers and 
readers, it appears that Nsd3 might also regulate several genes related to 
chromatin organization and modification. 
KEGG enrichment analysis revealed that cancer was the most significant 
pathway targeted by Setd2, Nsd1, and Nsd3. Indeed, defects in each member 
of the NSD family have been implicated in multiple cancer types (Morishita and 
di Luccio, 2011), and SETD2 has been hypothesized to be a tumor suppressor 
(Newbold and Mokbel, 2010; Zhu et al., 2014). 
Nsd1 second most significant enriched pathway was the mitogen activated 
protein kinase (MAPK) signaling. MAP kinases regulate numerous cellular 
processes including cell growth, stress response, apoptosis, and differentiation. 
Studies have shown that phosphorylation of transcription factors by MAPKs 
triggers the recruitment of transcriptional machinery, such as RNAPII, chromatin 
remodeling complexes, histone acetyltransferase complexes, and histone 
deacetylases to target genes (Suganuma and Workman, 2011). Genome-wide 
mRNA expression profiles of dermal fibroblasts from Sotos syndrome patients 
with a confirmed NSD1 abnormality showed a diminished activity state of the 
MAPK/extracellular signal-regulated kinase (ERK) pathway (Visser et al., 2012). 
Moreover, ZFX depletion inhibited gastric cancer cell growth in vitro and in vivo 
via downregulation of the extracellular MAPK/ERK pathway (Wu et al., 2013a). 
Therefore, Nsd1 might directly regulate the activation status of MAPK related 
genes by contributing to transcription initiation at their promoter regions. 
H3K27me3 loading is thought to impede subsequent deposition of H3K36me3, 
given the non-compatibility of both modifications to co-exist on the same 
histone tail (Schmitges et al., 2011; Voigt et al., 2012). Similarly, H3K36me3 
inhibits PRC2 activity (Schmitges et al., 2011; Yuan et al., 2011) and may serve 
to exclude PRC2 from active genes. Nevertheless, ChIP and sequential re-ChIP 
analyses showed the coexistence of H3K36me3 and H3K27me3 at bivalent 
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promoters, such as Otx2, Meis1, Hoxa5, and Fgf15, in mouse ESCs and ESC-
like embryonic carcinoma cell line F9 (Cai et al., 2013). Detection of such 
H3K27me3-H3K36me3 feature matches recent genomic studies at multivalent 
development genes in zebrafish sperm cells (Wu et al., 2011) as well as a 
proteomic study detecting a small percentage of H3 containing both H3K27 and 
H3K36 methylation in mammalian cells (Voigt et al., 2012). Conversely, our 
ChIP-seq analysis did not show H3K36me3 deposition at the bivalent genes 
mentioned above (data not shown). Nevertheless, the Nsd1-Zfx complex and 
Setd2 occupied bivalent promoters. Though, Setd2 was observed at lower 
levels and in a smaller subset of bivalent genes. Since we did not observe 
H3K36me3 at bivalent genes, we hypothesized that some H3K36 
methyltransferases such as Nsd1 might be paused at bivalent promoters, and 
they would only methylate histones after removal of the H3K27me3 mark upon 
differentiation. This is in agreement with one previous report (Miyazaki et al., 
2013), in which H3K36 methylation mediated by Ash1l was shown to counteract 
Polycomb silencing and promote Hox genes activation during ESCs 
differentiation. 
 
5.4. Nsd1 functional characterization 
Nsd1 contains several PHD and PWWP motifs, which might be important for its 
biological function. Our data suggested that deletion of the PHD5/C5HCH 
domains abolished Zfx protein interaction and significantly decreased Nsd1 
recruitment to chromatin in a subset of target genes. Specifically, the cysteine-
rich C5HCH domain of Nsd1 had also been reported to be the protein-protein 
interface for Zkscan17 interaction in mouse N2A neuroblastoma cells (Nielsen 
et al., 2004). Moreover, 8 of 9 mutations in NSD1’s PHD4 and C5HCH domains 
severely compromised binding to ZKSCAN17 (Pasillas et al., 2011). 
In agreement with the importance of the PHD5/C5HCH motifs, Zfx knockdown 
decreased Nsd1 binding at the Oct4 and Tcl1 promoter regions. Our results 
suggest Zfx might be an adapter protein that facilitates the recruitment of Nsd1 
to its target loci and, thus, might be necessary for Nsd1 proper function in 
mouse ESCs. Indeed, it has been reported that the PHD5/C5HCH is the sole 
region required for tight binding of the NUP98-NSD1 fusion protein to the 
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HoxA9 gene promoter (Wang et al., 2007). In contrast, the PHD5/C5HCH 
domains of NSD2 had no impact on histone methylation and recruitment to the 
DNA in t(4;14)+ multiple myeloma cells (Huang et al., 2013), though its loss 
impaired clonogenic growth. 
In addition to the chromatin-targeting ability of PHD5/C5HCH, deletion of the 
PHD1-4 domains also showed reduced Nsd1 loading at the Oct4 and Tcl1 
promoter regions. Studies on NSD2 reported a role for the PHD2 domain in 
NSD2 recruitment to oncogenic gene loci and H3K36me2 activity (Huang et al., 
2013). Moreover, it has been shown that 11 of 12 NSD1 mutations in the PHD4 
and PHD5/C5HCH domains disrupted the binding to methylated H3K4 and 
H3K9 (Pasillas et al., 2011). By interacting with various stages of H3K4 and 
H3K9 methylation, Nsd1 could recognize genes that are in stages of 
transcriptional activation or repression, respectively. Thereafter, Nsd1 cofactors, 
such as Zfx, and/or H3K36 methylation would ultimately lead to either enhanced 
activation or repression mechanisms. 
None of the deleted PHD and PWWP domains of Nsd1 affected its nuclear 
localization. In contrast, truncation of the PHD2 and PHD3 of NSD2 caused its 
localization into the cytoplasm (Huang et al., 2013). Furthermore, loss of the 
chromatin reader domains PHD1-4 and PWWP2 impaired Nsd1 chromatin 
binding over cell cycle progression. This suggests that Nsd1 might play a role in 
cell cycle regulation and it depends on the recruitment of Nsd1 to methylated 
histones, such as H3K4, H3K9, and H3K36. 
Nsd1 had been implicated with H3K36 mono- and dimethylase activity (Li et al., 
2009b; Lucio-Eterovic et al., 2010; Qiao et al., 2011). This matches our results 
in which Nsd1 knockdown led to decreased dimethylation of H3K36 in bulk 
histones and trimethylation of H3K36 at the coding regions of Oct4, Rif1, Brd2, 
and Ccnd1. In addition, Nsd1 depletion increased Zfx deposition at several 
promoter regions. Overall, an attractive hypothesis is that methylated histones 
and Zfx recruit Nsd1 to its target loci, whereas Nsd1 regulates Zfx chromatin 
release and further contributes to transcription regulation through its H3K36 
dimethylase activity. 
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5.5. Nsd3 chromatin reader domains 
As observed for Nsd1, deletion of the PWWP and PHD5/C5HCH domains did 
not disturb Nsd3 nuclear protein localization. On the other hand, loss of these 
domains compromised Nsd3 loading at promoter regions of a subset of target 
genes. The PHD5/C5HCH motifs of NSD3 seem to recognize unmodified H3K4 
and trimethylated H3K9 (He et al., 2013a). Herein, we showed that Nsd3 
interacts with the H3K4 demethylase Kdm1b. A plausible model is that Kdm1b 
would first mediate methylated H3K4 demethylation, thereafter, producing a 
histone modification pattern recognized by the PHD5/C5HCH of Nsd3, which 
guides Nsd3 to chromatin followed by H3K36 methylation. Another protein 
partner that would methylate H3K9 was not detected. Although, G9a (H3K9 
methyltransferase) was found to interact with NSD3 in HeLa cells (Fang et al., 
2010). 
Loss of the PWWP1 domain caused the most drastic effects on Nsd3 loading to 
chromatin. Originally identified in Nsd2, PWWP domains bind H3K36me3 to act 
as reader proteins (Vezzoli et al., 2010). Since Nsd3 cannot further methylate 
H3K36me3, it is more likely that Nsd3 could also work as an adapter that 
carries other protein partners to genes marked with H3K36me3, and these 
proteins would ultimately either enforce or reverse the current gene transcription 
status. Further investigation on how these domains affect Nsd3 protein 
interactions with Kdm1b and Brd4 is still ongoing. 
 
5.6. Role of Kdm1b and Brd4 in regulating Nsd3 and H3K36 methylation 
To gain insights into how Nsd3-mediated H3K36 methylation is regulated, we 
performed knockdown and knockout of Nsd3 protein partners Kdm1b and Brd4, 
respectively. Both Kdm1b and Brd4 did not affect H3K36 methylation in bulk 
histones and expression of Nsd3 isoforms 1 and 2. Interestingly, ChIP-seq 
analysis showed that Nsd3 loading was strongly reduced in Brd4 knockout 
cells, though H3K36me3 levels were unchanged. This indicates that Brd4 is 
important for Nsd3 recruitment to its target genes in mouse ESCs. We expected 
to observe some changes at the H3K36me3 levels in Brd4 knockout cells, since 
Nsd3 was poorly binding to chromatin. A previous study reported that NSD3 is 
recruited to BRD4 target genes in a BRD4-dependent manner, whereas 
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knockdown of either NSD3 or BRD4 led to reduction in H3K36me3 deposition 
(Rahman et al., 2011). Overall, this result suggests that the Nsd proteins might 
have some functional redundancy, in which Nsd1 or Nsd2 could compensate for 
the H3K36 methylation status after loss of Nsd3. 
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6. Summary 
 
The epigenetic status of chromatin influences DNA-based biological processes 
and plays a crucial role during embryogenesis and cell lineage commitment. 
H3K36 methylation has been implicated in multiple biological processes that 
regulate the transcriptional network and the genome integrity. 
The mammalian genome harbors at least eight enzymes that have been 
described to methylate H3K36 in vitro and/or in vivo: Setd2, Nsd1-3, Ash1l, 
Smyd2, Setmar, and Setd3. Multiple lines of evidence suggest these enzymes 
exhibit distinct and non-redundant functions (Wagner and Carpenter, 2012). So 
far, great efforts have been made to understand the substrate specificities of 
these enzymes, thus more functional studies are needed to unravel their 
relevance and regulatory network. 
In the present study, by using proteomic and regulomic data we aimed to better 
understand the complex mechanisms underlying H3K36 methylation in mouse 
embryonic stem cells (ESCs). Particularly, Setd2, Nsd1, and Nsd3 were the 
main focus of this thesis work, chosen on the basis of their expression level in 
mouse ESCs and their experimental performance. 
Proteomic data demonstrated that Setd2, Nsd1, and Nsd3 do not associate in 
the same protein complexes. Setd2 was associated with several RNAPII 
subunits and two transcription elongation factors (Supt5 and Supt6). Moreover, 
we provided supporting evidence by ChIP-seq that Supt6 and Setd2 travel with 
the elongating RNA polymerase II. A model was previously described where 
Supt6 is responsible for reassembly of nucleosomes displaced by promoter-
bound activators and Setd2 mediates de novo deposition of the H3K36me3 
mark as the polymerase elongates (Li et al., 2007). 
Here, we identified and characterized a novel Nsd1 protein partner, the Zinc 
finger X-chromosomal protein (Zfx). Interestingly, Nsd1 and Zfx showed similar 
properties. They both exhibited an association to chromatin during cell division. 
They also demonstrated high enrichment in the vicinity of transcription start 
sites of most active genes. Based on knockdown experiments, our findings 
suggest Zfx recruits Nsd1 to its target loci, whereas Nsd1 regulates Zfx 
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chromatin release and further contributes to transcription regulation through its 
H3K36 dimethylase activity. In addition, genome-wide mapping showed that 
Nsd1-Zfx binds to bivalent promoters, which encode lineage-specific 
developmental regulators that exhibit both the active H3K4me3 and the 
repressive H3K27me3 marks in mouse ESCs. 
Nsd3 was associated with multiple protein complexes, such as Kdm1b and 
Brd4 complexes. ChIP-seq results showed that Nsd3 preferentially localizes at 
the 5’ and 3’ gene regions. Nsd3 exhibited a more specific set of target genes 
than Setd2 and Nsd1. A subset of these target genes were particularly enriched 
for chromatin organization and modification processes. Additionally, we showed 
that Nsd3 is recruited to its target genes in a Brd4-dependent manner. 
Aside from the well characterized catalytic SET domain, Nsd proteins have 
multiple potential chromatin-binding motifs including the PWWP and zinger-
finger like domains (PHD and C5HCH). Herein, we showed that loss of either 
PHD1-4 or PHD5/C5HCH domains reduced Nsd1 recruitment to DNA. 
Moreover, the PHD5/C5HCH domains are crucial for Nsd1-Zfx interaction. On 
the other hand, loss of either PWWP or PHD5/C5HCH domains reduced Nsd3 
recruitment to DNA, particularly the PWWP1 domain. 
In conclusion, we provided further insights on how H3K36 methyltransferases 
are regulated, and how they contribute to changes in the epigenetic landscape 
in mouse embryonic stem cells. 
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